DownloadHi-Res Photo

Eric Velazquez, MD

Robert W. Berliner Professor of Medicine (Cardiology); Chief, Cardiovascular Medicine; Chief, Cardiovascular Medicine, Yale New Haven Hospital; Physician-in-Chief, Heart and Vascular Center, Yale New Haven Health System; Deputy Director, Clinical Trials Innovation, Yale Center for Clinical Investigation (YCCI); Co-Chair, Clinical and Translational Research Oversight Committee; President’s contingency planning committee, Clinical Practice/Clinical Research Subcommittee

Research & Publications
Biography
News

Research Summary

Dr. Velazquez has authored more than 250 peer-reviewed publications, chaired the American Society of Echocardiography's Taskforce on International Echocardiography, and is an associate editor for Circulation Cardiovascular Imaging. He is a fellow of the American College of Cardiology, American College of Physicians, American Society of Echocardiography, and American Heart Association. In 2014, he was elected to the American Society of Clinical Investigation.

Coauthors

Selected Publications

Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart FailureKrim S, Anand S, Greene S, Chen A, Wojdyla D, Vilaro J, Haught H, Herre J, Eisenstein E, Anstrom K, Pitt B, Velazquez E, Mentz R. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure. JAMA Cardiology 2024, 9: 182-188. PMID: 37955908, PMCID: PMC10644243, DOI: 10.1001/jamacardio.2023.4776.
Variation in Reader-Reported Severity of Paradoxical Low-Flow Low-Gradient Aortic StenosisShah N, Sugeng L, Zhang Z, Wang K, McNamara R, Agarwal V, Hur D, Lombo B, Bellumkonda L, Mankbadi M, Basem Dajani A, Forrest J, Krumholz H, Reinhardt S, Velazquez E, Faridi K. Variation in Reader-Reported Severity of Paradoxical Low-Flow Low-Gradient Aortic Stenosis. Journal Of The American Society Of Echocardiography 2023 PMID: 37995937, DOI: 10.1016/j.echo.2023.11.014.
Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trialGhazi L, Yamamoto Y, Fuery M, O'Connor K, Sen S, Samsky M, Riello R, Dhar R, Huang J, Olufade T, McDermott J, Inzucchi S, Velazquez E, Wilson F, Desai N, Ahmad T. Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial. European Heart Journal 2023, 44: 4233-4242. PMID: 37650264, DOI: 10.1093/eurheartj/ehad512.
Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic ImagesSangha V, Nargesi A, Dhingra L, Khunte A, Mortazavi B, Ribeiro A, Banina E, Adeola O, Garg N, Brandt C, Miller E, Ribeiro A, Velazquez E, Giatti L, Barreto S, Foppa M, Yuan N, Ouyang D, Krumholz H, Khera R. Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images. Circulation 2023, 148: 765-777. PMID: 37489538, DOI: 10.1161/circulationaha.122.062646.
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical TrialGreene S, Velazquez E, Anstrom K, Clare R, DeWald T, Psotka M, Ambrosy A, Stevens G, Rommel J, Alexy T, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Eisenstein E, Mentz R, Investigators O. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. Circulation 2023, 148: 124-134. PMID: 37212600, PMCID: PMC10524905, DOI: 10.1161/circulationaha.123.064842.
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart FailureMentz R, Ward J, Hernandez A, Lepage S, Morrow D, Sarwat S, Sharma K, Starling R, Velazquez E, Williamson K, Desai A, Zieroth S, Solomon S, Braunwald E, Investigators P. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure. Journal Of The American College Of Cardiology 2023, 82: 1-12. PMID: 37212758, DOI: 10.1016/j.jacc.2023.04.019.
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HFVaduganathan M, Mentz R, Claggett B, Miao Z, Kulac I, Ward J, Hernandez A, Morrow D, Starling R, Velazquez E, Williamson K, Desai A, Zieroth S, Lefkowitz M, McMurray J, Braunwald E, Solomon S. Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF. European Heart Journal 2023, 44: 2982-2993. PMID: 37210743, PMCID: PMC10424880, DOI: 10.1093/eurheartj/ehad344.
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure—ReplyMentz R, DeWald T, Velazquez E. Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure—Reply. JAMA 2023, 329: 1704-1704. PMID: 37191705, DOI: 10.1001/jama.2023.5291.
Cardiology Encounters for Underrepresented Racial and Ethnic Groups with Human Immunodeficiency Virus and Borderline Cardiovascular Disease RiskBloomfield G, Hill C, Chiswell K, Cooper L, Gray S, Longenecker C, Louzao D, Marsolo K, Meissner E, Morse C, Muiruri C, Thomas K, Velazquez E, Vicini J, Pettit A, Sanders G, Okeke N. Cardiology Encounters for Underrepresented Racial and Ethnic Groups with Human Immunodeficiency Virus and Borderline Cardiovascular Disease Risk. Journal Of Racial And Ethnic Health Disparities 2023, 1-11. PMID: 37160576, PMCID: PMC10632543, DOI: 10.1007/s40615-023-01627-0.
MECHANISTIC EVALUATION OF AN AI-DRIVEN CLINICAL DECISION SUPPORT TOOL TO PERSONALIZE THE USE OF ANATOMICAL TESTING IN SUSPECTED CORONARY ARTERY DISEASEOikonomou E, Suchard M, Miller E, Velazquez E, Khera R. MECHANISTIC EVALUATION OF AN AI-DRIVEN CLINICAL DECISION SUPPORT TOOL TO PERSONALIZE THE USE OF ANATOMICAL TESTING IN SUSPECTED CORONARY ARTERY DISEASE. Journal Of The American College Of Cardiology 2023, 81: 1360. DOI: 10.1016/s0735-1097(23)01804-1.
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure EventMentz R, Ward J, Hernandez A, Lepage S, Morrow D, Sarwat S, Sharma K, Solomon S, Starling R, Velazquez E, Williamson K, Zieroth S, Braunwald E. Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event. Journal Of Cardiac Failure 2023, 29: 922-930. PMID: 36796671, DOI: 10.1016/j.cardfail.2023.02.001.
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart FailureMentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.
Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trialGhazi L, O'Connor K, Yamamoto Y, Fuery M, Sen S, Samsky M, Riello R, Huang J, Olufade T, McDermott J, Inzucchi S, Velazquez E, Wilson F, Desai N, Ahmad T. Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial. American Heart Journal 2022, 257: 111-119. PMID: 36493842, DOI: 10.1016/j.ahj.2022.12.002.
Abstract 11232: Coronary Artery Bypass Graft Surgery Shows Improved Restricted Mean Survival Time and Time Lost Compared to Medical Therapy in Patients With Left Ventricular Dysfunction: From the STICH TrialReinhardt S, Huang H, Parise H, Ahmad T, Velazquez E, Faridi K. Abstract 11232: Coronary Artery Bypass Graft Surgery Shows Improved Restricted Mean Survival Time and Time Lost Compared to Medical Therapy in Patients With Left Ventricular Dysfunction: From the STICH Trial. Circulation 2022, 146: a11232-a11232. DOI: 10.1161/circ.146.suppl_1.11232.
Abstract 14057: Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic ImagesSangha V, Nargesi A, Dhingra L, Mortazavi B, Ribeiro A, Banina E, Brandt C, Miller E, Ribeiro A, Velazquez E, Krumholz H, Khera R. Abstract 14057: Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images. Circulation 2022, 146: a14057-a14057. DOI: 10.1161/circ.146.suppl_1.14057.
Abstract 10253: Integrating Mental Health Screening Into a Health System for Measurement-Based Care of Patients With Peripheral Artery DiseaseScierka L, Mena-Hurtado C, Romain G, Provance J, Bradley B, Lynch S, Bascombe A, Siddiqui W, Rahman M, Bogra P, van Roij E, Nagpal S, Lorusso F, Velazquez E, Churchwell K, Smolderen K. Abstract 10253: Integrating Mental Health Screening Into a Health System for Measurement-Based Care of Patients With Peripheral Artery Disease. Circulation 2022, 146: a10253-a10253. DOI: 10.1161/circ.146.suppl_1.10253.
Abstract 14375: Guideline Directed Medical Therapy After Peripheral Vascular Intervention and Association With Long-Term Outcomes at an Academic Health SystemHu J, Smolderen K, Provance J, Romain G, Baumbach A, Velazquez E, Lorusso F, Churchwell K, Schulz W, Scierka L, Mena-Hurtado C. Abstract 14375: Guideline Directed Medical Therapy After Peripheral Vascular Intervention and Association With Long-Term Outcomes at an Academic Health System. Circulation 2022, 146: a14375-a14375. DOI: 10.1161/circ.146.suppl_1.14375.
Abstract 12311: The Impact of Ejection Fraction on Major Adverse Limb Events After Lower Extremity RevascularizationJamil Y, Huttler J, Alameddine D, Zhuo H, Mena-Hurtado C, Velazquez E, Guzman R, Chaar C. Abstract 12311: The Impact of Ejection Fraction on Major Adverse Limb Events After Lower Extremity Revascularization. Circulation 2022, 146: a12311-a12311. DOI: 10.1161/circ.146.suppl_1.12311.
Abstract 13818: Health System Integrated Measurement-Based Care Using Patient-Reported Outcomes Assessment in Lower-Extremity Peripheral Artery DiseaseSmolderen K, Scierka L, Rahman M, van Roij E, Bradley B, Nagpal S, Spertus J, Bascombe A, Siddiqui W, Provance J, Romain G, Lynch S, Bogra P, Velazquez E, Churchwell K, Lorusso F, Mena-Hurtado C. Abstract 13818: Health System Integrated Measurement-Based Care Using Patient-Reported Outcomes Assessment in Lower-Extremity Peripheral Artery Disease. Circulation 2022, 146: a13818-a13818. DOI: 10.1161/circ.146.suppl_1.13818.
Association Between Depressive Symptoms and Cardiac Structure and Function in a Peruvian PopulationSantiago C, Peña M, Brown T, Shakil S, Januzzi J, Velazquez E, Miranda J, Rivera D, Checkley W. Association Between Depressive Symptoms and Cardiac Structure and Function in a Peruvian Population. Global Heart 2022, 17: 78. PMID: 36382157, PMCID: PMC9615600, DOI: 10.5334/gh.981.
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk PatientsVan Mieghem N, Deeb G, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen P, Heiser J, Merhi W, Kleiman N, Chetcuti S, Gleason T, Lee J, Cheng W, Makkar R, Crestanello J, George B, George I, Kodali S, Yakubov S, Serruys P, Lange R, Piazza N, Williams M, Oh J, Adams D, Li S, Reardon M, Gitter C, Meyer K, Roberts D, Bae R, Sorajja P, Sun B, Askew J, Eales F, Flavin T, Goessl M, Kshettry V, Mooney M, Pedersen W, Poulose A, Roohani P, Saeid Farivar R, Shronts R, Tarrel R, Young M, Butkus E, Pendleton K, Fry R, Heine C, La Roe K, Tran T, Weig L, Agarwal H, Langdon T, Satpathy R, Batter J, Bremer K, Indukuri U, Baas M, Oomes-Sistermans C, Smits M, Coenen C, Driesen I, Lauryssen L, Poorter M, Schaap J, Bentala M, den Heijer P, Pieter J, Remmers M, Story M, van Erven P, Verbiest H, Vos J, Bennett M, Dunaj W, Seaton D, Waller D, Khandheria B, Bajwa T, O'Hair D, Ahmed A, Allaqaband S, Gheith A, Marriott E, Qhavi A, Saxena V, Shhadeh A, Werner P, Yeomans C, Bessette L, Byrne J, Kieckhefer H, Munoz M, Russo E, Klein J, Morgan M, Byrne T, Caskey M, Amabile O, Brady K, Chung S, Dacanay K, Fang H, Franz D, Kelly C, Loli A, Payne J, Pershad A, Wang N, Lott J, Pool-Owens C, Porter C, Hennan J, Garrett H, Paulus B, Craig J, Elijovich L, Samaha J, Wolf B, Wright L, Zoghbi G, Willcott L, Roberts B, Hebeler R, Stoler R, Graybeal D, Grayburn P, Henry C, Mir O, Vallabhan R, Fanous M, Kaufman J, Chang J, Manning W, Riley M, Khabbaz K, Laham R, Popma J, Burke D, Caplan L, Chui S, Guibone K, Kumar S, Lioutas V, Liu D, Nathan S, Pinto D, Searls D, Fisher S, Guirgues L, Henderson S, Loving L, McWalters N, Patterson K, Burkart J, Carcedo B, Stacey R, Bladergroen M, Lim D, Edmonson S, Epps S, Katz M, Ng K, Sangha A, Aucoin J, Roberts M, Aubin J, Hotard C, Tassin M, Fail P, Feinberg E, Netherland D, Abben R, Allam M, Bates M, Dearman R, Gervais D, Haight E, Metes M, Naquin J, Tedesco V, Thibodeaux L, Thompson K, Aberle S, Amaro D, Grey W, Rose G, Scherer M, Rinaldi M, Skipper E, Bridges C, Downey W, Iyengar P, Martin J, Ryan L, Stiegel R, Story J, Alsabaawi K, Gheorghiu M, Singh C, Yashar J, Siegel R, Cheng W, Makkar R, Altman K, Jilaihawi H, Kar S, Khouw S, Mody C, Ramzy D, Salseth T, Stegic J, Trento A, Lazarte R, Sohn J, Hahn R, Khalique O, George I, Kodali S, Williams M, Gonzalez Castellon M, Gutierrez Contreras J, Kitago T, Kummer B, Lekic T, Miller E, Naka Y, Nazif T, Qureshi A, Rostanski S, Smith C, Willey J, Yaghi S, Abreu L, Clement E, Sabir S, Aji J, Bowen F, Kaddissi G, Mirsen T, Muntazar M, Ogbara J, Rosenbloom M, Schell W, Then R, Carl H, Huang H, Kreydi G, Wolak H, Sandidge G, Ali O, Asfaw Z, Henry S, Kafi A, Schreiber T, Andaya L, Baciewicz F, Bassett J, Choksi N, Kassas S, Munir A, Kothmeier F, Stroh A, Goppel G, Hettich I, Bleiziffer S, Hengstenberg C, Opitz A, Ruge H, Badiu C, Brenner S, Ehlmidi Y, Herold U, Kasel A, Kreuzpointner R, Lange R, Mazzitelli D, Poppert H, Seifert C, Vincze D, Voss B, Camuglia K, Cowhig D, Newbold S, Pierce C, Wootton S, Vemulapalli S, Velazquez E, Harrison J, Hughes G, Ali Y, Babi A, Banks A, Gaca J, Glower D, Gokhale S, Halim S, Hendry R, Hernandez C, Kiefer T, Klein M, Kolls B, Marrotte E, Pineda Maldonado A, Price A, Sherwood M, Swisher C, Van Wyck D, Vavalle J, Vora A, Wang A, Zeylikman Y, Amber K, Barnitt A, Lamm J, Mandelstam L, Schroeder R, Sumner R, Nair D, De A, Gaudiani V, Joye J, Brown L, Hessler C, Rammohan C, Vial C, Charles E, DeQuesada A, Kaner M, Mathewson S, Pitts K, Wheeler L, Wilson A, Davidson E, Frohwein S, Lerakis S, Merlino J, Sullivan A, Babaliaros V, Guyton R, Thourani V, Anderson A, Belagaje S, Benameur K, Devireddy C, Greene J, Harrison A, Hudson K, Leshnower B, Lieppe W, Macheers S, Mavromatis K, Miller J, Nahab F, Sanders K, Sarin E, Stewart J, Winkel D, Duininck L, Gussinklo T, Jadoenath-Oedai S, Ruiter A, van den Berg N, van der Velden-Macauley L, van Huis M, Verelst S, Geleijnse M, Vletter W, Bekker M, Kappetein A, Van Mieghem N, Bekkers J, Biesheuvel K, Birim O, Bol Raap G, Daemen J, de Jaegere P, de Lind van Wijngaarden R, Khajeh L, Kik C, Koudstaal P, Oei F, Scheele M, van de Woestijne P, van Geuns R, van Leeuwen W, Henderson A, Straight F, Schneider D, Tischler M, Dauerman H, Ittleman F, Schmoker J, Abernethy A, Alkhalil I, Azarbal A, Chava S, Commichau C, Coyle D, Denkmann J, Destephan C, Ehle G, El-Haddad M, Falduto C, Gorman M, Kadavath S, Leavitt B, Mack A, Malasana G, Moossavi S, Phuong N, Rambod M, Seecheran N, Sharma A, Terrien E, Worgan B, Zeglin-Sawczuk M, Burgess B, Killbride S, Temple A, Burnside J, Good C, Agarwal S, Casale A, Skelding K, Carter R, Cummings C, Grana V, Haegerl C, Harjai K, Holland N, Singh D, Stahl R, Stella J, Stewart B, Long D, Wood K, Alexander D, Barton S, Logtens E, Marsh A, McAdam J, Kovac J, Mariscalco G, Spyt T, Garimella S, Szostek J, Zlocha V, Kirkland L, Reid L, Reilly S, Menderhall M, Martin W, Park S, Seshiah P, Smith J, Gersch K, Hiratzka L, Kachoris J, Okum E, Cardozo M, Cyr G, Duvall W, Flynn A, Krupowies N, Parker M, Hagberg R, McKay R, Azemi T, Brown R, Fusco D, Hammond J, Hosley C, Kiernan F, Margey R, Preissler P, Sadiq I, Silverman I, Taboada S, Underhill D, Escobar J, Lopez B, Mullin S, Quesada C, Lawrence T, Naqvi T, Matthews R, Starnes V, Clavijo L, Cunningham M, Kim-Tenser M, Sanossian N, Shavelle D, DelMotte D, Henry S, Moltrassie J, Solanki A, Cooper R, Lee J, Parikh S, Wang D, Zweig B, O'Neill W, Paone G, Borgi J, Brewer R, Eng M, Greenbaum A, Guerrero M, Miller D, Mitsias P, Morgan J, Nemeh H, Alcaide Muñoz J, Medina Fernandez M, Carrasco Chinchilla F, Rodríguez Bailón I, Hernández García J, Such M, Alonso-Briales J, De La Cruz Cosme C, Dominguez-Franco A, Mataró López M, Melero J, Muñoz-Garcia A, Sanchez Espin G, Fernández Maese J, Torres M, Villa Suarez E, De La Hera J, Llosa Cortina J, Morís de la Tassa C, Avanzas Fernández P, Benavente Fernández L, Calleja S, Del Valle R, Morales Pérez C, Silva J, Bluntschli E, Keller D, Maritz S, Ruest R, Schönenberger C, Trovato M, Brugger N, Göber V, Kurmann R, Reineke S, Zürcher F, Carrel T, Windecker S, Arnold M, Balasubramaniam R, Bellwald S, Beyeler M, Broeg A, Bühlmann M, Büllesfeld L, Capek L, Chaloulos-Lakovidis P, Corpataux N, Englberger L, Gloekler S, Goldlin M, Huber C, Khattab A, Kurmann R, Lanz J, Liesirova K, Maamari B, Mattle H, Meinel T, Panos L, Praz F, Schönhoff F, Sleszak A, Spirito A, Stortecky S, Vaisnora L, Von Martial R, Wenaweser P, Zuk K, Musso I, Allen M, Gonzales M, Horton K, Doty J, Whisenant B, Caine W, Clayson S, Harkness J, Hoesch R, Huan M, Jones K, Miner E, Reid B, Sunderman E, Citro K, Fisher M, Willhide J, Corretti M, Conte J, Mandal K, Resar J, Chacko M, Hasan R, Heil B, Marsh E, Price J, Sciortino C, Shah A, Tolentino J, Bui A, Lee M, Watanabe C, Aharonian V, Moore N, Pfeffer T, Ajani Z, Mansukhani P, Sangha N, Yun K, Hylander S, Bäck M, Corbascio M, Hillebrant C, Rück A, De Palma R, Feldt K, Kostulas K, Settergren M, Yamasaki K, Anderson M, Bloomfield C, Burtonwood N, Harland C, Somers K, Ware T, Deakin S, Geldard S, Schlosshan D, Blackman D, Kaul P, Evans B, Javangula K, Limaye S, Malkin C, Wanklyn P, Farhi A, Manapat A, Maranan L, Mihelis E, Ng A, Ricketts M, Kronzon I, Perk G, Brinster D, Kliger C, Azhar S, Bonomo R, Dharva R, Fontana G, Mandel S, Mehla P, Patel N, Plestis K, Fox S, Mardell S, Novick T, Sandie K, de Jonge W, McLeod C, Mroz L, Weigand A, Chu M, Kiaii B, Teefy P, Bagur R, Debicki D, Diamantouros P, Gofton T, Mandzia J, McKenzie F, Mirsattari S, Valdis M, Young B, Klein W, Sawicki K, Dajani K, Darki A, Bakhos M, Leya F, Biller J, Lewis B, Morales-Vidal S, Schneck M, Schwartz J, Tuchek J, Biddle A, Ernst D, Haubenschild J, Howe-Clayton D, Johnson R, Mundt P, Reiter J, Bruce C, Freeman W, Kutzke K, Maalouf J, Nkomo V, Pislaru S, Sinak L, Pochettino A, Sandhu G, Alkhouli M, Best P, Bresnahan J, Eleid M, Fulgham J, Greason K, Gulati R, Holmes D, Maor E, Mathew V, Meissner I, Panaich S, Peterson A, Radford J, Raphael C, Reeder G, Sanon S, Sarraf M, Scharf E, Suri R, Swenson C, Williams L, Jiang Z, Lapierre S, Phan T, Buithieu J, de Varennes B, Piazza N, Lachapelle K, Liam D, Martucci G, Blömer H, Herder W, Van der Geest E, van der Wal M, Izaksson R, Kootstra H, Pultrum M, Walinga T, Boonstra P, van Boven A, Amrane H, Hofma S, Schuiling W, Terluin H, Timmerman M, van der Weerdt A, van Rooij F, Vossenberg T, Barnes C, Griffin S, Goldstein S, Marcus R, Wang Z, Widell J, Bafi A, Waksman R, Choi J, Corso P, Laureno R, Lin M, Lowery R, Malla P, Pichard A, Satler L, Shults C, Decklever C, Evans D, Tuttle K, Klein M, Marcus R, Chawla A, Hockmuth D, Jacoby M, Jenson B, McAllister D, Prabhakar G, Verhofste M, Morin C, Potvin L, St. Jean N, Garceau P, Asgar A, Cartier R, Bonan R, Dominquez M, Dorval J, Ibrahim R, Lavoie M, Benner A, Brunetti D, Ciprich C, Lobur E, Lonergan N, McGlew S, Oplinger J, Oster T, Polise L, Purpura J, Sentman S, Van Zile C, Arogundade O, Gillan L, Koulogiannis K, Brown J, Kipperman R, Blitz L, Cohen B, English K, Genereux P, Magovern C, Rosenberg R, Safirstein J, Slater J, Turner J, Xydas S, Jones T, Montgomery S, Barry M, Kovach T, Navas J, Patel V, Lin L, Rovin J, Arora A, Ofenloch J, Schneider J, Spriggs D, Stone L, Turner N, Basnet S, Bhat A, Fusilero M, Muthiki S, Muthyala S, Saint Vrestil N, Sharma M, Singh J, Chaudhry F, Sengupta P, Adams D, Sharma S, Tang G, Anyanwu A, Bronster D, Dangas G, Kini A, Stelzer P, Stewart A, Swain J, Annunziato S, Chan G, Delliliune D, Garzon R, Seeratan V, Rosman D, Suma V, Trost B, Hartman A, Katz S, Rutkin B, Boutis L, Carey R, DeAngelis T, DeOrchis V, Esposito R, Han M, Jauhar R, Kaplan B, Laighold S, Meraj P, Palazzo R, Parihar R, Podwall D, Wright P, Yu P, Abu M, Bavbekova S, Bowden M, Clark E, Gaudio S, Houanche P, Kalish C, Kapitman A, Lee H, Morales V, Oviedo F, Pushkar I, Robin T, Shaheen D, Sin D, Taylor Z, Tovar J, Van Daele J, Vidal S, Yung L, Saric M, Galloway A, Jilaihawi H, Attubato M, Fara M, Grossi E, Ischida K, Loulmet D, Siller K, Staniloae C, Torres J, Zhang C, Hartlev C, Huffman A, Jones D, Kellum A, Liptrot R, Orsinelli D, Ryan J, Ryan T, Crestanello J, George B, Lilly S, Rushing G, Grose N, Kilic A, Lee V, Mazzaferri E, Mutgi S, O'Neil S, Perchuk A, Sai-Sudhakar C, Slivka A, Cheatham J, Hanes S, Banowetz M, Dautenhahn D, Mehl B, Bodenhamer R, Ghani M, Raikar G, Randolph J, Tahirkheli N, Wasemiller W, Williams J, Amoroso E, Holt S, Tucker C, Martin R, Kauten J, Rajagopal V, Awad E, Brown W, Dean D, Gott J, Karmpaliotis D, Meduri C, Polsani V, Rinehart S, Russell C, Seiden L, Serbanescu A, Vannan M, Butler K, Elsessor K, Fehr B, Hancock A, Hollister R, MacFarlane D, Rodgers C, Todd A, Eubanks V, Spangler J, Wirt K, Wonders B, Bachinsky W, Gada H, Maini B, Mumtaz M, Aneja P, Loran D, Shah J, Gebhardt L, Jones U, Lauterborn M, John H, Parthier S, Schaprian K, Twelker K, Nickenig G, Welz A, Bode F, Fuchs A, Grube E, Mellert F, Petzold G, Sedaghat A, Sinning J, Vasa-Nicotera M, Werner N, Bang H, Brodersen B, Christensen P, Eriksen E, Groth S, Jensen Larsen M, Johansen M, Kristensen L, Lilleør T, Lund Larsen L, Preis A, Rieck-Broberg J, Rosenberg T, Ihlemann N, Møller J, Noerager B, Olsen P, Søndergaard L, Steinbrüchel D, Andersen H, Arendrup H, Bieliauskas G, Carranza C, De Backer O, Franzen O, Hansen K, Højgaard J, Holme S, Kjøeller M, Lund J, Perko M, Sander K, Smerup M, Thiis J, Thyregod H, Monnin K, Popelas L, Slyman M, Grewal K, Matros T, Richards D, Watson D, Yakubov S, Arshi A, Blossom G, Chapekis A, Duff S, Hicks W, Holland S, Kander N, Lyons J, Mejilla J, Reese B, Sanchez C, Vora N, Erwin S, Hall J, Hayes N, King D, Miller M, Main M, Allen K, Chhatriwalla A, Aggarwal S, Borkon M, Boutwell C, Cohen D, Davis J, Grantham A, Magalski A, Olds K, Buchanan T, Daniel M, Estrada K, Hollen M, Jensen A, Kennen J, Bechis M, Hu S, Rubenson D, Teirstein P, Tyner J, Ahmad D, Atri P, Azarbal F, Brewster S, Brown C, Foley T, Groves E, Hanna N, Kalafut M, Levisman J, Mellinger D, Odunukan O, Ong D, Oyama J, Panguluri P, Patel A, Raney A, Rao S, Schultz J, Sharma A, Stinis C, Thompson C, Wadia S, Walsh J, White J, Purrington E, Zulick C, Murillo J, Mahoney P, Newton J, Rich J, Bagameri G, Cohen D, Dimeling G, Jordan G, Mistry N, Philpott J, Sirak J, Sourbeer S, Talreja D, Zweifler R, Helm E, Postema K, Van Over E, Chilton D, Mitchell L, Heiser J, Merhi W, Berkompas D, Fanning J, Khan M, Leung Wai Sang S, Omran K, Patzelt L, Rai V, Thoits T, Vijayappa M, Kasle M, Trautman L, Dash R, Liang D, Fischbein M, Miller C, Yeung A, Fearon W, George P, Speight M, Tai W, Albersen I, Bras R, Feirabend C, Helwig-Vernooij J, Kranen G, Oostveen M, Rost I, van Deutekom I, van Weelden A, Heijmen R, ten Berg J, Bosschaert M, de Kroon T, Hilkens P, Mast E, Rensing B, Schonewille W, van den Akker A, Haag E, Jennings J, Krug P, Santiago L, Seth S, Dimsuyu N, Mihalatos D, Petrossian G, Robinson N, Bercow N, Berke A, Deutsch E, Stevens P, Brown S, Dos Santos Jardim V, Radford N, Sookhoo V, Kyereme K, Punzalan R, Reynolds R, Sculeany B, Sharma R, Stuart A, Brecker S, Jahangiri M, Alassa A, Chandrasekaran V, Clarke B, Dowling C, Moynihan B, Roy D, Sarsam M, Bess R, Henkel M, Herbert N, Cohen G, Batra S, Davis T, Aboukasm A, Cullis P, LaLonde T, Martin J, Yamasaki H, Burkert M, Kingma B, Wheatley J, Segar D, Heimansohn D, Hermiller J, Ball M, Elsner G, Hanan S, Moainie S, Nukes T, Reibold P, Robison R, Salerno C, Sampson A, Walts P, Wandel E, Li M, Sarker S, Ahmed S, Fremes S, Radhakrishnan S, Arbel Y, Christakis G, Cohen G, Czarnecki A, Elbaz-Greener G, Feld Y, Hopyan J, Komatsu I, McCraig K, Shuvy M, Toma J, Vincenzo B, Wheeler C, Wijeysundera H, Wolff R, Beck P, Cabral D, DaCosta C, Hudson L, Pastie M, Abrahams N, Altamar I, Buitrago M, Cassman G, Leibovici Z, Nelson A, Recchia K, Robbins G, Studor K, Bethea B, Beyer E, Evans S, Goodis C, Malek A, Mueller-Kronast N, Pan H, Pantoja C, Ramos A, Wells C, Youngblood C, Snelus P, Gopal D, Jackson K, Brown D, Ryan W, Brinkman W, Gopal A, Harrington K, Mack M, Nosnik P, Potluri S, Smith R, Szerlip M, Blaylock C, Brinegar P, Canter L, Green L, Green L, Hazen P, Jacobs A, Khan S, Ludwig S, Mata M, Moore T, Underwood C, Faza N, Little S, Nagueh S, Kleiman N, Reardon M, Albright K, Atkins M, Barker C, Bledsoe D, Chiu D, Goel S, Gray T, Imperial-Aubin D, Lin C, Moye S, Ramchandani M, Ramlawi B, Reul R, Reyes M, Scheinin S, Volpi J, White S, Wyler von Ballmoos M, Blackburn B, Wong R, Hart C, Whitacker P, Lau J, Spies C, Badawi R, Graner S, Nakamura D, Plank B, Salem R, Seto T, Valenta D, Cruz A, Gallagher L, Schuck L, Siki M, Weeks A, Fishman L, Schwarz T, Bavaria J, Herrmann H, Anwaruddin S, Desai N, Giri J, Khella S, Li R, McGarvery M, Messe S, Price R, Quinn C, Szeto W, Vallabhajosyula P, Sun Y, Wu L, Tsang W, Thavendiranathan D, Feindel C, Horlick E, Casaubon L, Cusimano R, Del Campo M, Osten M, Silver F, Höwisch-Pengel R, Lechner G, Steiger B, Allgeier M, Jander N, Beyersdorf F, Neumann F, Büttner H, Comberg T, Diab N, Gick M, Günkel L, Pingpoh C, Rothe H, Siepe M, Thoma M, Winker T, Hager C, Sänger U, Stader M, Biaggi P, Gruner C, Stämpfli S, Binder R, Corti R, Falk V, Holy E, Maisano F, Grünenfelder J, Holubec T, Maier W, Nietlispach F, Wegener S, Atkinson R, Davis A, Hall S, Mangene S, Mazzurco S, Hoit B, Musarra R, Costa M, Markowitz A, Asi K, Attizzani G, Chuang D, Elgudin Y, Garcia C, Jadhav V, Le S, Miller B, Serkin Z, Shams T, Sila C, Simon D, Bezerra H, Deo S, Anderson J, Greening K, Karson J, Page S, Shawgo T, Freeman J, Mulhern K, Nath J, Tadros P, Zorn G, Hockstad E, Lechtenberg C, Muehlebach G, Rippee M, Rosterman L, Sundararajan J, Wang Y, Wiley M, Atapattu S, Marin y Kall C, Lowery M, de Marchena E, Salerno T, Alfonso C, Carillo R, Ferreira A, Panos A, Romano J, Williams D, Bhatt S, Migda E, Oakley J, Warshal W, Wilcock S, Booher A, LaBounty T, Chetcuti S, Deeb G, Adelman E, Boyle M, Geml R, Grossman P, Guerin D, Hodges K, Kim K, Lammers D, McDermott M, Menees D, Pace R, Patel H, Prager R, Ramchandren S, Romano M, Stamper A, Wang M, Zahuranec D, Ziarkiewicz M, Charlebois C, Chilton C, Labinaz M, Ruel M, Glover C, Lam K, Masters R, Steffenhagen N, Enlow-Germovsek M, Konopka K, McGargle R, Travis M, Anderson K, Cavalcante J, Crock F, Edelman K, Katz W, Gleason T, Lee J, Sultan I, Aghaebrahim A, Al-Bayai A, Bonaccorsi C, Campbell D, Giurgiutiu D, Gulati D, Hawkes C, Henry L, Jadhav A, Kenmuir C, Klein B, Kliner D, Limaye K, Nanduri S, Navid F, Patel P, Rangaraju S, Rocha M, Schindler J, Shoirah H, Streib C, Tadi P, Tememe D, Totoraitis R, Walker G, Ziayee H, Caufield L, Yeager C, Forbes J, Schwart K, Knight P, Ling F, Benesch C, Bogachan S, Hicks G, Kelly A, Narins C, Stuver T, Adams K, Blair-Anton L, Haynes M, Watts C, Baker M, Mendes L, Ball S, Goel K, Kaiser C, Robbins M, Zhao D, Ahmad R, Crenshaw M, Fredi J, Hermann L, Hoff S, Kirshner H, Levack M, Mittal S, O'Duffy A, Petracek M, Baer J, Liang G, Nguyen S, Heidenreich P, Nguyen P, Burdon T, Giacomini J, Yong C, Buchbinder M, Fann J, Kilgore S, Mitchell R, McDaniel S, Pack A, White W, Young T, Burgess P, Pu M, Upadhya B, Applegate R, Kon N, Arnan M, Baghshomali S, Bishop L, Bradbury E, Gandhi S, Kincaid E, Lefkowitz D, Lisle B, Batteria M, Rerisi E, Stepinowski K, Senicola T, Goncalves J, Schubach S, Schwartz R, Antaky K, Christiansen C, Marzo K, Michel K, Misra A, Varghese P, Wirkowski E, Levesque L, Sugeng L, Cleman M, Forrest J, Hashim S, Mangi A, Amin H, Darr U, Dewar M, Faheem O, Geirsson A, Greer D, Kaleel A, Kaple R, Lansky A, MacGrory B, Pfau S, Schindler J, Thompson C, Youn T, Yuh D, Yun J. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients. JAMA Cardiology 2022, 7: 1000-1008. PMID: 36001335, PMCID: PMC9403849, DOI: 10.1001/jamacardio.2022.2695.
PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve OutcomesAhmad Y, Petrie M, Jolicoeur E, Madhavan M, Velazquez E, Moses J, Lansky A, Stone G. PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100020. DOI: 10.1016/j.jscai.2022.100020.
DAYS ALIVE OUT OF HOSPITAL FOR PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AND CORONARY ARTERY DISEASE TREATED WITH CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: FINDINGS FROM THE STICH TRIALFaridi K, Huang H, Parise H, Ahmad T, Mori M, Chung M, Yeh R, Velazquez E. DAYS ALIVE OUT OF HOSPITAL FOR PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AND CORONARY ARTERY DISEASE TREATED WITH CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: FINDINGS FROM THE STICH TRIAL. Journal Of The American College Of Cardiology 2022, 79: 1058. DOI: 10.1016/s0735-1097(22)02049-6.
Abstract 11543: Assessing Reporting of Low-Gradient Severe Aortic Stenosis Based on Race and Ethnicity: Observations from a Large Academic Health SystemShah N, Sugeng L, Wang K, McNamara R, Agarwal V, Hur D, Lombo B, Bellumkonda L, Forrest J, Krumholz H, Velazquez E, Faridi K. Abstract 11543: Assessing Reporting of Low-Gradient Severe Aortic Stenosis Based on Race and Ethnicity: Observations from a Large Academic Health System. Circulation 2021, 144: a11543-a11543. DOI: 10.1161/circ.144.suppl_1.11543.
Abstract 11588: Variation in Reader-Reported Severity of Paradoxical Low-Flow Low Gradient Aortic Stenosis: Observations from AaLarge Academic Health SystemShah N, Sugeng L, Wang K, McNamara R, Agarwal V, Hur D, Lombo B, Bellumkonda L, Forrest J, Krumholz H, Velazquez E, Faridi K. Abstract 11588: Variation in Reader-Reported Severity of Paradoxical Low-Flow Low Gradient Aortic Stenosis: Observations from AaLarge Academic Health System. Circulation 2021, 144: a11588-a11588. DOI: 10.1161/circ.144.suppl_1.11588.
WORSE OUTCOMES IN INDIVIDUALS WITH OBESITY UNDERGOING LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION: A LONGITUDINAL INTERMACS STUDYClark K, Guha A, Oikonomou E, Jastreboff A, Caraballo C, Weintraub N, Ahmad T, Velazquez E, Miller P, Desai N. WORSE OUTCOMES IN INDIVIDUALS WITH OBESITY UNDERGOING LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION: A LONGITUDINAL INTERMACS STUDY. Journal Of The American College Of Cardiology 2021, 77: 552. DOI: 10.1016/s0735-1097(21)01911-2.
MY BLEEDING HEART: SEVERE THROMBOCYTOPENIA AND ACUTE INTRAMYOCARDIAL HEMORRHAGEWang Y, Iyer K, Mcguone D, Velazquez E, Maulion C. MY BLEEDING HEART: SEVERE THROMBOCYTOPENIA AND ACUTE INTRAMYOCARDIAL HEMORRHAGE. Journal Of The American College Of Cardiology 2021, 77: 2139. DOI: 10.1016/s0735-1097(21)03495-1.
MYCOTIC ANEURYSMS COMPLICATED BY FISTULAS: A RARE CAUSE OF RECURRENT HEART FAILURE EXACERBATIONSWang Y, Sugeng L, Hur D, Hsueh C, Velazquez E, Maulion C. MYCOTIC ANEURYSMS COMPLICATED BY FISTULAS: A RARE CAUSE OF RECURRENT HEART FAILURE EXACERBATIONS. Journal Of The American College Of Cardiology 2021, 77: 2155. DOI: 10.1016/s0735-1097(21)03511-7.
Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathyFarsky PS, White J, Al-Khalidi HR, Sueta CA, Rouleau J, Panza J, Velazquez E, O'Connor C, Investigators W, Dabrowski R, Djokovic L, Drazner M, Haddad H, Ali I, Keltai M, Naik A, Sopko G, Golba K, Andersson B, Carson P, Kukulski T. Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy. Journal Of Thoracic And Cardiovascular Surgery 2021, 164: 1890-1899.e4. PMID: 33610365, PMCID: PMC8260609, DOI: 10.1016/j.jtcvs.2020.12.094.
Abstract 16397: Presence of Myocardial Injury on Admission is Associated With an Increase in All-cause Mortality in Patients With COVID-19Ahmed Z, Singh A, Vadlamani L, Eder M, Ghazizadeh Z, Park J, Pareek M, Pacor J, Gier C, Mena-hurtado C, Velazquez E, Desai N. Abstract 16397: Presence of Myocardial Injury on Admission is Associated With an Increase in All-cause Mortality in Patients With COVID-19. Circulation 2020, 142 DOI: 10.1161/circ.142.suppl_3.16397.
Implications of Abnormal Exercise Electrocardiography With Normal Stress EchocardiographyDaubert MA, Sivak J, Dunning A, Douglas PS, Coyne B, Wang TY, Mark DB, Velazquez EJ. Implications of Abnormal Exercise Electrocardiography With Normal Stress Echocardiography. JAMA Internal Medicine 2020, 180: 494-502. PMID: 31985749, PMCID: PMC6990669, DOI: 10.1001/jamainternmed.2019.6958.
Impact of Tricuspid Valve Repair for Moderate Tricuspid Regurgitation at the Time of Left Ventricular Assist Device Implantation on the Occurrence of Right Heart FailureBarac Y, Bishawi M, Milano C, Schroder J, Daneshmand M, Hashmi N, Velazquez E, Rogers J, Patel C, Nicoara A. Impact of Tricuspid Valve Repair for Moderate Tricuspid Regurgitation at the Time of Left Ventricular Assist Device Implantation on the Occurrence of Right Heart Failure. The Journal Of Heart And Lung Transplantation 2020, 39: s444. DOI: 10.1016/j.healun.2020.01.259.
LIMITED TESTING FOR CORONARY ARTERY DISEASE IN PATIENTS WITH NEW-ONSET HEART FAILURE: FINDINGS FROM GET WITH THE GUIDELINES - HEART FAILUREO'Connor K, Brophy T, Fonarow G, Blankstein R, Swaminathan R, Xu H, Matsouaka R, Albert N, Velazquez E, Yancy C, Heidenreich P, Hernandez A, DeVore A. LIMITED TESTING FOR CORONARY ARTERY DISEASE IN PATIENTS WITH NEW-ONSET HEART FAILURE: FINDINGS FROM GET WITH THE GUIDELINES - HEART FAILURE. Journal Of The American College Of Cardiology 2020, 75: 866. DOI: 10.1016/s0735-1097(20)31493-5.
Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT TrialBerk J, Damy T, Drachman B, Elliott P, Gottlieb S, Grogan M, Gundapaneni B, Hanna M, Hoffman J, Hummel S, Judge D, Lenihan D, Merlini G, Patterson T, Rapezzi C, Schwartz J, Shah S, Sultan M, Velazquez E, Cruz M, Witteles R. Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial. Heart & Lung 2020, 49: 209-210. DOI: 10.1016/j.hrtlng.2020.02.009.
Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literatureMuiruri C, Longenecker CT, Meissner EG, Okeke NL, Pettit AC, Thomas K, Velazquez E, Bloomfield GS. Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature. Progress In Cardiovascular Diseases 2020, 63: 142-148. PMID: 32057785, PMCID: PMC7237291, DOI: 10.1016/j.pcad.2020.02.006.
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart FailureDeVore AD, Braunwald E, Morrow DA, Duffy CI, Ambrosy AP, Chakraborty H, McCague K, Rocha R, Velazquez EJ. Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure. JAMA Cardiology 2020, 5: 202-207. PMID: 31825471, PMCID: PMC6990764, DOI: 10.1001/jamacardio.2019.4665.
Association between systolic ejection time and outcomes in heart failure by ejection fractionPatel PA, Ambrosy AP, Phelan M, Alenezi F, Chiswell K, Van Dyke MK, Tomfohr J, Honarpour N, Velazquez EJ. Association between systolic ejection time and outcomes in heart failure by ejection fraction. European Journal Of Heart Failure 2019, 22: 1174-1182. PMID: 31863532, PMCID: PMC7493053, DOI: 10.1002/ejhf.1659.
Biomarker Profile of Left Atrial Myopathy in Heart Failure With Preserved Ejection Fraction: Insights From the RELAX TrialPatel RB, Alenezi F, Sun JL, Alhanti B, Vaduganathan M, Oh JK, Redfield MM, Butler J, Hernandez AF, Velazquez EJ, Shah SJ. Biomarker Profile of Left Atrial Myopathy in Heart Failure With Preserved Ejection Fraction: Insights From the RELAX Trial. Journal Of Cardiac Failure 2019, 26: 270-275. PMID: 31857197, PMCID: PMC7078046, DOI: 10.1016/j.cardfail.2019.12.001.
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. Reply.Panza JA, Velazquez EJ, Bonow RO. Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. Reply. New England Journal Of Medicine 2019, 381: 2374. PMID: 31826352, DOI: 10.1056/nejmc1913972.
Durability and Efficacy of Tricuspid Valve Repair in Patients Undergoing Left Ventricular Assist Device ImplantationBarac YD, Nicoara A, Bishawi M, Schroder JN, Daneshmand MA, Hashmi NK, Velazquez E, Rogers JG, Patel CB, Milano CA. Durability and Efficacy of Tricuspid Valve Repair in Patients Undergoing Left Ventricular Assist Device Implantation. JACC Heart Failure 2019, 8: 141-150. PMID: 31838034, PMCID: PMC6995411, DOI: 10.1016/j.jchf.2019.08.016.
Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART StudyButler J, Greene SJ, Shah SH, Shah SJ, Anstrom KJ, Kim RJ, Kalogeropoulos AP, Velazquez EJ, Hernandez AF, Desvigne-Nickens P, Scherzer R, Hsue PY, Braunwald E. Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study. Journal Of Cardiac Failure 2019, 26: 371-380. PMID: 31682908, PMCID: PMC7195219, DOI: 10.1016/j.cardfail.2019.10.011.
4331Safety and efficacy of sacubitril/valsartan by dose level in patients hospitalized with acute heart failure: Observations from PIONEER-HFMorrow D, Velazquez E, Devore A, Duffy C, Gurmu Y, McCague K, Rocha R, Braunwald E. 4331Safety and efficacy of sacubitril/valsartan by dose level in patients hospitalized with acute heart failure: Observations from PIONEER-HF. European Heart Journal 2019, 40 DOI: 10.1093/eurheartj/ehz745.0168.
1135Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trialAmbrosy A, Braunwald E, Morrow D, Devore A, McCague K, Duffy C, Rocha R, Velazquez E. 1135Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial. European Heart Journal 2019, 40 DOI: 10.1093/eurheartj/ehz748.0004.
Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunctionDeVore AD, Yow E, Krucoff MW, Sherwood MW, Shaw LK, Chiswell K, O'Connor CM, Ohman EM, Velazquez EJ. Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction. ESC Heart Failure 2019, 6: 1233-1242. PMID: 31560171, PMCID: PMC6989282, DOI: 10.1002/ehf2.12510.
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy 10-Year Follow-Up of the STICH TrialHowlett JG, Stebbins A, Petrie MC, Jhund PS, Castelvecchio S, Cherniavsky A, Sueta CA, Roy A, Piña IL, Wurm R, Drazner MH, Andersson B, Batlle C, Senni M, Chrzanowski L, Merkely B, Carson P, Desvigne-Nickens PM, Lee KL, Velazquez EJ, Al-Khalidi HR, Investigators S. CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy 10-Year Follow-Up of the STICH Trial. JACC Heart Failure 2019, 7: 878-887. PMID: 31521682, PMCID: PMC7375257, DOI: 10.1016/j.jchf.2019.04.018.
Community Health Workers Improve Linkage to Hypertension Care in Western KenyaVedanthan R, Kamano JH, DeLong AK, Naanyu V, Binanay CA, Bloomfield GS, Chrysanthopoulou SA, Finkelstein EA, Hogan JW, Horowitz CR, Inui TS, Menya D, Orango V, Velazquez EJ, Were MC, Kimaiyo S, Fuster V. Community Health Workers Improve Linkage to Hypertension Care in Western Kenya. Journal Of The American College Of Cardiology 2019, 74: 1897-1906. PMID: 31487546, PMCID: PMC6788970, DOI: 10.1016/j.jacc.2019.08.003.
Myocardial Viability and Long-Term Outcomes in Ischemic CardiomyopathyPanza JA, Ellis AM, Al-Khalidi HR, Holly TA, Berman DS, Oh JK, Pohost GM, Sopko G, Chrzanowski L, Mark DB, Kukulski T, Favaloro LE, Maurer G, Farsky PS, Tan RS, Asch FM, Velazquez EJ, Rouleau JL, Lee KL, Bonow RO. Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. New England Journal Of Medicine 2019, 381: 739-748. PMID: 31433921, PMCID: PMC6814246, DOI: 10.1056/nejmoa1807365.
Sacubitril/Valsartan Initiated in Black Patients Admitted for Acute Decompensated Heart Failure Reduced NT-proBNP, was Safe and Led to Improved Clinical Outcomes- A Secondary Analysis of the PIONEER-HF TrialVelazquez E, Ambrosy A, Morrow D, McCague K, Duffy C, O'Brien T, Rocha R, DeVore A, Braunwald E. Sacubitril/Valsartan Initiated in Black Patients Admitted for Acute Decompensated Heart Failure Reduced NT-proBNP, was Safe and Led to Improved Clinical Outcomes- A Secondary Analysis of the PIONEER-HF Trial. Journal Of Cardiac Failure 2019, 25: s80. DOI: 10.1016/j.cardfail.2019.07.227.
Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized with Heart FailureSayeed S, Fudim M, Xu H, Matsouaka R, Heidenreich P, Yancy C, Fonarow G, Velazquez E, Hernandez A, DeVore A. Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized with Heart Failure. Journal Of Cardiac Failure 2019, 25: s151. DOI: 10.1016/j.cardfail.2019.07.436.
Echocardiographic Assessment of Right Ventricular Function and Response to Therapy in Pulmonary Arterial HypertensionShelburne NJ, Parikh KS, Chiswell K, Shaw LK, Sivak J, Arges K, Tomfohr J, Velazquez EJ, Kisslo J, Samad Z, Rajagopal S. Echocardiographic Assessment of Right Ventricular Function and Response to Therapy in Pulmonary Arterial Hypertension. The American Journal Of Cardiology 2019, 124: 1298-1304. PMID: 31481176, DOI: 10.1016/j.amjcard.2019.07.026.
Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency VirusAlenezi F, Bloomfield GS, Okeke NL, Velagapudi P, Abudaqa L, Ijioma N, Dunning A, Alajmi H, Clement ME, Shah SH, Naggie S, Velazquez EJ. Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency Virus. The American Journal Of Cardiology 2019, 124: 966-971. PMID: 31371060, PMCID: PMC6887515, DOI: 10.1016/j.amjcard.2019.06.013.
In‐hospital initiation of sacubitril/valsartan in acute decompensated heart failure: being in the right place at the right timeAmbrosy AP, DeVore AD, Velazquez EJ. In‐hospital initiation of sacubitril/valsartan in acute decompensated heart failure: being in the right place at the right time. European Journal Of Heart Failure 2019, 21: 1008-1011. PMID: 31218805, DOI: 10.1002/ejhf.1540.
Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal FunctionRao VS, Ahmad T, Brisco-Bacik MA, Bonventre JV, Wilson FP, Siew ED, Felker GM, Anstrom KK, Mahoney DD, Bart BA, Tang WHW, Velazquez EJ, Testani JM. Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function. Circulation Heart Failure 2019, 12: e005552. PMID: 31163974, PMCID: PMC6585463, DOI: 10.1161/circheartfailure.118.005552.
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trialMorrow DA, Velazquez EJ, DeVore AD, Prescott MF, Duffy CI, Gurmu Y, McCague K, Rocha R, Braunwald E. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. European Heart Journal 2019, 40: 3345-3352. PMID: 31093657, PMCID: PMC6801941, DOI: 10.1093/eurheartj/ehz240.
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF TrialMorrow DA, Velazquez EJ, DeVore AD, Desai AS, Duffy CI, Ambrosy AP, Gurmu Y, McCague K, Rocha R, Braunwald E. Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. Circulation 2019, 139: 2285-2288. PMID: 30955360, DOI: 10.1161/circulationaha.118.039331.
Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trialNicolau JC, Stevens SR, Al-Khalidi HR, Jatene FB, Furtado RHM, Dallan LAO, Lisboa LAF, Desvigne-Nickens P, Haddad H, Jolicoeur EM, Petrie MC, Doenst T, Michler RE, Ohman EM, Maddury J, Ali I, Deja MA, Rouleau JL, Velazquez EJ, Hill JA. Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial. International Journal Of Cardiology 2019, 291: 36-41. PMID: 30929973, PMCID: PMC6579621, DOI: 10.1016/j.ijcard.2019.03.029.
PCI and CABG for Treating Stable Coronary Artery Disease JACC Review Topic of the WeekDoenst T, Haverich A, Serruys P, Bonow RO, Kappetein P, Falk V, Velazquez E, Diegeler A, Sigusch H. PCI and CABG for Treating Stable Coronary Artery Disease JACC Review Topic of the Week. Journal Of The American College Of Cardiology 2019, 73: 964-976. PMID: 30819365, DOI: 10.1016/j.jacc.2018.11.053.
EFFECT OF SACUBITRIL/VALSARTAN INITIATION ON 30-DAY READMISSIONS AFTER A HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE: A SECONDARY ANALYSIS OF THE PIONEER-HF TRIALDeVore A, Morrow D, Braunwald E, Duffy C, Ambrosy A, McCague K, Rocha R, Velazquez E. EFFECT OF SACUBITRIL/VALSARTAN INITIATION ON 30-DAY READMISSIONS AFTER A HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE: A SECONDARY ANALYSIS OF THE PIONEER-HF TRIAL. Journal Of The American College Of Cardiology 2019, 73: 901. DOI: 10.1016/s0735-1097(19)31508-6.
EFFECT OF SACUBITRIL/VALSARTAN ON BIOMARKERS OF MYOCARDIAL STRESS IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE IN PIONEER-HFMorrow D, Velazquez E, DeVore A, Duffy C, Prescott M, McCague K, Rocha R, Braunwald E. EFFECT OF SACUBITRIL/VALSARTAN ON BIOMARKERS OF MYOCARDIAL STRESS IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE IN PIONEER-HF. Journal Of The American College Of Cardiology 2019, 73: 682. DOI: 10.1016/s0735-1097(19)31290-2.
PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIALAmbrosy A, DeVore A, Morrow D, Braunwald E, Duffy C, McCague K, Rocha R, Velazquez E. PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIAL. Journal Of The American College Of Cardiology 2019, 73: 1020. DOI: 10.1016/s0735-1097(19)31627-4.
OPTIMAL MEDICAL THERAPY USE AND LONG-TERM OUTCOMES IN CABG-ELIGIBLE HEART FAILURE PATIENTS: INSIGHTS FROM THE STICH TRIALFarsky P, White J, Sueta C, Dabrowski R, Djokovic L, Drazner M, Haddad H, Ali I, Keltai M, Naik A, Sopko G, Golba K, Andersson B, Carson P, Kukulski T, Al-Khalidi H, Rouleau J, Velazquez E. OPTIMAL MEDICAL THERAPY USE AND LONG-TERM OUTCOMES IN CABG-ELIGIBLE HEART FAILURE PATIENTS: INSIGHTS FROM THE STICH TRIAL. Journal Of The American College Of Cardiology 2019, 73: 45. DOI: 10.1016/s0735-1097(19)30654-0.
Burden of medical co‐morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathyAmbrosy AP, Stevens SR, Al‐Khalidi H, Rouleau JL, Bouabdallaoui N, Carson PE, Adlbrecht C, Cleland JGF, Dabrowski R, Golba KS, Pina IL, Sueta CA, Roy A, Sopko G, Bonow RO, Velazquez EJ, Investigators O. Burden of medical co‐morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. European Journal Of Heart Failure 2019, 21: 373-381. PMID: 30698316, PMCID: PMC6818499, DOI: 10.1002/ejhf.1404.
Speckle Tracking Analysis of Left Ventricular Systolic Function Following Traumatic Brain Injury: A Pilot Prospective Observational Cohort StudyKrishnamoorthy V, Chaikittisilpa N, Lee J, Mackensen GB, Gibbons EF, Laskowitz D, Hernandez A, Velazquez E, Lele AV, Vavilala MS. Speckle Tracking Analysis of Left Ventricular Systolic Function Following Traumatic Brain Injury: A Pilot Prospective Observational Cohort Study. Journal Of Neurosurgical Anesthesiology 2019, 32: 156-161. PMID: 30676403, PMCID: PMC6646112, DOI: 10.1097/ana.0000000000000578.
Effects of a Cookstove Intervention on Cardiac Structure, Cardiac Function, and Blood Pressure in Western KenyaBloomfield GS, Kirwa K, Agarwal A, Eliot MN, Alenezi F, Carter EJ, Foster MC, Kimaiyo S, Lumsden R, Menya D, Mitter SS, Velazquez EJ, Vedanthan R, Wellenius GA. Effects of a Cookstove Intervention on Cardiac Structure, Cardiac Function, and Blood Pressure in Western Kenya. Journal Of The American Society Of Echocardiography 2019, 32: 427-430. PMID: 30665729, DOI: 10.1016/j.echo.2018.11.013.
Trends in cardiorespiratory fitness: The evolution of exercise treadmill testing at a single Academic Medical Center from 1970 to 2012Kelly JP, Andonian BJ, Patel MJ, Huang Z, Shaw LK, McGarrah RW, Borges-Neto S, Velazquez EJ, Kraus WE. Trends in cardiorespiratory fitness: The evolution of exercise treadmill testing at a single Academic Medical Center from 1970 to 2012. American Heart Journal 2019, 210: 88-97. PMID: 30743212, PMCID: PMC6441626, DOI: 10.1016/j.ahj.2019.01.001.
Death: The Simple Clinical Trial Endpoint.Eisenstein EL, Prather K, Greene SJ, Harding T, Harrington A, Gabriel D, Jones I, Mentz RJ, Velazquez EJ, Anstrom KJ. Death: The Simple Clinical Trial Endpoint. 2019, 257: 86-91. PMID: 30741178, PMCID: PMC8228236.
High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection FractionHunter WG, McGarrah RW, Kelly JP, Khouri MG, Craig DM, Haynes C, Felker GM, Hernandez AF, Velazquez EJ, Kraus WE, Shah SH. High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction. Journal Of The American College Of Cardiology 2019, 73: 177-186. PMID: 30654890, DOI: 10.1016/j.jacc.2018.10.059.
Left Ventricular Global Longitudinal Strain Can Reliably Be Measured from a Single Apical Four-Chamber View in Patients with Heart FailureAlenezi F, Ambrosy AP, Phelan M, Chiswell K, Abudaqa L, Alajmi H, Kisslo J, Velazquez EJ. Left Ventricular Global Longitudinal Strain Can Reliably Be Measured from a Single Apical Four-Chamber View in Patients with Heart Failure. Journal Of The American Society Of Echocardiography 2018, 32: 317-318. PMID: 30552031, DOI: 10.1016/j.echo.2018.10.009.
Tricuspid Valve Regurgitation Immediately After Heart Transplant and Long-Term OutcomesBishawi M, Zanotti G, Shaw L, MacKenzie M, Castleberry A, Bartels K, Schroder J, Velazquez E, Swaminathan M, Rogers J, Milano C. Tricuspid Valve Regurgitation Immediately After Heart Transplant and Long-Term Outcomes. The Annals Of Thoracic Surgery 2018, 107: 1348-1355. PMID: 30529215, PMCID: PMC7256852, DOI: 10.1016/j.athoracsur.2018.10.065.
Predictors and Changes in Cardiac Hemodynamics and Geometry With Transcatheter Aortic Valve ImplantationAlenezi F, Fudim M, Rymer J, Dunning A, Chiswell K, Swaminathan M, Bottiger B, Velagapudi P, Nicoara A, Kisslo J, Velazquez E, Vemulapalli S, Bloomfield GS, Samad Z. Predictors and Changes in Cardiac Hemodynamics and Geometry With Transcatheter Aortic Valve Implantation. The American Journal Of Cardiology 2018, 123: 813-819. PMID: 30598241, DOI: 10.1016/j.amjcard.2018.11.038.
Disrupting Fellow Education Through Group Texting WhatsApp in Fellow Education?Kochar A, Rymer J, Samad Z, Group C, Banks A, Mandawat A, Sun A, Fanaroff A, Mandawat A, Amborsy A, Wang A, Lowenstern A, Manly D, Patel P, Black-Meier E, Velazquez E, Serfas J, Chakravartti J, Wosniak J, Wisler J, Sivak J, Friede K, Khouri M, Fudim M, Nanna M, Minder C, Loungani R, Al-Khatib S, Jones S, Hodovance S, Sen S, Greene S, Gaeta S, Bashore T, Loring Z, Nicoara A, Rehorn M, Kociol R, Swaminathan M, Liao L, Barnett A, Rao V, Coniglio A, Drescher C, Nafissi N, Ngeno G. Disrupting Fellow Education Through Group Texting WhatsApp in Fellow Education? Journal Of The American College Of Cardiology 2018, 72: 3366-3369. PMID: 30573034, DOI: 10.1016/j.jacc.2018.11.007.
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart FailureVelazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure. New England Journal Of Medicine 2018, 380: 539-548. PMID: 30415601, DOI: 10.1056/nejmoa1812851.
Clinical Utility and Prognostic Value of Right Atrial Function in Pulmonary HypertensionAlenezi F, Mandawat A, Il'Giovine ZJ, Shaw LK, Siddiqui I, Tapson VF, Arges K, Rivera D, Romano MMD, Velazquez EJ, Douglas PS, Samad Z, Rajagopal S. Clinical Utility and Prognostic Value of Right Atrial Function in Pulmonary Hypertension. Circulation Cardiovascular Imaging 2018, 11: e006984. PMID: 30571314, PMCID: PMC6309911, DOI: 10.1161/circimaging.117.006984.
Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial: Sensitivity Analyses Further Support the Primary ResultsMaurer M, Schwartz J, Gundapaneni B, Elliott P, Merlini G, Cruz M, Kristen A, Grogan M, Witteles R, Damy T, Drachman B, Shah S, Hanna M, Judge D, Gottlieb S, Berk J, Lenihan D, Hoffman J, Hummel S, Velazquez E, Patterson T, Sultan M, Rapezzi C. Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial: Sensitivity Analyses Further Support the Primary Results. Journal Of Cardiac Failure 2018, 24: 813. DOI: 10.1016/j.cardfail.2018.11.008.
Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical RevascularizationBouabdallaoui N, Stevens SR, Doenst T, Petrie MC, Al-Attar N, Ali IS, Ambrosy AP, Barton AK, Cartier R, Cherniavsky A, Demondion P, Desvigne-Nickens P, Favaloro RR, Gradinac S, Heinisch P, Jain A, Jasinski M, Jouan J, Kalil RAK, Menicanti L, Michler RE, Rao V, Smith PK, Zembala M, Velazquez EJ, Al-Khalidi HR, Rouleau JL, Investigators F. Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization. Circulation Heart Failure 2018, 11: e005531. PMID: 30571194, PMCID: PMC6309904, DOI: 10.1161/circheartfailure.118.005531.
Childhood and adult exposure to secondhand tobacco smoke and cardiac structure and function: results from Echo-SOLPeña M, Swett K, Kaplan RC, Perreira K, Daviglus M, Kansal MM, Cai J, Giachello AL, Gellman MD, Velazquez EJ, Rodriguez CJ. Childhood and adult exposure to secondhand tobacco smoke and cardiac structure and function: results from Echo-SOL. Open Heart 2018, 5: e000831. PMID: 30402256, PMCID: PMC6203071, DOI: 10.1136/openhrt-2018-000831.
Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of EchocardiographyMitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, Horton K, Ogunyankin KO, Palma RA, Velazquez EJ. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. Journal Of The American Society Of Echocardiography 2018, 32: 1-64. PMID: 30282592, DOI: 10.1016/j.echo.2018.06.004.
A meta‐analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patientsGiannini C, D'ascenzo F, Fiorelli F, Spontoni P, Swaans MJ, Velazquez EJ, Armeni P, Adamo M, De Carlo M, Petronio AS. A meta‐analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients. ESC Heart Failure 2018, 5: 1150-1158. PMID: 30191666, PMCID: PMC6300824, DOI: 10.1002/ehf2.12339.
Transcatheter Aortic Valve Replacement versus Medical Management among Patients with Aortic Stenosis and Left Ventricular Systolic DysfunctionLowenstern A, Vora A, Dunning A, Schulte P, Vemulapalli S, Hughes G, Velazquez E, Harrison J, Samad Z. Transcatheter Aortic Valve Replacement versus Medical Management among Patients with Aortic Stenosis and Left Ventricular Systolic Dysfunction. Structural Heart 2018, 2: 388-395. DOI: 10.1080/24748706.2018.1500049.
Crowdsourcing consensus: proposal of a novel method for assessing accuracy in echocardiography interpretationMinter S, Armour A, Tinnemore A, Strub K, Crowley AL, Bloomfield GS, Alexander JH, Douglas PS, Kisslo JA, Velazquez EJ, Samad Z. Crowdsourcing consensus: proposal of a novel method for assessing accuracy in echocardiography interpretation. The International Journal Of Cardiovascular Imaging 2018, 34: 1725-1730. PMID: 30128849, DOI: 10.1007/s10554-018-1389-y.
Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trialSharma A, Ambrosy AP, DeVore AD, Margulies KB, McNulty SE, Mentz RJ, Hernandez AF, Felker G, Cooper LB, Lala A, Vader J, Groake JD, Borlaug BA, Velazquez EJ. Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial. ESC Heart Failure 2018, 5: 1035-1043. PMID: 30120812, PMCID: PMC6300815, DOI: 10.1002/ehf2.12334.
The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized TrialCrowley AL, Yow E, Rabineau D, Norris C, White J, Daubert MA, Velazquez EJ, Barnhart H, Krucoff MW, Rao SV, Douglas PS. The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized Trial. JACC Cardiovascular Imaging 2018, 11: 1918-1920. PMID: 30121272, DOI: 10.1016/j.jcmg.2018.05.024.
Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular DysfunctionPellikka PA, She L, Holly TA, Lin G, Varadarajan P, Pai RG, Bonow RO, Pohost GM, Panza JA, Berman DS, Prior DL, Asch FM, Borges-Neto S, Grayburn P, Al-Khalidi HR, Miszalski-Jamka K, Desvigne-Nickens P, Lee KL, Velazquez EJ, Oh JK. Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction. JAMA Network Open 2018, 1: e181456-e181456. PMID: 30646130, PMCID: PMC6324278, DOI: 10.1001/jamanetworkopen.2018.1456.
The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trialAndersson B, She L, Tan RS, Jeemon P, Mokrzycki K, Siepe M, Romanov A, Favaloro LE, Djokovic LT, Raju PK, Betlejewski P, Racine N, Ostrzycki A, Nawarawong W, Das S, Rouleau JL, Sopko G, Lee KL, Velazquez EJ, Panza JA. The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial. European Heart Journal 2018, 39: 3464-3471. PMID: 30113633, PMCID: PMC6166135, DOI: 10.1093/eurheartj/ehy438.
The Renal Effects of Aggressive Volume Removal in Heart Failure Patients with Preexisting Worsening Renal FunctionMahoney D, Ahmad T, Rao V, Brisco-Bacik M, Wilson F, Siew E, Felker G, Anstrom K, Bart B, Tang W, O'Connor C, Velazquez E, Testani J. The Renal Effects of Aggressive Volume Removal in Heart Failure Patients with Preexisting Worsening Renal Function. Journal Of Cardiac Failure 2018, 24: s26. DOI: 10.1016/j.cardfail.2018.07.074.
HFrEF other treatment: revascularizationVelazquez E, Petrie M. HFrEF other treatment: revascularization. 2018, 1881-1884. DOI: 10.1093/med/9780198784906.003.0431.
Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical CohortOkeke NL, Alenezi F, Bloomfield GS, Dunning A, Clement ME, Shah SH, Naggie S, Velazquez EJ. Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort. Journal Of Cardiac Failure 2018, 24: 496-503. PMID: 29964194, PMCID: PMC6231907, DOI: 10.1016/j.cardfail.2018.06.003.
Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary HypertensionSiddiqui I, Rajagopal S, Brucker A, Chiswell K, Christopher B, Alenezi F, Mandawat A, Rivera D, Arges K, Tapson V, Kisslo J, Velazquez E, Douglas PS, Samad Z. Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary Hypertension. The American Journal Of Cardiology 2018, 122: 872-878. PMID: 30093068, PMCID: PMC6280670, DOI: 10.1016/j.amjcard.2018.05.019.
Revascularization for Heart Failure Can We Do Better? ∗Ohman EM, Velazquez EJ. Revascularization for Heart Failure Can We Do Better? ∗. JACC Heart Failure 2018, 6: 527-529. PMID: 29852934, DOI: 10.1016/j.jchf.2018.05.002.
Long-term outcomes of mitral regurgitation by type and severitySamad Z, Shaw LK, Phelan M, Glower DD, Ersboll M, Toptine JH, Alexander JH, Kisslo JA, Wang A, Mark DB, Velazquez EJ. Long-term outcomes of mitral regurgitation by type and severity. American Heart Journal 2018, 203: 39-48. PMID: 30015067, DOI: 10.1016/j.ahj.2018.05.001.
The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patientsFriedman DJ, Fudim M, Overton R, Shaw LK, Patel D, Pokorney SD, Velazquez EJ, Al-Khatib SM. The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients. American Heart Journal 2018, 201: 17-24. PMID: 29910051, PMCID: PMC6309220, DOI: 10.1016/j.ahj.2018.03.017.
Right Ventricular Longitudinal Strain Reproducibility Using Vendor-Dependent and Vendor-Independent SoftwareIl'Giovine ZJ, Mulder H, Chiswell K, Arges K, Tomfohr J, Hashmi A, Velazquez EJ, Kisslo JA, Samad Z, Rajagopal S. Right Ventricular Longitudinal Strain Reproducibility Using Vendor-Dependent and Vendor-Independent Software. Journal Of The American Society Of Echocardiography 2018, 31: 721-732.e5. PMID: 29525250, PMCID: PMC6825401, DOI: 10.1016/j.echo.2018.01.008.
Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) StudyButler J, Kalogeropoulos AP, Anstrom KJ, Hsue PY, Kim RJ, Scherzer R, Shah SJ, Shah SH, Velazquez EJ, Hernandez AF, Desvigne-Nickens P, Braunwald E. Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study. Journal Of Cardiac Failure 2018, 24: 255-265. PMID: 29482027, PMCID: PMC5880702, DOI: 10.1016/j.cardfail.2018.02.001.
Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical RevascularizationPiña IL, Zheng Q, She L, Szwed H, Lang IM, Farsky PS, Castelvecchio S, Biernat J, Paraforos A, Kosevic D, Favaloro LE, Nicolau JC, Varadarajan P, Velazquez EJ, Pai RG, Cyrille N, Lee KL, Desvigne-Nickens P. Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization. Circulation 2018, 137: 771-780. PMID: 29459462, PMCID: PMC5896331, DOI: 10.1161/circulationaha.117.030526.
Angiotensin receptor-neprilysin inhibitor therapy in heart failure: An end that justifies the meansAmbrosy AP, Velazquez EJ. Angiotensin receptor-neprilysin inhibitor therapy in heart failure: An end that justifies the means. American Heart Journal 2018, 199: 176-177. PMID: 29754658, DOI: 10.1016/j.ahj.2018.02.007.
Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathyStewart RAH, Szalewska D, Stebbins A, Al-Khalidi HR, Cleland JGH, Rynkiewicz A, Drazner MH, White HD, Mark DB, Roy A, Kosevic D, Rajda M, Jasinski M, Leng CY, Tungsubutra W, Desvigne-Nickens P, Velazquez EJ, Petrie MC. Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy. Open Heart 2018, 5: e000752. PMID: 29531766, PMCID: PMC5845417, DOI: 10.1136/openhrt-2017-000752.
CABG or PCI for Diabetic Patients With Left Ventricular Dysfunction Closing in on the Truth? ∗Velazquez EJ, Petrie MC. CABG or PCI for Diabetic Patients With Left Ventricular Dysfunction Closing in on the Truth? ∗. Journal Of The American College Of Cardiology 2018, 71: 828-831. PMID: 29471932, DOI: 10.1016/j.jacc.2018.01.014.
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trialVelazquez EJ, Morrow DA, DeVore AD, Ambrosy AP, Duffy CI, McCague K, Hernandez AF, Rocha RA, Braunwald E. Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. American Heart Journal 2018, 198: 145-151. PMID: 29653636, DOI: 10.1016/j.ahj.2018.01.004.
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive PatientsBrook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber M, Zappe DH, Hau T, Jamerson KA. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients. Journal Of The American Heart Association 2018, 7: e006940. PMID: 29301757, PMCID: PMC5778960, DOI: 10.1161/jaha.117.006940.
Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch BlockSze E, Samad Z, Dunning A, Campbell KB, Loring Z, Atwater BD, Chiswell K, Kisslo JA, Velazquez EJ, Daubert JP. Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block. Journal Of The American College Of Cardiology 2018, 71: 306-317. PMID: 29348023, PMCID: PMC8352572, DOI: 10.1016/j.jacc.2017.11.020.
Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) TrialBouabdallaoui N, Stevens SR, Doenst T, Wrobel K, Bouchard D, Deja MA, Michler RE, Chua YL, Kalil RAK, Selzman CH, Daly RC, Sun B, Djokovic LT, Sopko G, Velazquez EJ, Rouleau JL, Lee KL, Al-Khalidi HR, Investigators F. Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. Journal Of Cardiothoracic And Vascular Anesthesia 2017, 32: 1256-1263. PMID: 29422280, PMCID: PMC6517319, DOI: 10.1053/j.jvca.2017.12.038.
Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND‐HFPokorney SD, Al‐Khatib S, Sun J, Schulte P, O'Connor CM, Teerlink JR, Armstrong PW, Ezekowitz JA, Starling RC, Voors AA, Velazquez EJ, Hernandez AF, Mentz RJ. Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND‐HF. European Journal Of Heart Failure 2017, 20: 525-532. PMID: 29266564, DOI: 10.1002/ejhf.1078.
On Books, Covers, and Judgments in Heart Failure ∗Borlaug BA, Velazquez EJ. On Books, Covers, and Judgments in Heart Failure ∗. JACC Cardiovascular Imaging 2017, 11: 1747-1749. PMID: 29153569, DOI: 10.1016/j.jcmg.2017.08.021.
Prevalence and Outcomes of Left‐Sided Valvular Heart Disease Associated With Chronic Kidney DiseaseSamad Z, Sivak JA, Phelan M, Schulte PJ, Patel U, Velazquez EJ. Prevalence and Outcomes of Left‐Sided Valvular Heart Disease Associated With Chronic Kidney Disease. Journal Of The American Heart Association 2017, 6: e006044. PMID: 29021274, PMCID: PMC5721834, DOI: 10.1161/jaha.117.006044.
Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in KenyaTemu TM, Lane KA, Shen C, Ng'ang'a L, Akwanalo CO, Chen PS, Emonyi W, Heckbert SR, Koech MM, Manji I, Vatta M, Velazquez EJ, Wessel J, Kimaiyo S, Inui TS, Bloomfield GS. Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya. PLOS ONE 2017, 12: e0185204. PMID: 28934312, PMCID: PMC5608343, DOI: 10.1371/journal.pone.0185204.
Household Air Pollution Is Associated with Altered Cardiac Function among Women in KenyaAgarwal A, Kirwa K, Eliot MN, Alenezi F, Menya D, Mitter SS, Velazquez EJ, Vedanthan R, Wellenius GA, Bloomfield GS. Household Air Pollution Is Associated with Altered Cardiac Function among Women in Kenya. American Journal Of Respiratory And Critical Care Medicine 2017, 197: 958-961. PMID: 28925740, PMCID: PMC6020413, DOI: 10.1164/rccm.201704-0832le.
Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS DurationSze E, Dunning A, Loring Z, Atwater BD, Chiswell K, Daubert JP, Kisslo JA, Mark DB, Velazquez EJ, Samad Z. Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS Duration. The American Journal Of Cardiology 2017, 120: 1990-1997. PMID: 28958452, DOI: 10.1016/j.amjcard.2017.08.003.
Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation doseLu MT, Douglas PS, Udelson JE, Adami E, Ghoshhajra BB, Picard MH, Roberts R, Lee KL, Einstein AJ, Mark DB, Velazquez EJ, Carter W, Ridner M, Al-Khalidi HR, Hoffmann U. Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose. Journal Of Cardiovascular Computed Tomography 2017, 11: 373-382. PMID: 28838846, PMCID: PMC6201309, DOI: 10.1016/j.jcct.2017.08.005.
Usefulness of Myocardial Annular Velocity Change During Mental Stress to Predict Cardiovascular Outcome in Patients With Coronary Artery Disease (From the Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram Treatment Trial)Alenezi F, Brummett BH, Boyle SH, Samad Z, Babyak MA, Alzaeim N, Wilson J, Romano MMD, Sun JL, Ersboll M, O'Connor CM, Velazquez EJ, Jiang W. Usefulness of Myocardial Annular Velocity Change During Mental Stress to Predict Cardiovascular Outcome in Patients With Coronary Artery Disease (From the Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram Treatment Trial). The American Journal Of Cardiology 2017, 120: 1495-1500. PMID: 28917493, DOI: 10.1016/j.amjcard.2017.07.039.
Measures of Ventricular-Arterial Coupling and Incident Heart Failure With Preserved Ejection Fraction: A Matched Case-Control AnalysisLekavich CL, Barksdale DJ, Wu JR, Neelon V, Crandell J, Velazquez EJ. Measures of Ventricular-Arterial Coupling and Incident Heart Failure With Preserved Ejection Fraction: A Matched Case-Control Analysis. Journal Of Cardiac Failure 2017, 23: 659-665. PMID: 28716687, PMCID: PMC5585062, DOI: 10.1016/j.cardfail.2017.07.395.
Adverse Remodeling and Reverse Remodeling After Myocardial InfarctionBhatt AS, Ambrosy AP, Velazquez EJ. Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Current Cardiology Reports 2017, 19: 71. PMID: 28660552, DOI: 10.1007/s11886-017-0876-4.
Value of Cardiovascular Magnetic Resonance Imaging–Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) TrialPai RG, Varadarajan P, Rouleau JL, Stebbins AL, Velazquez EJ, Al-Khalidi HR, Pohost GM. Value of Cardiovascular Magnetic Resonance Imaging–Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. JAMA Cardiology 2017, 2: 577-579. PMID: 28199489, PMCID: PMC5814980, DOI: 10.1001/jamacardio.2016.5492.
Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalizationBuggey J, Alenezi F, Yoon HJ, Phelan M, DeVore AD, Khouri MG, Schulte PJ, Velazquez EJ. Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization. ESC Heart Failure 2017, 4: 432-439. PMID: 29154416, PMCID: PMC5695196, DOI: 10.1002/ehf2.12159.
Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipientDeVore AD, Alenezi F, Krishnamoorthy A, Ersboll M, Samsky MD, Schulte PJ, Patel CB, Rogers JG, Milano CA, Velazquez EJ, Khouri MG. Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipient. Clinical Transplantation 2017, 31: e12961. PMID: 28294407, DOI: 10.1111/ctr.12961.
Improving on the diagnostic characteristics of echocardiography for pulmonary hypertensionBroderick-Forsgren K, Davenport CA, Sivak JA, Hargett CW, Foster MC, Monteagudo A, Armour A, Rajagopal S, Arges K, Velazquez EJ, Samad Z. Improving on the diagnostic characteristics of echocardiography for pulmonary hypertension. The International Journal Of Cardiovascular Imaging 2017, 33: 1341-1349. PMID: 28337558, DOI: 10.1007/s10554-017-1114-2.
Race and Sex Differences in QRS Interval and Associated Outcome Among Patients with Left Ventricular Systolic DysfunctionRandolph TC, Broderick S, Shaw LK, Chiswell K, Mentz RJ, Kutyifa V, Velazquez EJ, Gilliam FR, Thomas KL. Race and Sex Differences in QRS Interval and Associated Outcome Among Patients with Left Ventricular Systolic Dysfunction. Journal Of The American Heart Association 2017, 6: e004381. PMID: 28320746, PMCID: PMC5523998, DOI: 10.1161/jaha.116.004381.
Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease)Banks A, Broderick S, Chiswell K, Shaw L, Devore A, Fiuzat M, O'Connor C, Felker GM, Velazquez E, Mentz R. Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease). The American Journal Of Cardiology 2017, 119: 1703-1709. PMID: 28395884, DOI: 10.1016/j.amjcard.2017.02.053.
LIRAGLUTIDE AND WEIGHT LOSS AMONG PATIENTS WITH ADVANCED HEART FAILURE AND A REDUCED EJECTION FRACTION: INSIGHTS FROM THE FIGHT TRIALAmbrosy A, Sharma A, McNulty S, Borlaug B, Cappola T, Cooper L, DeVore A, Dunlay S, Lala-Trindade A, Margulies K, Mentz R, Velazquez E. LIRAGLUTIDE AND WEIGHT LOSS AMONG PATIENTS WITH ADVANCED HEART FAILURE AND A REDUCED EJECTION FRACTION: INSIGHTS FROM THE FIGHT TRIAL. Journal Of The American College Of Cardiology 2017, 69: 684. DOI: 10.1016/s0735-1097(17)34073-1.
THE ROLE OF BASELINE VERSUS LONG-TERM FOLLOW-UP EJECTION FRACTION IN PREDICTING ADVERSE EVENTS AMONG PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATOR RECIPIENTSFriedman D, Overton R, Shaw L, Fudim M, Patel D, Velazquez E, Al-Khatib S. THE ROLE OF BASELINE VERSUS LONG-TERM FOLLOW-UP EJECTION FRACTION IN PREDICTING ADVERSE EVENTS AMONG PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATOR RECIPIENTS. Journal Of The American College Of Cardiology 2017, 69: 741. DOI: 10.1016/s0735-1097(17)34130-x.
MEASURES OF VENTRICULAR-ARTERIAL COUPLING AND INCIDENT HEART FAILURE PRESERVED EJECTION FRACTION: A MATCHED CASE-CONTROL ANALYSISLekavich C, Barksdale D, Neelon V, Crandell J, Wu J, Velazquez E. MEASURES OF VENTRICULAR-ARTERIAL COUPLING AND INCIDENT HEART FAILURE PRESERVED EJECTION FRACTION: A MATCHED CASE-CONTROL ANALYSIS. Journal Of The American College Of Cardiology 2017, 69: 896. DOI: 10.1016/s0735-1097(17)34285-7.
THE IMPACT OF RIGOROUS QUALITY IMPROVEMENT ON 3D ECHOCARDIOGRAPHY IMAGE AND DATA QUALITY IN AN INTERNATIONAL MULTISITE RANDOMIZED TRIALCrowley A, Yow E, Rabineau D, Barnhart H, White J, Velazquez E, Daubert M, Krucoff M, Rao S, Douglas P. THE IMPACT OF RIGOROUS QUALITY IMPROVEMENT ON 3D ECHOCARDIOGRAPHY IMAGE AND DATA QUALITY IN AN INTERNATIONAL MULTISITE RANDOMIZED TRIAL. Journal Of The American College Of Cardiology 2017, 69: 1533. DOI: 10.1016/s0735-1097(17)34922-7.
LOW UTILIZATION OF SURGICAL INTERVENTION TO TREAT SEVERE AORTIC STENOSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASESamad Z, Sivak J, Phelan M, Schulte P, Velazquez E. LOW UTILIZATION OF SURGICAL INTERVENTION TO TREAT SEVERE AORTIC STENOSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal Of The American College Of Cardiology 2017, 69: 1938. DOI: 10.1016/s0735-1097(17)35327-5.
Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trialDeVore AD, McNulty S, Alenezi F, Ersboll M, Vader JM, Oh JK, Lin G, Redfield MM, Lewis G, Semigran MJ, Anstrom KJ, Hernandez AF, Velazquez EJ. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial. European Journal Of Heart Failure 2017, 19: 893-900. PMID: 28194841, PMCID: PMC5511088, DOI: 10.1002/ejhf.754.
Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass GraftingRao MP, Al-Khatib SM, Pokorney SD, She L, Romanov A, Nicolau JC, Lee KL, Carson P, Selzman CH, Stepinska J, Cleland JG, Tungsubutra W, Desvigne-Nickens PM, Sueta CA, Siepe M, Lang I, Feldman AM, Yii M, Rouleau JL, Velazquez EJ. Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting. Circulation 2017, 135: 1136-1144. PMID: 28154006, PMCID: PMC5516272, DOI: 10.1161/circulationaha.116.026075.
Approaches to Sustainable Capacity Building for Cardiovascular Disease Care in KenyaBarasa FA, Vedanthan R, Pastakia SD, Crowe SJ, Aruasa W, Sugut WK, White R, Ogola ES, Bloomfield GS, Velazquez EJ. Approaches to Sustainable Capacity Building for Cardiovascular Disease Care in Kenya. Cardiology Clinics 2017, 35: 145-152. PMID: 27886785, DOI: 10.1016/j.ccl.2016.08.014.
Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patientsSun JL, Boyle SH, Samad Z, Babyak MA, Wilson JL, Kuhn C, Becker RC, Ortel TL, Williams RB, Rogers JG, O’Connor C, Velazquez EJ, Jiang W. Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients. European Journal Of Preventive Cardiology 2017, 24: 591-599. PMID: 28067532, PMCID: PMC6093615, DOI: 10.1177/2047487316686435.
Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial FibrillationWyrembak J, Campbell KB, Steinberg BA, Bahnson TD, Daubert JP, Velazquez EJ, Samad Z, Atwater BD. Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation. The American Journal Of Cardiology 2017, 119: 1017-1022. PMID: 28153350, DOI: 10.1016/j.amjcard.2016.12.008.
Rethinking Revascularization in Left Ventricular Systolic DysfunctionDeVore AD, Velazquez EJ. Rethinking Revascularization in Left Ventricular Systolic Dysfunction. Circulation Heart Failure 2017, 10: e003770. PMID: 28087689, PMCID: PMC5516273, DOI: 10.1161/circheartfailure.116.003770.
Associations between positive emotional well-being and stress-induced myocardial ischemia Well-being scores predict exercise-induced ischemiaFeigal JP, Boyle SH, Samad Z, Velazquez EJ, Wilson JL, Becker RC, Williams RB, Kuhn CM, Ortel TL, Rogers JG, O'Connor CM, Jiang W. Associations between positive emotional well-being and stress-induced myocardial ischemia Well-being scores predict exercise-induced ischemia. Journal Of Psychosomatic Research 2016, 93: 14-18. PMID: 28107887, PMCID: PMC6044283, DOI: 10.1016/j.jpsychores.2016.11.012.
Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial InfarctionPokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, Al-Khatib SM, Velazquez EJ, Peterson ED, Wang TY. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction. Circulation 2016, 135: 38-47. PMID: 27881561, DOI: 10.1161/circulationaha.116.022359.
Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment StrategiesSamad Z, Velazquez EJ. Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies. Current Cardiology Reports 2016, 18: 128. PMID: 27796864, DOI: 10.1007/s11886-016-0808-8.
Clinical and echocardiographic predictors of mortality in acute pulmonary embolismDahhan T, Siddiqui I, Tapson VF, Velazquez EJ, Sun S, Davenport CA, Samad Z, Rajagopal S. Clinical and echocardiographic predictors of mortality in acute pulmonary embolism. Cardiovascular Ultrasound 2016, 14: 44. PMID: 27793158, PMCID: PMC5086059, DOI: 10.1186/s12947-016-0087-y.
Pulmonary function and adverse cardiovascular outcomes: Can cardiac function explain the link?Peña M, Dunning A, Schulte PJ, Durheim MT, Kussin P, Checkley W, Velazquez EJ. Pulmonary function and adverse cardiovascular outcomes: Can cardiac function explain the link? Respiratory Medicine 2016, 121: 4-12. PMID: 27888991, DOI: 10.1016/j.rmed.2016.10.009.
Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic DysfunctionPetrie MC, Jhund PS, She L, Adlbrecht C, Doenst T, Panza JA, Hill JA, Lee KL, Rouleau JL, Prior DL, Ali IS, Maddury J, Golba KS, White HD, Carson P, Chrzanowski L, Romanov A, Miller AB, Velazquez EJ. Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction. Circulation 2016, 134: 1314-1324. PMID: 27573034, PMCID: PMC5089908, DOI: 10.1161/circulationaha.116.024800.
013 The Identification of Biomarkers That Predict Impending Heart Failure Preserved Ejection Fraction: Time to Diagnosis AnalysisLekavich C, Barksdale D, Velazquez E. 013 The Identification of Biomarkers That Predict Impending Heart Failure Preserved Ejection Fraction: Time to Diagnosis Analysis. Journal Of Cardiac Failure 2016, 22: s6. DOI: 10.1016/j.cardfail.2016.06.029.
Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart FailureHunter WG, Kelly JP, McGarrah RW, Khouri MG, Craig D, Haynes C, Ilkayeva O, Stevens RD, Bain JR, Muehlbauer MJ, Newgard CB, Felker GM, Hernandez AF, Velazquez EJ, Kraus WE, Shah SH. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure. Journal Of The American Heart Association 2016, 5: e003190. PMID: 27473038, PMCID: PMC5015273, DOI: 10.1161/jaha.115.003190.
Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial InfarctionLopes RD, Pieper KS, Stevens SR, Solomon SD, McMurray JJ, Pfeffer MA, Leimberger JD, Velazquez EJ. Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction. Journal Of The American Heart Association 2016, 5: e003045. PMID: 27353607, PMCID: PMC4937254, DOI: 10.1161/jaha.115.003045.
Platypnea-Orthodeoxia Syndrome: To Shunt or Not to Shunt, That is the QuestionKlein MR, Kiefer TL, Velazquez EJ. Platypnea-Orthodeoxia Syndrome: To Shunt or Not to Shunt, That is the Question. Texas Heart Institute Journal 2016, 43: 264-6. PMID: 27303248, PMCID: PMC4894711, DOI: 10.14503/thij-15-5280.
Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANTAbdul-Rahim AH, Docherty KF, Skali H, Køber L, Dickstein K, Maggioni AP, Mareev V, Zannad F, Velazquez EJ, Califf RM, Pfeffer MA, Solomon SD, Lees KR, McMurray JJ. Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT. European Stroke Journal 2016, 1: 93-100. PMID: 31008270, PMCID: PMC6301225, DOI: 10.1177/2396987316646025.
Nitrates in Heart Failure with Preserved Ejection FractionRedfield MM, Velazquez EJ, Braunwald E. Nitrates in Heart Failure with Preserved Ejection Fraction. New England Journal Of Medicine 2016, 374: 1587-1589. PMID: 27096585, DOI: 10.1056/nejmc1601507.
Coronary-Artery Bypass Surgery in Patients with Ischemic CardiomyopathyVelazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. New England Journal Of Medicine 2016, 374: 1511-1520. PMID: 27040723, PMCID: PMC4938005, DOI: 10.1056/nejmoa1602001.
MENTAL STRESS-INDUCED PLATELET AGGREGATION PREDICTS ADVERSE CARDIOVASCULAR OUTCOME IN ISCHEMIC HEART DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPYSun J, Boyle S, Ortel T, Samad Z, Babyak M, Wilson J, Kuhn C, Williams R, Rogers J, Velazquez E, O’Connor C, Becker R, Jiang W. MENTAL STRESS-INDUCED PLATELET AGGREGATION PREDICTS ADVERSE CARDIOVASCULAR OUTCOME IN ISCHEMIC HEART DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY. Journal Of The American College Of Cardiology 2016, 67: 2159. DOI: 10.1016/s0735-1097(16)32160-x.
Getting to a Man's Heart through His ColonSamsky MD, DeVore AD, Durkin M, Stout JE, Velazquez EJ, Milano CA. Getting to a Man's Heart through His Colon. Texas Heart Institute Journal 2016, 43: 168-70. PMID: 27127437, PMCID: PMC4845564, DOI: 10.14503/thij-14-4946.
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyWeber MA, Bloch M, Bakris GL, Weir MR, Zappe DH, Dahlof B, Velazquez EJ, Pitt B, Basile JN, Jamerson K, Hua TA. Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. Journal Of Clinical Hypertension 2016, 18: 299-307. PMID: 27060568, PMCID: PMC8032014, DOI: 10.1111/jch.12816.
Tackling NCD in LMIC Achievements and Lessons Learned From the NHLBI–UnitedHealth Global Health Centers of Excellence ProgramEngelgau M, Sampson U, Rabadan-Diehl C, Smith R, Miranda J, Bloomfield G, Belis D, Narayan K, National Health L, Rubinstein A, He J, Alam D, Peters D, Wu Y, Yan L, Merson M, Ramirez M, Caballero B, Xavier D, Yusuf S, Prabhakaran D, Narayan K, Kimaiyo S, Velazquez E, Denman C, Cornejo E, de Zapien J, Rosales C, Miranda J, Gilman R, Levitt N, Gaziano T, Ghannem H, Laatikainen T, Rabadan-Diehl C, Engelgau M, Belis D, Sampson U, Smith R, Dianis N, Wolbach T, Matta G, Gutierrez L, Elorriaga N, Poggio R, Irazola V, Bazzano L, Bhuiya A, Wazed A, Khan A, Siddiquee A, Islam A, Khan J, Uddin J, Hasan K, Khanam M, Yunus M, Chowdhury M, Monalisa N, Alam N, Streatfield P, Ahmed S, Parvin S, Ali T, Niessen L, Hossain M, Koehlmoos T, Standing H, Lucas H, Bleich S, Anderson G, Trujillo A, Mirelman A, Hao J, Zhang J, Tian M, Huang P, Luo R, Fang W, Li X, Feng X, Li Z, Deal K, Peterson E, DeLong E, Zhou B, Shi J, Neal B, Jan S, Li N, McMahon S, Zhang J, Sun J, Elliot P, Zhao Y, Zhang Y, Yao C, Sun N, Han Q, Shen R, Niu W, Wang Y, Ke Y, Huang Y, Leeder S, Lopez A, Zhang R, Yu Y, Roman A, Mendoza C, Roche D, Mejicano G, Cordova M, Kroker M, Fort M, Letona P, Kanter R, Garcia R, Murillo S, Chacon V, Montero R, Lopez E, Peña L, Castro M, Dengo A, Ulate E, Alvarado N, Sibrian J, Alegria A, Gutierrez A, Fontes F, Sigamani A, Kamath D, Xavier F, Deepthi K, Anupama M, Mathu N, George N, Rahul P, Pais P, Girish P, Thomas S, Usha T, Thomas T, Joshi R, Chidambaram N, Gupta R, Chow C, Pogue J, O'Donnell M, Devereaux P, Misquith D, Agrawal T, Fathima F, Reddy K, Shivashankar R, Ajay V, Khan H, Kadir M, Masood M, Fatmi Z, Krishnan A, Singh K, Tandon N, Khadgawat R, Menon V, Sethi B, Unnikrishnan A, Hutcheson M, Ali M, Cunningham S, Patel S, Gujral U, Desai A, Mohan D, Pradeepa R, Mohan V, Viswanathan V, Sahay R, Shah S, Bantwal G, Varthakavi P, Nair M, Akwanalo C, Lagat D, Barasa F, Koech M, Sugut W, Korir B, Mosol P, Ali S, Sherman C, Carter J, Bloomfield G, Binanay C, Vedanthan R, Bernabé-Ortiz A, León-Velarde F, Smith G, Málaga G, García H, Casas J, Sacksteder K, Smeeth L, Huicho L, Rivera M, Gamboa R, Ebrahim S, Montori V, Wise R, Checkley W, Diette G, Nojilana B, Majikela-Dlangamandla B, Sylvester C, Malan J, Murphy K, Steyn K, van Niekerk L, Mash R, Puoane T, Kim G, Pandya A, Abrahams-Gessel S, Rhode H, Pather M, Andrade A, Garcia B, Velasco C, Medina D, Bravo D, Munguia D, Bateman E, Castro F, Schneider H, Ibarra I, Zulu J, Felix J, Tribe K, Bobrow K, Fairall L, Folb N, Murillo N, Pacheco N, Rodriguez P, Navarro P, Flores R, Van Zyl Smit R, Meddoza R, Surka S, Van Haght S, Hernandez Y, Tsolekile L, Jeridi G, Harrabi I, Maatoug J, Boughammoura L, Chaieb L, Mrizek N, Gaha R, Limam K, Amimi S, Gaha K, Gamra H, Al'Absi M, Vartiainen E, Moore C, Spillan D, Cooper K, Mitchell M, Kirby R, Gao Y, Aluko E. Tackling NCD in LMIC Achievements and Lessons Learned From the NHLBI–UnitedHealth Global Health Centers of Excellence Program. Global Heart 2016, 11: 5-15. PMID: 27102018, PMCID: PMC4843818, DOI: 10.1016/j.gheart.2015.12.016.
Implementing a Continuous Quality Improvement Program in a High-Volume Clinical Echocardiography LaboratorySamad Z, Minter S, Armour A, Tinnemore A, Sivak JA, Sedberry B, Strub K, Horan SM, Harrison JK, Kisslo J, Douglas PS, Velazquez EJ. Implementing a Continuous Quality Improvement Program in a High-Volume Clinical Echocardiography Laboratory. Circulation Cardiovascular Imaging 2016, 9: e003708. PMID: 26957220, DOI: 10.1161/circimaging.115.003708.
Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural KenyaBloomfield GS, DeLong AK, Akwanalo CO, Hogan JW, Carter EJ, Aswa DF, Binanay C, Koech M, Kimaiyo S, Velazquez EJ. Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya. Global Heart 2016, 11: 97-107. PMID: 27102027, PMCID: PMC4843836, DOI: 10.1016/j.gheart.2015.12.014.
An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective EndocarditisSivak JA, Vora AN, Navar AM, Schulte PJ, Crowley AL, Kisslo J, Corey GR, Liao L, Wang A, Velazquez EJ, Samad Z. An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective Endocarditis. Journal Of The American Society Of Echocardiography 2016, 29: 315-322. PMID: 26850679, PMCID: PMC6052444, DOI: 10.1016/j.echo.2015.12.009.
Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunctionSamad Z, Vora AN, Dunning A, Schulte PJ, Shaw LK, Al-Enezi F, Ersboll M, McGarrah RW, Vavalle JP, Shah SH, Kisslo J, Glower D, Harrison JK, Velazquez EJ. Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction. European Heart Journal 2016, 37: 2276-2286. PMID: 26787441, PMCID: PMC5841220, DOI: 10.1093/eurheartj/ehv701.
Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and CostsDeVore AD, Schulte PJ, Mentz RJ, Hardy NC, Kelly JP, Velazquez EJ, Maya JF, Kielhorn A, Patel HK, Reed SD, Hernandez AF. Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs. The American Journal Of Cardiology 2015, 117: 946-951. PMID: 26805662, PMCID: PMC5429586, DOI: 10.1016/j.amjcard.2015.12.031.
Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western KenyaBinanay CA, Akwanalo CO, Aruasa W, Barasa FA, Corey GR, Crowe S, Esamai F, Einterz R, Foster MC, Gardner A, Kibosia J, Kimaiyo S, Koech M, Korir B, Lawrence JE, Lukas S, Manji I, Maritim P, Ogaro F, Park P, Pastakia SD, Sugut W, Vedanthan R, Yanoh R, Velazquez EJ, Bloomfield GS. Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya. Journal Of The American College Of Cardiology 2015, 66: 2550-2560. PMID: 26653630, PMCID: PMC4680855, DOI: 10.1016/j.jacc.2015.09.086.
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)Mentz RJ, Hasselblad V, DeVore AD, Metra M, Voors AA, Armstrong PW, Ezekowitz JA, Tang WH, Schulte PJ, Anstrom KJ, Hernandez AF, Velazquez EJ, O'Connor CM. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). The American Journal Of Cardiology 2015, 117: 404-411. PMID: 26704029, PMCID: PMC4718787, DOI: 10.1016/j.amjcard.2015.10.059.
Abstract 15647: Mental Stress-Induced Reductions in Left Ventricular Ejection Fraction Predict Future Heart Failure ExacerbationNewhouse A, Boyle S, Sun J, Zainab S, Babyak M, Wilson J, Kuhn C, Becker R, Ortel T, Williams R, Rogers J, O'Connor C, Velazquez E, Jiang W. Abstract 15647: Mental Stress-Induced Reductions in Left Ventricular Ejection Fraction Predict Future Heart Failure Exacerbation. Circulation 2015, 132 DOI: 10.1161/circ.132.suppl_3.15647.
Abstract 17580: Angina Pectoris in Diabetic Patients: Insights From the Duke Databank for Cardiovascular DiseaseMentz R, Banks A, Broderick S, DeVore A, Chiswell K, Shaw L, Fiuzat M, Velazquez E, Felker G, O'Connor C. Abstract 17580: Angina Pectoris in Diabetic Patients: Insights From the Duke Databank for Cardiovascular Disease. Circulation 2015, 132 DOI: 10.1161/circ.132.suppl_3.17580.
Abstract 19770: TAVR Versus Medical Management Among Patients With Severe Aortic Stenosis and Left Ventricular Systolic DysfunctionVora A, Harrison J, Dunning A, Schulte P, Sherwood M, Kisslo J, Hughes G, Alenezi F, Velazquez E, Samad Z. Abstract 19770: TAVR Versus Medical Management Among Patients With Severe Aortic Stenosis and Left Ventricular Systolic Dysfunction. Circulation 2015, 132 DOI: 10.1161/circ.132.suppl_3.19770.
Abstract 17304: Sudden Cardiac Death After Acute Heart Failure Hospitalization: Insights From ASCEND-HFPokorney S, Al-Khatib S, Sun J, Schulte P, O'Connor C, Teerlink J, Armstrong P, Ezekowitz J, Starling R, Voors A, Velazquez E, Hernandez A, Mentz R. Abstract 17304: Sudden Cardiac Death After Acute Heart Failure Hospitalization: Insights From ASCEND-HF. Circulation 2015, 132 DOI: 10.1161/circ.132.suppl_3.17304.
Isosorbide Mononitrate in Heart Failure with Preserved Ejection FractionRedfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, LeWinter MM, Joseph SM, Shah SJ, Semigran MJ, Felker GM, Cole RT, Reeves GR, Tedford RJ, Tang WH, McNulty SE, Velazquez EJ, Shah MR, Braunwald E. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. New England Journal Of Medicine 2015, 373: 2314-2324. PMID: 26549714, PMCID: PMC4712067, DOI: 10.1056/nejmoa1510774.
Importance of Angina in Patients With Coronary Disease, Heart Failure, and Left Ventricular Systolic Dysfunction Insights From STICHJolicœur EM, Dunning A, Castelvecchio S, Dabrowski R, Waclawiw MA, Petrie MC, Stewart R, Jhund PS, Desvigne-Nickens P, Panza JA, Bonow RO, Sun B, San TR, Al-Khalidi HR, Rouleau JL, Velazquez EJ, Cleland JGF. Importance of Angina in Patients With Coronary Disease, Heart Failure, and Left Ventricular Systolic Dysfunction Insights From STICH. Journal Of The American College Of Cardiology 2015, 66: 2092-2100. PMID: 26541919, PMCID: PMC4655599, DOI: 10.1016/j.jacc.2015.08.882.
Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trialMentz RJ, Velazquez EJ, Metra M, McKendry C, Chiswell K, Fiuzat M, Givertz MM, Voors AA, Teerlink JR, O'Connor CM. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial. Future Cardiology 2015, 11: 585-595. PMID: 26403536, PMCID: PMC5558519, DOI: 10.2217/fca.15.56.
Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical RevascularizationBonow RO, Castelvecchio S, Panza JA, Berman DS, Velazquez EJ, Michler RE, She L, Holly TA, Desvigne-Nickens P, Kosevic D, Rajda M, Chrzanowski L, Deja M, Lee KL, White H, Oh JK, Doenst T, Hill JA, Rouleau JL, Menicanti L, Investigators S. Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. JACC Cardiovascular Imaging 2015, 8: 1121-1129. PMID: 26363840, PMCID: PMC4633018, DOI: 10.1016/j.jcmg.2015.03.013.
Temporal Trends in Disease Severity and Predicted Surgical Risk at the Time of Referral for Echocardiography in Patients Diagnosed with Aortic StenosisErsboll M, Samad Z, Enezi F, Kisslo J, Schulte PJ, Shaw LK, Køber L, Harrison JK, Bashore T, Brennan M, Velazquez EJ. Temporal Trends in Disease Severity and Predicted Surgical Risk at the Time of Referral for Echocardiography in Patients Diagnosed with Aortic Stenosis. Critical Pathways In Cardiology A Journal Of Evidence-Based Medicine 2015, 14: 103-109. PMID: 26214813, DOI: 10.1097/hpc.0000000000000048.
Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular DysfunctionWrobel K, Stevens SR, Jones RH, Selzman CH, Lamy A, Beaver TM, Djokovic LT, Wang N, Velazquez EJ, Sopko G, Kron IL, DiMaio JM, Michler RE, Lee KL, Yii M, Leng CY, Zembala M, Rouleau JL, Daly RC, Al-Khalidi HR. Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction. Circulation 2015, 132: 720-730. PMID: 26304663, PMCID: PMC4551105, DOI: 10.1161/circulationaha.114.014932.
Household Air Pollution From Burning Wood Is Associated With Altered Cardiac Hemodynamics And Function Among Women In Western Kenya: Results From The Kenya Hap Echo StudyKirwa K, Agarwal A, Bloomfield G, Alenezi F, Eliot M, Carter J, Ogaro F, Sherman C, Kimaiyo S, Mitter S, Velazquez E, Menya D, Welllenius G, Vedanthan R. Household Air Pollution From Burning Wood Is Associated With Altered Cardiac Hemodynamics And Function Among Women In Western Kenya: Results From The Kenya Hap Echo Study. ISEE Conference Abstracts 2015, 2015 DOI: 10.1289/isee.2015.2015-2522.
The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparisonVelazquez EJ, Samad Z, Al-Khalidi HR, Sangli C, Grayburn PA, Massaro JM, Stevens SR, Feldman TE, Krucoff MW. The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. American Heart Journal 2015, 170: 1050-1059.e3. PMID: 26542516, DOI: 10.1016/j.ahj.2015.08.004.
Novel Protein Glycan Inflammatory Biomarkers Predict Adverse Events in Heart Failure with Preserved Ejection FractionKelly J, Hunter W, McGarrah R, Craig D, Haynes C, Velazquez E, Felker G, Hernandez A, Newgard C, Shah S, Kraus W. Novel Protein Glycan Inflammatory Biomarkers Predict Adverse Events in Heart Failure with Preserved Ejection Fraction. Journal Of Cardiac Failure 2015, 21: s89. DOI: 10.1016/j.cardfail.2015.06.266.
Elevated Heart Rate in Patients with Heart Failure with Reduced Ejection Fraction: Associations with One-Year Survival and CostsDeVore A, Schulte P, Mentz R, Hardy N, Kelly J, Velazquez E, Maya J, Kielhorn A, Patel H, Reed S, Hernandez A. Elevated Heart Rate in Patients with Heart Failure with Reduced Ejection Fraction: Associations with One-Year Survival and Costs. Journal Of Cardiac Failure 2015, 21: s121-s122. DOI: 10.1016/j.cardfail.2015.06.349.
Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunctionSamad Z, Shaw LK, Phelan M, Ersboll M, Risum N, Al-Khalidi HR, Glower DD, Milano CA, Alexander JH, O'Connor CM, Wang A, Velazquez EJ. Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. European Heart Journal 2015, 36: 2733-2741. PMID: 26233850, DOI: 10.1093/eurheartj/ehv343.
Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income CountriesBloomfield GS, Alenezi F, Barasa FA, Lumsden R, Mayosi BM, Velazquez EJ. Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries. JACC Heart Failure 2015, 3: 579-590. PMID: 26251085, PMCID: PMC4530470, DOI: 10.1016/j.jchf.2015.05.003.
Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarctionGarber AM, Mentz RJ, Al-Khalidi HR, Shaw LK, Fiuzat M, O’Connor C, Velazquez EJ. Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarction. Journal Of Thrombosis And Thrombolysis 2015, 41: 365-373. PMID: 26202909, DOI: 10.1007/s11239-015-1252-0.
Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Mechanistic Action and Clinical ImpactBuggey J, Mentz RJ, DeVore AD, Velazquez EJ. Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Mechanistic Action and Clinical Impact. Journal Of Cardiac Failure 2015, 21: 741-750. PMID: 26209000, DOI: 10.1016/j.cardfail.2015.07.008.
Current and emerging modalities for detection of cardiotoxicity in cardio-oncologyKhouri MG, Klein MR, Velazquez EJ, Jones LW. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology. Future Cardiology 2015, 11: 471-484. PMID: 26235924, PMCID: PMC5558528, DOI: 10.2217/fca.15.16.
Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial)Grayburn PA, She L, Roberts BJ, Golba KS, Mokrzycki K, Drozdz J, Cherniavsky A, Przybylski R, Wrobel K, Asch FM, Holly TA, Haddad H, Yii M, Maurer G, Kron I, Schaff H, Velazquez EJ, Oh JK. Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial). The American Journal Of Cardiology 2015, 116: 913-918. PMID: 26170249, PMCID: PMC4554976, DOI: 10.1016/j.amjcard.2015.06.015.
Use of outcome measures in pulmonary hypertension clinical trialsParikh KS, Rajagopal S, Arges K, Ahmad T, Sivak J, Kaul P, Shah SH, Tapson V, Velazquez EJ, Douglas PS, Samad Z. Use of outcome measures in pulmonary hypertension clinical trials. American Heart Journal 2015, 170: 419-429.e3. PMID: 26385024, DOI: 10.1016/j.ahj.2015.06.010.
Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL)Bloomfield GS, Temu TM, Akwanalo CO, Chen PS, Emonyi W, Heckbert SR, Koech MM, Manji I, Shen C, Vatta M, Velazquez EJ, Wessel J, Kimaiyo S, Inui TS. Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL). American Heart Journal 2015, 170: 455-464.e5. PMID: 26385028, PMCID: PMC4575772, DOI: 10.1016/j.ahj.2015.06.008.
A balanced assessment of the STICH trialHolly TA, Bonow RO, Velazquez EJ, Panza JA. A balanced assessment of the STICH trial. Journal Of Thoracic And Cardiovascular Surgery 2015, 149: 1683-1684. PMID: 26060013, DOI: 10.1016/j.jtcvs.2015.03.036.
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trialMacDonald MR, She L, Doenst T, Binkley PF, Rouleau JL, Tan R, Lee KL, Miller AB, Sopko G, Szalewska D, Waclawiw MA, Dabrowski R, Castelvecchio S, Adlbrecht C, Michler RE, Oh JK, Velazquez EJ, Petrie MC. Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. European Journal Of Heart Failure 2015, 17: 725-734. PMID: 26011509, PMCID: PMC4668269, DOI: 10.1002/ejhf.288.
Influence of QRS infarct score and QRS duration prior to transcatheter aortic valve replacement on follow-up left ventricular end systolic volume in patients with new persistent left bundle branch blockHannink LG, Wagner GS, Kisslo J, Alenezi FA, Shaw LK, Hofmann P, Zusterzeel R, Phelan M, Velazquez EJ, Gorgels AP. Influence of QRS infarct score and QRS duration prior to transcatheter aortic valve replacement on follow-up left ventricular end systolic volume in patients with new persistent left bundle branch block. Journal Of Electrocardiology 2015, 48: 637-642. PMID: 25959263, DOI: 10.1016/j.jelectrocard.2015.04.010.
Torsemide Versus Furosemide in Heart Failure PatientsMentz RJ, Buggey J, Fiuzat M, Ersbøll MK, Schulte PJ, DeVore AD, Eisenstein EL, Anstrom KJ, O'Connor C, Velazquez EJ. Torsemide Versus Furosemide in Heart Failure Patients. Journal Of Cardiovascular Pharmacology 2015, 65: 438-443. PMID: 25945862, PMCID: PMC4423558, DOI: 10.1097/fjc.0000000000000212.
Response to Letter Regarding Article, “Surgical Revascularization Is Associated With Maximal Survival in Patients With Ischemic Mitral RegurgitationCastleberry AW, Williams JB, Daneshmand MA, Honeycutt E, Shaw LK, Samad Z, Lopes RD, Alexander JH, Mathew JP, Velazquez EJ, Milano CA, Smith PK. Response to Letter Regarding Article, “Surgical Revascularization Is Associated With Maximal Survival in Patients With Ischemic Mitral Regurgitation. Circulation 2015, 131: e378-e379. PMID: 25779550, PMCID: PMC5126645, DOI: 10.1161/circulationaha.114.013125.
Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow‐up from the STICH trialChoi J, Daly RC, Lin G, Lahr BD, Wiste HJ, Beaver TM, Iacovoni A, Malinowski M, Friedrich I, Rouleau JL, Favaloro RR, Sopko G, Lang IM, White HD, Milano CA, Jones RH, Lee KL, Velazquez EJ, Oh JK. Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow‐up from the STICH trial. European Journal Of Heart Failure 2015, 17: 453-463. PMID: 25779355, PMCID: PMC4664050, DOI: 10.1002/ejhf.256.
Outcomes of Anatomical versus Functional Testing for Coronary Artery DiseaseDouglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, Cole J, Dolor RJ, Fordyce CB, Huang M, Khan MA, Kosinski AS, Krucoff MW, Malhotra V, Picard MH, Udelson JE, Velazquez EJ, Yow E, Cooper LS, Lee KL. Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease. New England Journal Of Medicine 2015, 372: 1291-1300. PMID: 25773919, PMCID: PMC4473773, DOI: 10.1056/nejmoa1415516.
Relationship Between Daily Exposure to Biomass Fuel Smoke and Blood Pressure in High-Altitude PeruBurroughs Peña M, Romero KM, Velazquez EJ, Davila-Roman VG, Gilman RH, Wise RA, Miranda JJ, Checkley W. Relationship Between Daily Exposure to Biomass Fuel Smoke and Blood Pressure in High-Altitude Peru. Hypertension 2015, 65: 1134-1140. PMID: 25753976, PMCID: PMC4466100, DOI: 10.1161/hypertensionaha.114.04840.
DOES BASELINE GLOBAL LONGITUDINAL STRAIN PREDICT MORTALITY IN HIGH RISK PATIENTS WITH AORTIC STENOSIS AND LEFT VENTRICULAR DYSFUNCTION?Vora A, Alenezi F, Dunning A, Schulte P, Shah S, Kisslo J, Harrison J, Velazquez E, Samad Z. DOES BASELINE GLOBAL LONGITUDINAL STRAIN PREDICT MORTALITY IN HIGH RISK PATIENTS WITH AORTIC STENOSIS AND LEFT VENTRICULAR DYSFUNCTION? Journal Of The American College Of Cardiology 2015, 65: a1982. DOI: 10.1016/s0735-1097(15)61982-9.
METABOLOMIC PROFILING IN HEART FAILURE IDENTIFIES BIOMARKERS OF MITOCHONDRIAL FUNCTION IN PRESERVED VERSUS REDUCED EJECTION FRACTIONHunter W, Kelly J, Craig D, Haynes C, McGarrah R, Velazquez E, Felker G, Hernandez A, Ilkayeva O, Stevens R, Bain J, Muehlbauer M, Newgard C, Kraus W, Shah S. METABOLOMIC PROFILING IN HEART FAILURE IDENTIFIES BIOMARKERS OF MITOCHONDRIAL FUNCTION IN PRESERVED VERSUS REDUCED EJECTION FRACTION. Journal Of The American College Of Cardiology 2015, 65: a774. DOI: 10.1016/s0735-1097(15)60774-4.
IMPAIRED LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: INSIGHTS FROM THE RELAX TRIALDeVore A, McNulty S, Alenezi F, Ersboll M, Oh J, Lin G, Redfield M, Lewis G, Semigran M, Anstrom K, Hernandez A, Velazquez E. IMPAIRED LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: INSIGHTS FROM THE RELAX TRIAL. Journal Of The American College Of Cardiology 2015, 65: a979. DOI: 10.1016/s0735-1097(15)60979-2.
TO SHUNT OR NOT TO SHUNT, THAT IS THE QUESTION: THE PLATYPNEA-ORTHODEOXIA SYNDROMEKlein M, Kiefer T, Velazquez E. TO SHUNT OR NOT TO SHUNT, THAT IS THE QUESTION: THE PLATYPNEA-ORTHODEOXIA SYNDROME. Journal Of The American College Of Cardiology 2015, 65: a587. DOI: 10.1016/s0735-1097(15)60587-3.
METABOLOMIC PROFILING IDENTIFIES BIOMARKERS PREDICTING ADVERSE OUTCOMES IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTIONKelly J, Hunter W, Craig D, Haynes C, McGarrah R, Velazquez E, Felker M, Hernandez A, Ilkayeva O, Stevens R, Bain J, Muehlbauer M, Newgard C, Kraus W, Shah S. METABOLOMIC PROFILING IDENTIFIES BIOMARKERS PREDICTING ADVERSE OUTCOMES IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION. Journal Of The American College Of Cardiology 2015, 65: a772. DOI: 10.1016/s0735-1097(15)60772-0.
THE PROGNOSTIC SIGNIFICANCE OF POSITIVE ELECTROCARDIOGRAPHY FINDINGS WITH NORMAL EXERCISE ECHOCARDIOGRAPHYSivak J, Daubert M, Minter S, Armour A, Tinnemore A, Smith R, Benedict L, Coyne B, Samad Z, Velazquez E. THE PROGNOSTIC SIGNIFICANCE OF POSITIVE ELECTROCARDIOGRAPHY FINDINGS WITH NORMAL EXERCISE ECHOCARDIOGRAPHY. Journal Of The American College Of Cardiology 2015, 65: a1635. DOI: 10.1016/s0735-1097(15)61635-7.
Implementation of Management Strategies for Diabetes and Hypertension From Local to Global Health in Cardiovascular DiseasesBloomfield GS, Wang TY, Boulware LE, Califf RM, Hernandez AF, Velazquez EJ, Peterson ED, Li JS. Implementation of Management Strategies for Diabetes and Hypertension From Local to Global Health in Cardiovascular Diseases. Global Heart 2015, 10: 31-38. PMID: 25754564, PMCID: PMC4754665, DOI: 10.1016/j.gheart.2014.12.010.
Outcomes After Nonemergent Electrical Cardioversion for Atrial ArrhythmiasSteinberg BA, Schulte PJ, Hofmann P, Ersbøll M, Alexander JH, Broderick-Forsgren K, Anstrom KJ, Granger CB, Piccini JP, Velazquez EJ, Shah BR. Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias. The American Journal Of Cardiology 2015, 115: 1407-1414. PMID: 25784514, PMCID: PMC4414802, DOI: 10.1016/j.amjcard.2015.02.030.
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Lam CS, McEntegart M, Claggett B, Liu J, Skali H, Lewis E, Køber L, Rouleau J, Velazquez E, Califf R, McMurray JJ, Pfeffer M, Solomon S. Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). European Journal Of Heart Failure 2015, 17: 301-312. PMID: 25655011, DOI: 10.1002/ejhf.238.
Revascularization in Severe Left Ventricular DysfunctionVelazquez EJ, Bonow RO. Revascularization in Severe Left Ventricular Dysfunction. Journal Of The American College Of Cardiology 2015, 65: 615-624. PMID: 25677320, DOI: 10.1016/j.jacc.2014.10.070.
Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) TrialsFeldman AM, She L, McNamara DM, Mann DL, Bristow MR, Maisel AS, Wagner DR, Andersson B, Chiariello L, Hayward CS, Hendry P, Parker JD, Racine N, Selzman CH, Senni M, Stepinska J, Zembala M, Rouleau J, Velazquez EJ, Lee KL. Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials. Cardiology 2015, 130: 69-81. PMID: 25592552, PMCID: PMC4367125, DOI: 10.1159/000368221.
A reappraisal of loop diuretic choice in heart failure patientsBuggey J, Mentz RJ, Pitt B, Eisenstein EL, Anstrom KJ, Velazquez EJ, O'Connor CM. A reappraisal of loop diuretic choice in heart failure patients. American Heart Journal 2015, 169: 323-333. PMID: 25728721, PMCID: PMC4346710, DOI: 10.1016/j.ahj.2014.12.009.
Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) studyJiang W, Boyle SH, Ortel TL, Samad Z, Velazquez EJ, Harrison RW, Wilson J, Kuhn C, Williams RB, O’Connor C, Becker RC. Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study. American Heart Journal 2014, 169: 496-507.e1. PMID: 25819856, PMCID: PMC4382806, DOI: 10.1016/j.ahj.2014.12.002.
Abstract 11123: Outcomes After Percutaneous Coronary Intervention for Patients With Stable Coronary Disease and Left Ventricular Systolic DysfunctionDeVore A, Yow E, Krucoff M, Shaw L, Chiswell K, O’Connor C, Ohman E, Velazquez E. Abstract 11123: Outcomes After Percutaneous Coronary Intervention for Patients With Stable Coronary Disease and Left Ventricular Systolic Dysfunction. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.11123.
Abstract 14658: Comparative Effectiveness of Torsemide versus Furosemide in Acute Heart Failure Patients: Insights from ASCEND-HFMentz R, Hasselblad V, DeVore A, Armstrong P, Ezekowitz J, Tang W, Voors A, Metra M, Hernandez A, Califf R, Anstrom K, Velazquez E, O’Connor C. Abstract 14658: Comparative Effectiveness of Torsemide versus Furosemide in Acute Heart Failure Patients: Insights from ASCEND-HF. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.14658.
Abstract 15545: Incremental Prognostic Value of Echocardiographic Markers of Left Ventricular Remodeling and Diastolic Function in the Surgical Treatment for Ischemic Heart Failure TrialLin G, She L, Lee K, Dabrowski R, Grayburn P, Rajda M, Prior D, Desvigne-Nickens P, Zoghbi W, Miller D, Senni M, Stefanelli G, Hathaway W, Beghi C, Hyunh T, Velazquez E, Oh J. Abstract 15545: Incremental Prognostic Value of Echocardiographic Markers of Left Ventricular Remodeling and Diastolic Function in the Surgical Treatment for Ischemic Heart Failure Trial. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.15545.
Abstract 16620: The Prognostic Value of Mechanical Dyssynchrony Measured by GSPECT MPI versus Electrical Dyssnchrony Measured by QRS Duration Among Patients With an Ejection Fraction >35%Hess P, Shaw L, Al-Khatib S, Samad Z, Velazquez E, O’Connor C, Borges-Neto S. Abstract 16620: The Prognostic Value of Mechanical Dyssynchrony Measured by GSPECT MPI versus Electrical Dyssnchrony Measured by QRS Duration Among Patients With an Ejection Fraction >35%. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.16620.
Abstract 16683: Reduced Lung Function is Associated With Decreased Ejection Fraction and Decreased Left Ventricular Size in Patients in a Tertiary Care CenterBurroughs Pena M, Durheim M, Schulte P, Kussin P, Checkley W, Velazquez E. Abstract 16683: Reduced Lung Function is Associated With Decreased Ejection Fraction and Decreased Left Ventricular Size in Patients in a Tertiary Care Center. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.16683.
Abstract 17973: Biomass Fuel Use is Associated With Elevated Blood Pressure and Hypertension Status in Puno, PeruBurroughs Pena M, Romero K, Bernabe Ortiz A, Velazquez E, Miranda J, Gilman R, Checkley W. Abstract 17973: Biomass Fuel Use is Associated With Elevated Blood Pressure and Hypertension Status in Puno, Peru. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.17973.
Abstract 18699: Negative Predictive Value of Transthoracic Echocardiography for Infective Endocarditis in the Modern EraSivak J, Vora A, Navar-Boggan A, Crowley A, Kisslo J, Velazquez E, Samad Z. Abstract 18699: Negative Predictive Value of Transthoracic Echocardiography for Infective Endocarditis in the Modern Era. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.18699.
Abstract 18816: Relationship of Aortic Valve Surgery and Survival in Patients with Moderate or Severe Aortic Stenosis and Left Ventricular DysfunctionSamad Z, Vora A, Dunning A, Sivak J, Shaw L, Vavalle J, Sherwood M, Hofmann P, Glower D, Kisslo J, Harrison J, Velazquez E. Abstract 18816: Relationship of Aortic Valve Surgery and Survival in Patients with Moderate or Severe Aortic Stenosis and Left Ventricular Dysfunction. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.18816.
Abstract 19392: A Landmark Analysis of 30-day Mortality after Coronary Artery Bypass Surgery in Patients with Ischemic Heart Failure: Results of the Surgical Treatment for Ischemic Heart Failure (STICH) TrialWrobel K, Stevens S, Jones R, Selzman C, Lamy A, Beaver T, Djokovic L, Wang N, Velazquez E, Sopko G, Kron I, DiMaio M, Michler R, Lee K, Yii M, Chua Y, Zembala M, Rouleau J, Al-Khalidi H, Daly R. Abstract 19392: A Landmark Analysis of 30-day Mortality after Coronary Artery Bypass Surgery in Patients with Ischemic Heart Failure: Results of the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.19392.
Abstract 19474: Clinical Characteristics and Outcomes of Patients With and Without Diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trialMacDonald M, She L, Doenst T, Binkley P, Rouleau J, San T, Lee K, Sopko G, Szalewski D, Velazquez E, Petrie M. Abstract 19474: Clinical Characteristics and Outcomes of Patients With and Without Diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.19474.
Predictors and Progression of Aortic Stenosis in Patients With Preserved Left Ventricular Ejection FractionErsboll M, Schulte PJ, Enezi F, Shaw L, Køber L, Kisslo J, Siddiqui I, Piccini J, Glower D, Harrison JK, Bashore T, Risum N, Jollis JG, Velazquez EJ, Samad Z. Predictors and Progression of Aortic Stenosis in Patients With Preserved Left Ventricular Ejection Fraction. The American Journal Of Cardiology 2014, 115: 86-92. PMID: 25456876, DOI: 10.1016/j.amjcard.2014.09.049.
Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstructionKukulski T, She L, Racine N, Gradinac S, Panza JA, Velazquez EJ, Chan K, Petrie MC, Lee KL, Pellikka PA, Romanov A, Biernat J, Rouleau JL, Batlle C, Rogowski J, Ferrazzi P, Zembala M, Oh JK, Investigators S. Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. Journal Of Thoracic And Cardiovascular Surgery 2014, 149: 1312-1321. PMID: 25451487, PMCID: PMC4385741, DOI: 10.1016/j.jtcvs.2014.09.117.
Sex Differences in Platelet Reactivity and Cardiovascular and Psychological Response to Mental Stress in Patients With Stable Ischemic Heart Disease Insights From the REMIT StudySamad Z, Boyle S, Ersboll M, Vora AN, Zhang Y, Becker RC, Williams R, Kuhn C, Ortel TL, Rogers JG, O’Connor C, Velazquez EJ, Jiang W, Investigators R. Sex Differences in Platelet Reactivity and Cardiovascular and Psychological Response to Mental Stress in Patients With Stable Ischemic Heart Disease Insights From the REMIT Study. Journal Of The American College Of Cardiology 2014, 64: 1669-1678. PMID: 25323254, PMCID: PMC4752118, DOI: 10.1016/j.jacc.2014.04.087.
Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial.Mark DB, Knight JD, Velazquez EJ, Wasilewski J, Howlett JG, Smith PK, Spertus JA, Rajda M, Yadav R, Hamman BL, Malinowski M, Naik A, Rankin G, Harding TM, Drew LA, Desvigne-Nickens P, Anstrom KJ. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Annals Of Internal Medicine 2014, 161: 392-9. PMID: 25222386, PMCID: PMC4182862, DOI: 10.7326/m13-1380.
Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunctionBoyle SH, Matson WR, Velazquez EJ, Samad Z, Williams RB, Sharma S, Thomas B, Wilson JL, O’Connor C, Jiang W. Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunction. Metabolomics 2014, 11: 571-582. PMID: 25983674, PMCID: PMC4431771, DOI: 10.1007/s11306-014-0718-y.
HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART EraBloomfield GS, Khazanie P, Morris A, Rabadán-Diehl C, Benjamin LA, Murdoch D, Radcliff VS, Velazquez EJ, Hicks C. HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART Era. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2014, 67: s40-s53. PMID: 25117960, PMCID: PMC4133739, DOI: 10.1097/qai.0000000000000257.
Clinical outcome as a function of the PR-interval—there is virtue in moderation: data from the Duke Databank for cardiovascular diseaseHolmqvist F, Thomas KL, Broderick S, Ersbøll M, Singh D, Chiswell K, Shaw LK, Hegland DD, Velazquez EJ, Daubert JP. Clinical outcome as a function of the PR-interval—there is virtue in moderation: data from the Duke Databank for cardiovascular disease. EP Europace 2014, 17: 978-985. PMID: 25164430, DOI: 10.1093/europace/euu211.
Differential Response to Low Dose Dopamine or Nesiritide in Patients with Acute Heart Failure and Renal Dysfunction in Accordance to LV EF: Sub-Group Analysis of the ROSE AHF TrialChen H, Anstrom K, Stevens S, Deswal A, Felker G, Givertz M, A. B, Tang W, McNulty S, Velazquez E, Lee K, Borlaug B, Shah M, Hernandez A, Braunwald E, Redfield M. Differential Response to Low Dose Dopamine or Nesiritide in Patients with Acute Heart Failure and Renal Dysfunction in Accordance to LV EF: Sub-Group Analysis of the ROSE AHF Trial. Journal Of Cardiac Failure 2014, 20: s94. DOI: 10.1016/j.cardfail.2014.06.264.
Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University HospitalMentz R, Buggey J, Schulte P, DeVore A, Anstrom K, Eisenstein E, Fiuzat M, O'Connor C, Velazquez E. Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital. Journal Of Cardiac Failure 2014, 20: s95. DOI: 10.1016/j.cardfail.2014.06.267.
Extent of Coronary and Myocardial Disease and Benefit From Surgical Revascularization in LV DysfunctionPanza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Szwed H, Larbalestier R, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL. Extent of Coronary and Myocardial Disease and Benefit From Surgical Revascularization in LV Dysfunction. Journal Of The American College Of Cardiology 2014, 64: 553-561. PMID: 25104523, PMCID: PMC4129547, DOI: 10.1016/j.jacc.2014.04.064.
Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: Results of the Surgical Treatment for Ischemic Heart Failure trialHolly TA, Bonow RO, Arnold JM, Oh JK, Varadarajan P, Pohost GM, Haddad H, Jones RH, Velazquez EJ, Birkenfeld B, Asch FM, Malinowski M, Barretto R, Kalil RA, Berman DS, Sun JL, Lee KL, Panza JA. Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: Results of the Surgical Treatment for Ischemic Heart Failure trial. Journal Of Thoracic And Cardiovascular Surgery 2014, 148: 2677-2684.e1. PMID: 25152476, PMCID: PMC4250319, DOI: 10.1016/j.jtcvs.2014.06.090.
Exercise Capacity and Mortality in Patients With Ischemic Left Ventricular Dysfunction Randomized to Coronary Artery Bypass Graft Surgery or Medical Therapy An Analysis From the STICH Trial (Surgical Treatment for Ischemic Heart Failure)Stewart RA, Szalewska D, She L, Lee KL, Drazner MH, Lubiszewska B, Kosevic D, Ruengsakulrach P, Nicolau JC, Coutu B, Choudhary SK, Mark DB, Cleland JG, Piña IL, Velazquez EJ, Rynkiewicz A, White H. Exercise Capacity and Mortality in Patients With Ischemic Left Ventricular Dysfunction Randomized to Coronary Artery Bypass Graft Surgery or Medical Therapy An Analysis From the STICH Trial (Surgical Treatment for Ischemic Heart Failure). JACC Heart Failure 2014, 2: 335-343. PMID: 25023813, PMCID: PMC4127151, DOI: 10.1016/j.jchf.2014.02.009.
Mobile health for non-communicable diseases in Sub-Saharan Africa: a systematic review of the literature and strategic framework for researchBloomfield GS, Vedanthan R, Vasudevan L, Kithei A, Were M, Velazquez EJ. Mobile health for non-communicable diseases in Sub-Saharan Africa: a systematic review of the literature and strategic framework for research. Globalization And Health 2014, 10: 49. PMID: 24927745, PMCID: PMC4064106, DOI: 10.1186/1744-8603-10-49.
Factors Associated With Isolated Right Heart Failure in Women A Pilot Study From Western KenyaLagat DK, DeLong AK, Wellenius GA, Carter EJ, Bloomfield GS, Velazquez EJ, Hogan J, Kimaiyo S, Sherman CB. Factors Associated With Isolated Right Heart Failure in Women A Pilot Study From Western Kenya. Global Heart 2014, 9: 249-254. PMID: 25667096, PMCID: PMC4405788, DOI: 10.1016/j.gheart.2014.04.003.
Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health recordsBloomfield GS, Hogan JW, Keter A, Holland TL, Sang E, Kimaiyo S, Velazquez EJ. Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records. BMC Infectious Diseases 2014, 14: 284. PMID: 24886474, PMCID: PMC4046023, DOI: 10.1186/1471-2334-14-284.
Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trialVedanthan R, Kamano JH, Naanyu V, Delong AK, Were MC, Finkelstein EA, Menya D, Akwanalo CO, Bloomfield GS, Binanay CA, Velazquez EJ, Hogan JW, Horowitz CR, Inui TS, Kimaiyo S, Fuster V. Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial. Trials 2014, 15: 143. PMID: 24767476, PMCID: PMC4113229, DOI: 10.1186/1745-6215-15-143.
Nurse Management of Hypertension in Rural Western Kenya: Implementation Research to Optimize DeliveryVedanthan R, Kamano JH, Horowitz CR, Ascheim D, Velazquez EJ, Kimaiyo S, Fuster V. Nurse Management of Hypertension in Rural Western Kenya: Implementation Research to Optimize Delivery. Annals Of Global Health 2014, 80: 5-12. PMID: 24751560, PMCID: PMC4036099, DOI: 10.1016/j.aogh.2013.12.002.
Surgical Revascularization Is Associated With Maximal Survival in Patients With Ischemic Mitral RegurgitationCastleberry AW, Williams JB, Daneshmand MA, Honeycutt E, Shaw LK, Samad Z, Lopes RD, Alexander JH, Mathew JP, Velazquez EJ, Milano CA, Smith PK. Surgical Revascularization Is Associated With Maximal Survival in Patients With Ischemic Mitral Regurgitation. Circulation 2014, 129: 2547-2556. PMID: 24744275, PMCID: PMC4142433, DOI: 10.1161/circulationaha.113.005223.
ASSESSMENT OF CARDIAC ALLOGRAFT SYSTOLIC FUNCTION BY GLOBAL LONGITUDINAL STRAIN: FROM DONOR TO RECIPIENTDeVore A, Alenezi F, Ersboll M, Patel C, Rogers J, Milano C, Velazquez E, Khouri M. ASSESSMENT OF CARDIAC ALLOGRAFT SYSTOLIC FUNCTION BY GLOBAL LONGITUDINAL STRAIN: FROM DONOR TO RECIPIENT. Journal Of The American College Of Cardiology 2014, 63: a1133. DOI: 10.1016/s0735-1097(14)61133-5.
DOES SEVERITY OF LEFT VENTRICULAR REMODELING INFLUENCE THE RELATION BETWEEN MYOCARDIAL VIABILITY AND SURVIVAL WITH MEDICAL OR SURGICAL THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE AND LEFT VENTRICULAR DYSFUNCTION?Bonow R, Castelvecchio S, Panza J, Berman D, Velazquez E, Michler R, She L, Holly T, Nickens P, Kosevic D, Rajda M, Chrzanowski L, Deja M, Lee K, White H, Oh J, Doenst T, Hill J, Rouleau J, Menicanti L. DOES SEVERITY OF LEFT VENTRICULAR REMODELING INFLUENCE THE RELATION BETWEEN MYOCARDIAL VIABILITY AND SURVIVAL WITH MEDICAL OR SURGICAL THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE AND LEFT VENTRICULAR DYSFUNCTION? Journal Of The American College Of Cardiology 2014, 63: a1625. DOI: 10.1016/s0735-1097(14)61628-4.
EXERCISE CAPACITY AND MORTALITY IN PATIENTS WITH ISCHEMIC LEFT VENTRICULAR DYSFUNCTION RANDOMIZED TO CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: AN ANALYSIS FROM THE SURGICAL TREATMENT FOR ISCHEMIC HEART FAILURE TRIALStewart R, Szalewska D, She L, Drazner M, Lee K, Lubiszewska B, Kosevic D, Ruengsakulrach P, Nicolau J, Coutu B, Choudhary S, Mark D, Cleland J, Pina I, Velazquez E, Rynkiewicz A, White H. EXERCISE CAPACITY AND MORTALITY IN PATIENTS WITH ISCHEMIC LEFT VENTRICULAR DYSFUNCTION RANDOMIZED TO CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: AN ANALYSIS FROM THE SURGICAL TREATMENT FOR ISCHEMIC HEART FAILURE TRIAL. Journal Of The American College Of Cardiology 2014, 63: a1531. DOI: 10.1016/s0735-1097(14)61534-5.
IMPACT OF SURGICAL VENTRICULAR RECONSTRUCTION ON SPHERICITY INDEX IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY: FOLLOW-UP FROM STICH TRIALChoi J, Daly R, Lin G, Lahr B, Wiste H, Beaver T, Iacovoni A, Malinowski M, Friedrich I, Rouleau J, Favaloro R, Sopko G, Lang I, White H, Milano C, Jones R, Lee K, Velazquez E, Oh J. IMPACT OF SURGICAL VENTRICULAR RECONSTRUCTION ON SPHERICITY INDEX IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY: FOLLOW-UP FROM STICH TRIAL. Journal Of The American College Of Cardiology 2014, 63: a856. DOI: 10.1016/s0735-1097(14)60856-1.
GLOBAL LONGITUDINAL STRAIN BECOMES IMPAIRED IN CHEMOTHERAPY TREATED BREAST CANCER PATIENTSKhouri M, Yoon H, Schulte P, Velazquez E. GLOBAL LONGITUDINAL STRAIN BECOMES IMPAIRED IN CHEMOTHERAPY TREATED BREAST CANCER PATIENTS. Journal Of The American College Of Cardiology 2014, 63: a1135. DOI: 10.1016/s0735-1097(14)61135-9.
IMPORTANCE OF AORTIC STENOSIS IN PATIENTS PRESENTING WITH ACUTE MYOCARDIAL INFARCTIONErsboll M, Alenezi F, Samad Z, Kisslo J, Schulte P, Shaw L, Kober L, Velazquez E. IMPORTANCE OF AORTIC STENOSIS IN PATIENTS PRESENTING WITH ACUTE MYOCARDIAL INFARCTION. Journal Of The American College Of Cardiology 2014, 63: a123. DOI: 10.1016/s0735-1097(14)60123-6.
GLOBAL LONGITUDINAL STRAIN AS A PREDICTOR OF SUDDEN CARDIAC DEATH AND DEATH FROM OTHER CAUSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONErsboll M, Alenezi F, Yoon H, Samad Z, Kisslo J, Schulte P, Shaw L, Kober L, Velazquez E. GLOBAL LONGITUDINAL STRAIN AS A PREDICTOR OF SUDDEN CARDIAC DEATH AND DEATH FROM OTHER CAUSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. Journal Of The American College Of Cardiology 2014, 63: a1129. DOI: 10.1016/s0735-1097(14)61129-3.
PROGRESSION OF SIGNIFICANT FUNCTIONAL MR IN MEDICALLY MANAGED PATIENTSAlenezi F, Ersboll M, Yoon H, Siddiqui I, Armour A, Al-Khalidi H, Samad Z, Velazquez E. PROGRESSION OF SIGNIFICANT FUNCTIONAL MR IN MEDICALLY MANAGED PATIENTS. Journal Of The American College Of Cardiology 2014, 63: a2007. DOI: 10.1016/s0735-1097(14)62010-6.
SERIAL CHANGES IN MYOCARDIAL STRAIN IN MEDICALLY MANAGED SEVERE AORTIC STENOSIS AND LONG TERM OUTCOMESErsboll M, Enezi F, Kisslo J, Kober L, Samad Z, Velazquez E. SERIAL CHANGES IN MYOCARDIAL STRAIN IN MEDICALLY MANAGED SEVERE AORTIC STENOSIS AND LONG TERM OUTCOMES. Journal Of The American College Of Cardiology 2014, 63: a2022. DOI: 10.1016/s0735-1097(14)62025-8.
GLOBAL LONGITUDINAL STRAIN IS SUBSTANTIALLY IMPAIRED IN HOSPITALIZED ACUTE HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTIONYoon H, Alenezi F, Ersboll M, Khouri M, Samad Z, Velazquez E. GLOBAL LONGITUDINAL STRAIN IS SUBSTANTIALLY IMPAIRED IN HOSPITALIZED ACUTE HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION. Journal Of The American College Of Cardiology 2014, 63: a554. DOI: 10.1016/s0735-1097(14)60554-4.
Prior antihypertensive regimen usage and the cardiovascular risk reduction derived from combination therapy with angiotensin converting enzyme inhibition-calcium channel blockade: a secondary analysis of the avoiding cardiovascular events through combinatBrook R, Kaciroti N, Bakris G, Dahof B, Pitt B, Velazquez E, Weber M, Jamerson K. Prior antihypertensive regimen usage and the cardiovascular risk reduction derived from combination therapy with angiotensin converting enzyme inhibition-calcium channel blockade: a secondary analysis of the avoiding cardiovascular events through combinat. International Journal Of Cardiology Cardiovascular Risk And Prevention 2014, 8: e71. DOI: 10.1016/j.jash.2014.03.164.
LEFT BUNDLE BRANCH BLOCK IS NOT INDEPENDENTLY ASSOCIATED WITH LONG TERM MORTALITY AMONG PATIENTS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTIONErsboll M, Samad Z, Alenezi F, Wagner G, Daubert J, Kisslo J, Kober L, Velazquez E. LEFT BUNDLE BRANCH BLOCK IS NOT INDEPENDENTLY ASSOCIATED WITH LONG TERM MORTALITY AMONG PATIENTS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION. Journal Of The American College Of Cardiology 2014, 63: a343. DOI: 10.1016/s0735-1097(14)60343-0.
DIVERGING EFFECTS OF SILDENAFIL ON VENTRICULAR-VASCULAR FUNCTION IN HFPEFBorlaug B, Lewis G, McNulty S, Semigran M, LeWinter M, Chen H, Lin G, Anstrom K, Velazquez E, Shah M, Margulies K, Redfield M. DIVERGING EFFECTS OF SILDENAFIL ON VENTRICULAR-VASCULAR FUNCTION IN HFPEF. Journal Of The American College Of Cardiology 2014, 63: a759. DOI: 10.1016/s0735-1097(14)60759-2.
Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction A VALIANT Study (Valsartan In Acute Myocardial Infarction)Lewis EF, Li Y, Pfeffer MA, Solomon SD, Weinfurt KP, Velazquez EJ, Califf RM, Rouleau JL, Kober L, White HD, Schulman KA, Reed SD. Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction A VALIANT Study (Valsartan In Acute Myocardial Infarction). JACC Heart Failure 2014, 2: 159-165. PMID: 24720924, DOI: 10.1016/j.jchf.2013.12.003.
Abstract P359: High Blood Pressure in African HIV+ Patients Increases Long-Term MortalityBloomfield G, Hogan J, Keter A, Holland T, Sang E, Kimaiyo S, Velazquez E. Abstract P359: High Blood Pressure in African HIV+ Patients Increases Long-Term Mortality. Circulation 2014, 129 DOI: 10.1161/circ.129.suppl_1.p359.
Comprehensive Assessment of Right Ventricular Function in Patients with Pulmonary Hypertension with Global Longitudinal Peak Systolic Strain Derived from Multiple Right Ventricular ViewsRajagopal S, Forsha DE, Risum N, Hornik CP, Poms AD, Fortin TA, Tapson VF, Velazquez EJ, Kisslo J, Samad Z. Comprehensive Assessment of Right Ventricular Function in Patients with Pulmonary Hypertension with Global Longitudinal Peak Systolic Strain Derived from Multiple Right Ventricular Views. Journal Of The American Society Of Echocardiography 2014, 27: 657-665.e3. PMID: 24656881, DOI: 10.1016/j.echo.2014.02.001.
PROspective Multicenter Imaging Study for Evaluation of chest pain: Rationale and design of the PROMISE trialDouglas PS, Hoffmann U, Lee KL, Mark DB, Al-Khalidi HR, Anstrom K, Dolor RJ, Kosinski A, Krucoff MW, Mudrick DW, Patel MR, Picard MH, Udelson JE, Velazquez EJ, Cooper L, investigators P. PROspective Multicenter Imaging Study for Evaluation of chest pain: Rationale and design of the PROMISE trial. American Heart Journal 2014, 167: 796-803.e1. PMID: 24890527, PMCID: PMC4044617, DOI: 10.1016/j.ahj.2014.03.003.
Impaired Resting Myocardial Annular Velocities Are Independently Associated With Mental Stress–Induced Ischemia in Coronary Heart DiseaseErsbøll M, Enezi F, Samad Z, Sedberry B, Boyle SH, O’Connor C, Jiang W, Velazquez EJ, Investigators R. Impaired Resting Myocardial Annular Velocities Are Independently Associated With Mental Stress–Induced Ischemia in Coronary Heart Disease. JACC Cardiovascular Imaging 2014, 7: 351-361. PMID: 24631512, PMCID: PMC3992174, DOI: 10.1016/j.jcmg.2013.10.014.
Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapyKhouri MG, Hornsby WE, Risum N, Velazquez EJ, Thomas S, Lane A, Scott JM, Koelwyn GJ, Herndon JE, Mackey JR, Douglas PS, Jones LW. Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy. Breast Cancer Research And Treatment 2014, 143: 531-539. PMID: 24390149, PMCID: PMC4521213, DOI: 10.1007/s10549-013-2818-1.
Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized TrialChen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, A. B, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM. Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial. JAMA 2013, 310: 2533-2543. PMID: 24247300, PMCID: PMC3934929, DOI: 10.1001/jama.2013.282190.
Depressive Symptoms and Mental Stress–Induced Myocardial Ischemia in Patients With Coronary Heart DiseaseBoyle SH, Samad Z, Becker RC, Williams R, Kuhn C, Ortel TL, Kuchibhatla M, Prybol K, Rogers J, O’Connor C, Velazquez EJ, Jiang W. Depressive Symptoms and Mental Stress–Induced Myocardial Ischemia in Patients With Coronary Heart Disease. Psychosomatic Medicine 2013, 75: 822-831. PMID: 24163385, PMCID: PMC4378828, DOI: 10.1097/psy.0b013e3182a893ae.
Therapy for Mental Stress–Induced Myocardial Ischemia—ReplyJiang W, O’Connor C, Velazquez EJ. Therapy for Mental Stress–Induced Myocardial Ischemia—Reply. JAMA 2013, 310: 1401-1402. PMID: 24084928, DOI: 10.1001/jama.2013.277975.
Mechanisms of Functional Mitral Regurgitation in Ischemic Cardiomyopathy Determined by Transesophageal Echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial)Golba K, Mokrzycki K, Drozdz J, Cherniavsky A, Wrobel K, Roberts BJ, Haddad H, Maurer G, Yii M, Asch FM, Handschumacher MD, Holly TA, Przybylski R, Kron I, Schaff H, Aston S, Horton J, Lee KL, Velazquez EJ, Grayburn PA, Investigators S. Mechanisms of Functional Mitral Regurgitation in Ischemic Cardiomyopathy Determined by Transesophageal Echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). The American Journal Of Cardiology 2013, 112: 1812-1818. PMID: 24035166, PMCID: PMC3830629, DOI: 10.1016/j.amjcard.2013.07.047.
The STICH Trial (Surgical Treatment for Ischemic Heart Failure) Mode-of-Death ResultsCarson P, Wertheimer J, Miller A, O'Connor CM, Pina IL, Selzman C, Sueta C, She L, Greene D, Lee KL, Jones RH, Velazquez EJ, Investigators S. The STICH Trial (Surgical Treatment for Ischemic Heart Failure) Mode-of-Death Results. JACC Heart Failure 2013, 1: 400-408. PMID: 24621972, PMCID: PMC3829618, DOI: 10.1016/j.jchf.2013.04.012.
Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarctionWang N, Shah A, Querejeta G, Gupta D, Velazquez E, Califf R, Mcmurray J, Pfeffer M, Solomon S. Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction. European Heart Journal 2013, 34: p662-p662. DOI: 10.1093/eurheartj/eht307.p662.
Early Echocardiographic Deformation Analysis for the Prediction of Sudden Cardiac Death and Life-Threatening Arrhythmias After Myocardial InfarctionErsbøll M, Valeur N, Andersen MJ, Mogensen UM, Vinther M, Svendsen JH, Møller JE, Kisslo J, Velazquez EJ, Hassager C, Søgaard P, Køber L. Early Echocardiographic Deformation Analysis for the Prediction of Sudden Cardiac Death and Life-Threatening Arrhythmias After Myocardial Infarction. JACC Cardiovascular Imaging 2013, 6: 851-860. PMID: 23850252, DOI: 10.1016/j.jcmg.2013.05.009.
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure PatientsGivertz MM, Mann DL, Lee KL, Ibarra JC, Velazquez EJ, Hernandez AF, Mascette AM, Braunwald E. Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients. Circulation Heart Failure 2013, 6: 862-868. PMID: 23861505, PMCID: PMC3902033, DOI: 10.1161/circheartfailure.113.000394.
Effect of Escitalopram on Mental Stress–Induced Myocardial Ischemia: Results of the REMIT TrialJiang W, Velazquez EJ, Kuchibhatla M, Samad Z, Boyle SH, Kuhn C, Becker RC, Ortel TL, Williams RB, Rogers JG, O’Connor C. Effect of Escitalopram on Mental Stress–Induced Myocardial Ischemia: Results of the REMIT Trial. JAMA 2013, 309: 2139-2149. PMID: 23695483, PMCID: PMC4378823, DOI: 10.1001/jama.2013.5566.
Heart Failure in Sub-Saharan AfricaBloomfield GS, Barasa FA, Doll JA, Velazquez EJ. Heart Failure in Sub-Saharan Africa. Current Cardiology Reviews 2013, 9: 157-173. PMID: 23597299, PMCID: PMC3682399, DOI: 10.2174/1573403x11309020008.
Prognostic Significance of Biomarkers in Predicting Outcome in Patients With Coronary Artery Disease and Left Ventricular DysfunctionFeldman AM, Mann DL, She L, Bristow MR, Maisel AS, McNamara DM, Walsh R, Lee DL, Wos S, Lang I, Wells G, Drazner MH, Schmedtje JF, Pauly DF, Sueta CA, Di Maio M, Kron IL, Velazquez EJ, Lee KL. Prognostic Significance of Biomarkers in Predicting Outcome in Patients With Coronary Artery Disease and Left Ventricular Dysfunction. Circulation Heart Failure 2013, 6: 461-472. PMID: 23584092, PMCID: PMC3905743, DOI: 10.1161/circheartfailure.112.000185.
Prediction of All-Cause Mortality and Heart Failure Admissions From Global Left Ventricular Longitudinal Strain in Patients With Acute Myocardial Infarction and Preserved Left Ventricular Ejection FractionErsbøll M, Valeur N, Mogensen UM, Andersen MJ, Møller JE, Velazquez EJ, Hassager C, Søgaard P, Køber L. Prediction of All-Cause Mortality and Heart Failure Admissions From Global Left Ventricular Longitudinal Strain in Patients With Acute Myocardial Infarction and Preserved Left Ventricular Ejection Fraction. Journal Of The American College Of Cardiology 2013, 61: 2365-2373. PMID: 23563128, DOI: 10.1016/j.jacc.2013.02.061.
Natural History of Tricuspid Valve Regurgitation (TR) Diagnosed Immediately after Heart TransplantZanotti G, Shaw L, Castleberry A, Schroder J, Velazquez E, Swaminathan M, Rogers J, Milano C. Natural History of Tricuspid Valve Regurgitation (TR) Diagnosed Immediately after Heart Transplant. The Journal Of Heart And Lung Transplantation 2013, 32: s256. DOI: 10.1016/j.healun.2013.01.663.
Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of HypertensionWeber MA, Bakris GL, Hester A, Weir MR, Hua TA, Zappe D, Dahlof B, Velazquez EJ, Pitt B, Jamerson K. Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of Hypertension. The American Journal Of Medicine 2013, 126: 501-508. PMID: 23541376, DOI: 10.1016/j.amjmed.2013.01.007.
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical TrialRedfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O’Connor C, Felker GM, Goldsmith SR, A. B, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E, Trial F. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA 2013, 309: 1268-1277. PMID: 23478662, PMCID: PMC3835156, DOI: 10.1001/jama.2013.2024.
HIV and Cardiovascular Disease in Sub-Saharan Africa The Sutton Law as Applied to Global HealthBloomfield GS, Velazquez EJ. HIV and Cardiovascular Disease in Sub-Saharan Africa The Sutton Law as Applied to Global Health. Journal Of The American College Of Cardiology 2013, 61: 2395. PMID: 23524216, DOI: 10.1016/j.jacc.2013.02.041.
Influence of Crossover on Mortality in a Randomized Study of Revascularization in Patients With Systolic Heart Failure and Coronary Artery DiseaseDoenst T, Cleland JG, Rouleau JL, She L, Wos S, Ohman EM, Krzeminska-Pakula M, Airan B, Jones RH, Siepe M, Sopko G, Velazquez EJ, Racine N, Gullestad L, Filgueira JL, Lee KL. Influence of Crossover on Mortality in a Randomized Study of Revascularization in Patients With Systolic Heart Failure and Coronary Artery Disease. Circulation Heart Failure 2013, 6: 443-450. PMID: 23515275, PMCID: PMC3721746, DOI: 10.1161/circheartfailure.112.000130.
Inducible Myocardial Ischemia and Outcomes in Patients With Coronary Artery Disease and Left Ventricular DysfunctionPanza JA, Holly TA, Asch FM, She L, Pellikka PA, Velazquez EJ, Lee KL, Borges-Neto S, Farsky PS, Jones RH, Berman DS, Bonow RO. Inducible Myocardial Ischemia and Outcomes in Patients With Coronary Artery Disease and Left Ventricular Dysfunction. Journal Of The American College Of Cardiology 2013, 61: 1860-1870. PMID: 23500234, PMCID: PMC3755503, DOI: 10.1016/j.jacc.2013.02.014.
ASSOCIATION BETWEEN PLATELET AGGREGATION AND MENTAL STRESS INDUCED MYOCARDIAL ISCHEMIA: RESULTS FROM THE REMIT TRIALHarrison R, Becker R, Ortel T, Kuchibhatla M, Boyle S, Samad Z, Velazquez E, Wilson J, Kuhn C, Williams R. ASSOCIATION BETWEEN PLATELET AGGREGATION AND MENTAL STRESS INDUCED MYOCARDIAL ISCHEMIA: RESULTS FROM THE REMIT TRIAL. Journal Of The American College Of Cardiology 2013, 61: e1135. DOI: 10.1016/s0735-1097(13)61135-3.
RELATIONSHIPS BETWEEN SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HIGH RISK HYPERTENSION: AN ANALYSIS OF THE ACCOMPLISH TRIALWeber M, Bakris G, Hester A, Weir M, Hua T, Zappe D, Dahlof B, Velazquez E, Pitt B, Jamerson K. RELATIONSHIPS BETWEEN SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HIGH RISK HYPERTENSION: AN ANALYSIS OF THE ACCOMPLISH TRIAL. Journal Of The American College Of Cardiology 2013, 61: e1382. DOI: 10.1016/s0735-1097(13)61382-0.
Prevalence and Clinical Characteristics of Mental Stress–Induced Myocardial Ischemia in Patients With Coronary Heart DiseaseJiang W, Samad Z, Boyle S, Becker RC, Williams R, Kuhn C, Ortel TL, Rogers J, Kuchibhatla M, O'Connor C, Velazquez EJ. Prevalence and Clinical Characteristics of Mental Stress–Induced Myocardial Ischemia in Patients With Coronary Heart Disease. Journal Of The American College Of Cardiology 2013, 61: 714-722. PMID: 23410543, PMCID: PMC3913125, DOI: 10.1016/j.jacc.2012.11.037.
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trialWeber MA, Jamerson K, Bakris GL, Weir MR, Zappe D, Zhang Y, Dahlof B, Velazquez EJ, Pitt B. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. The Lancet 2012, 381: 537-545. PMID: 23219284, DOI: 10.1016/s0140-6736(12)61343-9.
Ultrafiltration in Decompensated Heart Failure with Cardiorenal SyndromeBart B, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome. New England Journal Of Medicine 2012, 367: 2296-2304. PMID: 23131078, PMCID: PMC3690472, DOI: 10.1056/nejmoa1210357.
Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstructionMichler RE, Rouleau JL, Al-Khalidi HR, Bonow RO, Pellikka PA, Pohost GM, Holly TA, Oh JK, Dagenais F, Milano C, Wrobel K, Pirk J, Ali IS, Jones RH, Velazquez EJ, Lee KL, Di Donato M, Investigators S. Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. Journal Of Thoracic And Cardiovascular Surgery 2012, 146: 1139-1145.e6. PMID: 23111018, PMCID: PMC3810307, DOI: 10.1016/j.jtcvs.2012.09.007.
Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community settingHan SY, Palmeri ST, Broderick SH, Hasselblad V, Rendall D, Stevens S, Tenaglia A, Velazquez E, Whellan D, Wagner G, Heitner JF. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting. Journal Of Electrocardiology 2012, 46: 45-50. PMID: 23063241, DOI: 10.1016/j.jelectrocard.2012.08.011.
Variability of Global Left Ventricular Deformation Analysis Using Vendor Dependent and Independent Two-Dimensional Speckle-Tracking Software in AdultsRisum N, Ali S, Olsen NT, Jons C, Khouri MG, Lauridsen TK, Samad Z, Velazquez EJ, Sogaard P, Kisslo J. Variability of Global Left Ventricular Deformation Analysis Using Vendor Dependent and Independent Two-Dimensional Speckle-Tracking Software in Adults. Journal Of The American Society Of Echocardiography 2012, 25: 1195-1203. PMID: 22981228, DOI: 10.1016/j.echo.2012.08.007.
Conditions That Predispose to Pulmonary Hypertension and Right Heart Failure in Persons Exposed to Household Air Pollution in LMICBloomfield GS, Lagat DK, Akwanalo OC, Carter EJ, Lugogo N, Vedanthan R, Velazquez EJ, Kimaiyo S, Sherman CB. Conditions That Predispose to Pulmonary Hypertension and Right Heart Failure in Persons Exposed to Household Air Pollution in LMIC. Global Heart 2012, 7: 249-259. PMID: 23687634, PMCID: PMC3653331, DOI: 10.1016/j.gheart.2012.06.015.
Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: Results from the Duke Databank for Cardiovascular Disease (DDCD)Williams ES, Thomas KL, Broderick S, Shaw LK, Velazquez EJ, Al-Khatib SM, Daubert JP. Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: Results from the Duke Databank for Cardiovascular Disease (DDCD). American Heart Journal 2012, 164: 434-441. PMID: 22980312, DOI: 10.1016/j.ahj.2012.05.024.
Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathyOh JK, Velazquez EJ, Menicanti L, Pohost GM, Bonow RO, Lin G, Hellkamp AS, Ferrazzi P, Wos S, Rao V, Berman D, Bochenek A, Cherniavsky A, Rogowski J, Rouleau JL, Lee KL. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. European Heart Journal 2012, 34: 39-47. PMID: 22584648, PMCID: PMC3533917, DOI: 10.1093/eurheartj/ehs021.
Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure TrialDeja MA, Grayburn PA, Sun B, Rao V, She L, Krejca M, Jain AR, Chua Y, Daly R, Senni M, Mokrzycki K, Menicanti L, Oh JK, Michler R, Wróbel K, Lamy A, Velazquez EJ, Lee KL, Jones RH. Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial. Circulation 2012, 125: 2639-2648. PMID: 22553307, PMCID: PMC3776601, DOI: 10.1161/circulationaha.111.072256.
Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapyRisum N, Williams ES, Khouri MG, Jackson KP, Olsen NT, Jons C, Storm KS, Velazquez EJ, Kisslo J, Bruun NE, Sogaard P. Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapy. European Heart Journal 2012, 34: 48-56. PMID: 22390911, DOI: 10.1093/eurheartj/ehs035.
A Quality Improvement Framework for Equity in Cardiovascular Care: Results of a National CollaborativeSiegel B, Sears V, Bretsch JK, Wilson M, Jones KC, Mead H, Hasnain-Wynia R, Ayala RK, Bhalla R, Cornue CM, Emrich CM, Patel P, Setzer JR, Suitonu J, Velazquez EJ, Eagle KA, Winniford MD. A Quality Improvement Framework for Equity in Cardiovascular Care: Results of a National Collaborative. Journal For Healthcare Quality 2012, 34: 32-43. PMID: 23552200, DOI: 10.1111/j.1945-1474.2011.00196.x.
Myocardial Imaging Should Not Exclude Patients With Ischemic Heart Failure From Coronary RevascularizationVelazquez EJ. Myocardial Imaging Should Not Exclude Patients With Ischemic Heart Failure From Coronary Revascularization. Circulation Cardiovascular Imaging 2012, 5: 271-279. PMID: 22438425, PMCID: PMC3878903, DOI: 10.1161/circimaging.111.964650.
SURVIVAL IN PATIENTS WITH MODERATE OR SEVERE MITRAL REGURGITATION AT HIGH RISK FOR SURGERY TREATED WITH AND WITHOUT THE MITRACLIP: A PROPENSITY MATCHED COMPARISONVelazquez E, Sangli C, Al-Khalidi H, Grayburn P, Massaro J, Stevens S, Feldman T, Krucoff M. SURVIVAL IN PATIENTS WITH MODERATE OR SEVERE MITRAL REGURGITATION AT HIGH RISK FOR SURGERY TREATED WITH AND WITHOUT THE MITRACLIP: A PROPENSITY MATCHED COMPARISON. Journal Of The American College Of Cardiology 2012, 59: e1997. DOI: 10.1016/s0735-1097(12)61998-6.
Mechanisms and Predictors of Mitral Regurgitation after High-Risk Myocardial InfarctionMeris A, Amigoni M, Verma A, Thune JJ, Køber L, Velazquez E, McMurray JJ, Pfeffer MA, Califf R, Levine RA, Solomon SD, Investigators V. Mechanisms and Predictors of Mitral Regurgitation after High-Risk Myocardial Infarction. Journal Of The American Society Of Echocardiography 2012, 25: 535-542. PMID: 22305962, PMCID: PMC3501447, DOI: 10.1016/j.echo.2012.01.006.
Coronary Artery Bypass Surgery in Patients with Left Ventricular DysfunctionVelazquez E, Lee K, Deja M, Jain A, Sopko G, Marchenko A, Ali I, Pohost G, Gradinac S, Abraham W, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie M, O’Connor C, Panchavinnin P, She L, Bonow R, Rankin G, Jones R, Rouleau J. Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. Survey Of Anesthesiology 2012, 56: 9-10. DOI: 10.1097/01.sa.0000410152.66408.1c.
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical TherapyVelazquez EJ, Williams JB, Yow E, Shaw LK, Lee KL, Phillips HR, O'Connor CM, Smith PK, Jones RH. Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy. The Annals Of Thoracic Surgery 2012, 93: 523-530. PMID: 22269720, PMCID: PMC3638256, DOI: 10.1016/j.athoracsur.2011.10.064.
Core Lab Analysis of Baseline Echocardiographic Studies in the STICH Trial and Recommendation for Use of Echocardiography in Future Clinical TrialsOh JK, Pellikka PA, Panza JA, Biernat J, Attisano T, Manahan BG, Wiste HJ, Lin G, Lee K, Miller FA, Stevens S, Sopko G, She L, Velazquez EJ, Investigators S. Core Lab Analysis of Baseline Echocardiographic Studies in the STICH Trial and Recommendation for Use of Echocardiography in Future Clinical Trials. Journal Of The American Society Of Echocardiography 2012, 25: 327-336. PMID: 22227341, PMCID: PMC3310914, DOI: 10.1016/j.echo.2011.12.002.
Renal outcomes in hypertensive Black patients at high cardiovascular riskWeir MR, Bakris GL, Weber MA, Dahlof B, Devereux RB, Kjeldsen SE, Pitt B, Wright JT, Kelly RY, Hua TA, Hester RA, Velazquez E, Jamerson KA. Renal outcomes in hypertensive Black patients at high cardiovascular risk. Kidney International 2011, 81: 568-576. PMID: 22189843, DOI: 10.1038/ki.2011.417.
Moderated Poster Sessions 4Sonne C, Bott-Fluegel L, Hauck S, Michalk F, Lesevic H, Demetz G, Braun D, Hausleiter J, Schoemig A, Kolb C, Hirayama Y, Tsukamoto M, Hotta D, Yokoyama H, Kikuchi K, Ohori K, Sato N, Kawamura Y, Hasebe N, Kaladaridis A, Bramos D, Skaltsiotis I, Kottis G, Antoniou A, Matthaios I, Agrios I, Vasiladiotis N, Pamboucas C, Toumanidis S, Minati M, Cavarretta E, De Ruvo E, Rebecchi M, Sciarra L, Matera S, Fratini S, Zuccaro L, Lioy E, Calo' L, Esposito C, Chinali M, D' Asaro M, Toscano A, Iacobelli R, Del Pasqua A, Di Clemente S, Parisi F, Pongiglione G, Rinelli G, Djordjevic-Dikic A, Nikcevic G, Raspopovic S, Jovanovic V, Tesic M, Djordjevic S, Milasinovic G, Gurel E, Tigen K, Karaahmet T, Dundar C, Guler A, Fotbolcu H, Basaran Y, Risum N, Williams E, Khouri M, Jackson K, Olsen N, Jons C, Storm K, Velazquez E, Kisslo J, Sogaard P, Separovic Hanzevacki J, Baricevic Z, Pezo Nikolic B, Lovric D, Ivanac Vranesic I, Ernst A, Milicic D, Jurin H, Esmaeilzadeh M, Salehi Omran M, Maleki M, Haghjoo M, Noohi F, Ojaghi Haghighi Z, Sadeghpour A, Nakhostin Davari P, Bakhshandeh Abkenar H. Moderated Poster Sessions 4. European Heart Journal - Cardiovascular Imaging 2011, 12: ii121-ii124. DOI: 10.1093/ejechocard/jer215.
Responses of mental stress–induced myocardial ischemia to escitalopram treatment: Background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trialJiang W, Velazquez EJ, Samad Z, Kuchibhatla M, Martsberger C, Rogers J, Williams R, Kuhn C, Ortel TL, Becker RC, Pristera N, Krishnan R, O'Connor CM. Responses of mental stress–induced myocardial ischemia to escitalopram treatment: Background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial. American Heart Journal 2011, 163: 20-26. PMID: 22172432, PMCID: PMC3254211, DOI: 10.1016/j.ahj.2011.09.018.
Surgical Treatment of Ischemic Heart Failure TrialMark D, Knight J, Velazquez E, Wasilewski J, Howlett J, Smith P, Rajda M, Yadav R, Hamman L, Malinowski M, Naik A, Rankin G, Harding T, Drew L, Desvigne-Nickens P, Anstrom K, Investigators S. Surgical Treatment of Ischemic Heart Failure Trial. Journal Of Cardiac Failure 2011, 17: 971-972. DOI: 10.1016/j.cardfail.2011.10.006.
Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or bothShah AM, Hung CL, Shin SH, Skali H, Verma A, Ghali JK, Køber L, Velazquez EJ, Rouleau JL, McMurray JJ, Pfeffer MA, Solomon SD. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. American Heart Journal 2011, 162: 685-691. PMID: 21982661, DOI: 10.1016/j.ahj.2011.07.015.
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH StudyKjeldsen SE, Jamerson KA, Bakris GL, Pitt B, Dahlöf B, Velazquez EJ, Hua TA, Kelly RY, Zappe D, Hester A, Tuomilehto J, Östergren J, Ibsen H, Weber M, INVESTIGATORS F. Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study. Blood Pressure 2011, 21: 82-87. PMID: 21830844, DOI: 10.3109/08037051.2011.598699.
Hypertension and Obesity as Cardiovascular Risk Factors among HIV Seropositive Patients in Western KenyaBloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ, Kimaiyo S. Hypertension and Obesity as Cardiovascular Risk Factors among HIV Seropositive Patients in Western Kenya. PLOS ONE 2011, 6: e22288. PMID: 21779407, PMCID: PMC3136516, DOI: 10.1371/journal.pone.0022288.
LV Thrombus Detection by Routine Echocardiography Insights Into Performance Characteristics Using Delayed Enhancement CMRWeinsaft JW, Kim HW, Crowley AL, Klem I, Shenoy C, Van Assche L, Brosnan R, Shah DJ, Velazquez EJ, Parker M, Judd RM, Kim RJ. LV Thrombus Detection by Routine Echocardiography Insights Into Performance Characteristics Using Delayed Enhancement CMR. JACC Cardiovascular Imaging 2011, 4: 702-712. PMID: 21757159, PMCID: PMC3724234, DOI: 10.1016/j.jcmg.2011.03.017.
Circumstances and Outcomes of Sudden Unexpected Death in Patients With High-Risk Myocardial InfarctionYe S, Grunnert M, Thune JJ, Stephenson KM, Uno H, Finn PV, McMurray JJ, Velazquez EJ, Califf R, Pfeffer MA, Solomon SD. Circumstances and Outcomes of Sudden Unexpected Death in Patients With High-Risk Myocardial Infarction. Circulation 2011, 123: 2674-2680. PMID: 21606398, DOI: 10.1161/circulationaha.110.990655.
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarctionVerma A, Pfeffer MA, Skali H, Rouleau J, Maggioni A, McMurray JJ, Califf RM, Velazquez EJ, Solomon SD. Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction. American Heart Journal 2011, 161: 1156-1162. PMID: 21641363, DOI: 10.1016/j.ahj.2011.03.024.
Response to Letter Regarding Article, “Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both”Pouleur A, Barkoudah E, Uno H, Skali H, Finn P, Zelenkofske S, Belenkov Y, Mareev V, Velazquez E, Rouleau J, Maggioni A, Køber L, Califf R, McMurray J, Pfeffer M, Solomon S. Response to Letter Regarding Article, “Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both”. Circulation 2011, 123: e586-e587. DOI: 10.1161/circulationaha.111.021600.
No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH TrialVelazquez E. No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial. MD Conference Express 2011, 11: 20-21. DOI: 10.1177/155989771103012.
Utility of a Simple Algorithm to Grade Diastolic Dysfunction and Predict Outcome After Coronary Artery Bypass Graft SurgerySwaminathan M, Nicoara A, Phillips-Bute BG, Aeschlimann N, Milano CA, Mackensen GB, Podgoreanu MV, Velazquez EJ, Stafford-Smith M, Mathew JP, Group C. Utility of a Simple Algorithm to Grade Diastolic Dysfunction and Predict Outcome After Coronary Artery Bypass Graft Surgery. The Annals Of Thoracic Surgery 2011, 91: 1844-1850. PMID: 21492828, DOI: 10.1016/j.athoracsur.2011.02.008.
Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: An academic model for countering the epidemicBloomfield GS, Kimaiyo S, Carter EJ, Binanay C, Corey GR, Einterz RM, Tierney WM, Velazquez EJ. Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: An academic model for countering the epidemic. American Heart Journal 2011, 161: 842-847. PMID: 21570512, PMCID: PMC3093664, DOI: 10.1016/j.ahj.2010.12.020.
Myocardial Viability and Survival in Ischemic Left Ventricular DysfunctionBonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza JA. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction. New England Journal Of Medicine 2011, 364: 1617-1625. PMID: 21463153, PMCID: PMC3290901, DOI: 10.1056/nejmoa1100358.
Coronary-Artery Bypass Surgery in Patients with Left Ventricular DysfunctionVelazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL. Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. New England Journal Of Medicine 2011, 364: 1607-1616. PMID: 21463150, PMCID: PMC3415273, DOI: 10.1056/nejmoa1100356.
INCIDENTAL DETECTION OF LEFT VENTRICULAR THROMBUS BY ROUTINE ECHOCARDIOGRAPHY: INSIGHTS INTO PERFORMANCE CHARACTERISTICS USING DELAYED ENHANCEMENT (DE) CMRWeinsaft J, Kim H, Crowley A, Klem I, Shenoy C, Chen D, Brosnan R, Shah D, Velazquez E, Parker M, Judd R, Kim R. INCIDENTAL DETECTION OF LEFT VENTRICULAR THROMBUS BY ROUTINE ECHOCARDIOGRAPHY: INSIGHTS INTO PERFORMANCE CHARACTERISTICS USING DELAYED ENHANCEMENT (DE) CMR. Journal Of The American College Of Cardiology 2011, 57: e784. DOI: 10.1016/s0735-1097(11)60784-5.
Diuretic Strategies in Patients with Acute Decompensated Heart FailureFelker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart B, Mascette AM, Braunwald E, O'Connor CM. Diuretic Strategies in Patients with Acute Decompensated Heart Failure. New England Journal Of Medicine 2011, 364: 797-805. PMID: 21366472, PMCID: PMC3412356, DOI: 10.1056/nejmoa1005419.
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarctionThune JJ, Signorovitch JE, Kober L, McMurray JJ, Swedberg K, Rouleau J, Maggioni A, Velazquez E, Califf R, Pfeffer MA, Solomon SD. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. European Journal Of Heart Failure 2011, 13: 148-153. PMID: 21037250, DOI: 10.1093/eurjhf/hfq194.
Efficacy and Duration of Benazepril Plus Amlodipine or Hydrochlorthiazide on 24-Hour Ambulatory Systolic Blood Pressure ControlJamerson KA, Devereux R, Bakris GL, Dahlöf B, Pitt B, Velazquez EJ, Weir M, Kelly RY, Hua TA, Hester A, Weber MA. Efficacy and Duration of Benazepril Plus Amlodipine or Hydrochlorthiazide on 24-Hour Ambulatory Systolic Blood Pressure Control. Hypertension 2010, 57: 174-179. PMID: 21189401, DOI: 10.1161/hypertensionaha.110.159939.
Prevalence and predictors of mechanical dyssynchrony as defined by phase analysis in patients with left ventricular dysfunction undergoing gated SPECT myocardial perfusion imagingSamad Z, Atchley AE, Trimble MA, Sun JL, Shaw LK, Pagnanelli R, Chen J, Garcia EV, Iskandrian AE, Velazquez EJ, Borges-Neto S. Prevalence and predictors of mechanical dyssynchrony as defined by phase analysis in patients with left ventricular dysfunction undergoing gated SPECT myocardial perfusion imaging. Journal Of Nuclear Cardiology 2010, 18: 24-30. PMID: 21082299, PMCID: PMC3077282, DOI: 10.1007/s12350-010-9310-7.
Impact of early surgery on survival of patients with severe mitral regurgitationSamad Z, Kaul P, Shaw LK, Glower DD, Velazquez EJ, Douglas PS, Jollis JG. Impact of early surgery on survival of patients with severe mitral regurgitation. Heart 2010, 97: 221. PMID: 21071750, DOI: 10.1136/hrt.2010.202432.
Longitudinal and Circumferential Strain Rate, Left Ventricular Remodeling, and Prognosis After Myocardial InfarctionHung CL, Verma A, Uno H, Shin SH, Bourgoun M, Hassanein AH, McMurray JJ, Velazquez EJ, Kober L, Pfeffer MA, Solomon SD, Investigators V. Longitudinal and Circumferential Strain Rate, Left Ventricular Remodeling, and Prognosis After Myocardial Infarction. Journal Of The American College Of Cardiology 2010, 56: 1812-1822. PMID: 21087709, DOI: 10.1016/j.jacc.2010.06.044.
The inter‐relationship of diabetes and left ventricular systolic function on outcome after high‐risk myocardial infarctionShah AM, Uno H, Køber L, Velazquez EJ, Maggioni AP, MacDonald MR, Petrie MC, McMurray JJ, Califf RM, Pfeffer MA, Solomon SD. The inter‐relationship of diabetes and left ventricular systolic function on outcome after high‐risk myocardial infarction. European Journal Of Heart Failure 2010, 12: 1229-1237. PMID: 20965879, DOI: 10.1093/eurjhf/hfq179.
The STICH trial: evidence‐based conclusionsRouleau JL, Michler RE, Velazquez EJ, Oh JK, O'Connor CM, Desvigne‐Nickens P, Sopko G, Lee KL, Jones RH. The STICH trial: evidence‐based conclusions. European Journal Of Heart Failure 2010, 12: 1028-1030. PMID: 20861132, DOI: 10.1093/eurjhf/hfq140.
Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curveTaekman J, Stafford-Smith M, Velazquez E, Wright M, Phillips-Bute B, Pfeffer M, Sellers M, Pieper K, Newman M, Van de Werf F, Diaz R, Leimberger J, Califf R. Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curve. BMJ Quality & Safety 2010, 19: 405. PMID: 20702441, PMCID: PMC3258507, DOI: 10.1136/qshc.2008.028605.
Revascularization Leads to Greater Reduction in Ischemia Than Medical Therapy in Patients With Left Ventricular Dysfunction and Stable Coronary Artery DiseaseBorges-Neto S, Farzaneh-Far A, Shaw L, Fiuzat M, Phillips H, Velazquez E, O'Connor C. Revascularization Leads to Greater Reduction in Ischemia Than Medical Therapy in Patients With Left Ventricular Dysfunction and Stable Coronary Artery Disease. Journal Of Cardiac Failure 2010, 16: s113. DOI: 10.1016/j.cardfail.2010.06.395.
STICH (Surgical Treatment for Ischemic Heart Failure) Trial EnrollmentJones RH, White H, Velazquez EJ, Shaw LK, Pietrobon R, Panza JA, Bonow RO, Sopko G, O'Connor CM, Rouleau JL. STICH (Surgical Treatment for Ischemic Heart Failure) Trial Enrollment. Journal Of The American College Of Cardiology 2010, 56: 490-498. PMID: 20670760, PMCID: PMC3259709, DOI: 10.1016/j.jacc.2009.11.102.
Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or BothPouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD. Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. Circulation 2010, 122: 597-602. PMID: 20660803, DOI: 10.1161/circulationaha.110.940619.
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)Shamshad F, Kenchaiah S, Finn PV, Soler-Soler J, McMurray JJ, Velazquez EJ, Maggioni AP, Califf RM, Swedberg K, Kober L, Belenkov Y, Varshavsky S, Pfeffer MA, Solomon SD, Investigators F. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). American Heart Journal 2010, 160: 145-151. PMID: 20598985, DOI: 10.1016/j.ahj.2010.02.037.
Cardiovascular Events During Differing Hypertension Therapies in Patients With DiabetesWeber MA, Bakris GL, Jamerson K, Weir M, Kjeldsen SE, Devereux RB, Velazquez EJ, Dahlöf B, Kelly RY, Hua TA, Hester A, Pitt B, Investigators A. Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes. Journal Of The American College Of Cardiology 2010, 56: 77-85. PMID: 20620720, DOI: 10.1016/j.jacc.2010.02.046.
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) TrialNilsson KR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, Kober L, Granger CB, Lewis EF, McMurray JJ, Califf RM, Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart 2010, 96: 838. PMID: 20406769, DOI: 10.1136/hrt.2009.180182.
Evidence for the efficacy of ARBs across the cardiovascular continuumGupta M, Honos GN, Velazquez EJ, Chung N, Oigman W, Maggioni AP. Evidence for the efficacy of ARBs across the cardiovascular continuum. Current Medical Research And Opinion 2010, 26: 1203-1218. PMID: 20302552, DOI: 10.1185/03007991003712159.
REVASCULARIZATION IMPROVES MYOCARDIAL PERFUSION ABNORMALITIES TO A GREATER EXTENT THAN MEDICAL THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: INSIGHTS FROM THE NUCLEAR CARDIOLOGY DATABANK AND DUKE DATABANK FOR CARDIOVASCULAR DISEASEPhillips H, Shaw L, Fiuzat M, O'Connor C, Velazquez E, Borges-Neto S. REVASCULARIZATION IMPROVES MYOCARDIAL PERFUSION ABNORMALITIES TO A GREATER EXTENT THAN MEDICAL THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: INSIGHTS FROM THE NUCLEAR CARDIOLOGY DATABANK AND DUKE DATABANK FOR CARDIOVASCULAR DISEASE. Journal Of The American College Of Cardiology 2010, 55: a88.e836. DOI: 10.1016/s0735-1097(10)60837-6.
IMPACT OF MYOCARDIAL VIABILITY ON ECHOCARDIOGRAPHIC PARAMETERS OF CARDIAC STRUCTURE AND FUNCTION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY. A REPORT FROM THE STICH TRIALAsch F, Holly T, She L, Maurer G, Myc J, Zoghbi W, Teresinska A, Birkenfeld B, Velazquez E, Pellikka P, Adlbrecht C, Bonow R, Panza J. IMPACT OF MYOCARDIAL VIABILITY ON ECHOCARDIOGRAPHIC PARAMETERS OF CARDIAC STRUCTURE AND FUNCTION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY. A REPORT FROM THE STICH TRIAL. Journal Of The American College Of Cardiology 2010, 55: a127.e1191. DOI: 10.1016/s0735-1097(10)61192-8.
MITRAL REGURGITATION AFTER MYOCARDIAL INFARCTION PREDICTS INCREASED MEDICAL COSTS AND DECREASED QUALITY OF LIFE: ANALYSIS OF THE VALIANT (VALSARTAN IN ACUTE MYOCARDIAL INFARCTION) TRIALMudrick D, Reed S, Li Y, McMurray J, Kober L, Califf R, Lewis E, Solomon S, Velazquez E. MITRAL REGURGITATION AFTER MYOCARDIAL INFARCTION PREDICTS INCREASED MEDICAL COSTS AND DECREASED QUALITY OF LIFE: ANALYSIS OF THE VALIANT (VALSARTAN IN ACUTE MYOCARDIAL INFARCTION) TRIAL. Journal Of The American College Of Cardiology 2010, 55: a125.e1174. DOI: 10.1016/s0735-1097(10)61175-8.
RELATION BETWEEN MYOCARDIAL VIABILITY, CLINICAL PRESENTATION, AND RISK STRATIFICATION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY ON OPTIMAL MEDICAL THERAPY. A REPORT FROM THE STICH TRIALAsch F, Holly T, She L, Maurer G, Siepe M, Velazquez E, Ostrzycki A, Sredniawa B, Attisano T, Howlett J, Bonow R, Panza J. RELATION BETWEEN MYOCARDIAL VIABILITY, CLINICAL PRESENTATION, AND RISK STRATIFICATION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY ON OPTIMAL MEDICAL THERAPY. A REPORT FROM THE STICH TRIAL. Journal Of The American College Of Cardiology 2010, 55: a29.e273. DOI: 10.1016/s0735-1097(10)60274-4.
Does Myocardial Perfusion Imaging Provide Incremental Prognostic Information to Left Ventricular Ejection Fraction?Mudrick DW, Velazquez E, Borges-Neto S. Does Myocardial Perfusion Imaging Provide Incremental Prognostic Information to Left Ventricular Ejection Fraction? Current Cardiology Reports 2010, 12: 155-161. PMID: 20425171, DOI: 10.1007/s11886-010-0093-x.
Mechanical Dyssynchrony After Myocardial Infarction in Patients With Left Ventricular Dysfunction, Heart Failure, or BothShin SH, Hung CL, Uno H, Hassanein AH, Verma A, Bourgoun M, Køber L, Ghali JK, Velazquez EJ, Califf RM, Pfeffer MA, Solomon SD. Mechanical Dyssynchrony After Myocardial Infarction in Patients With Left Ventricular Dysfunction, Heart Failure, or Both. Circulation 2010, 121: 1096-1103. PMID: 20176989, DOI: 10.1161/circulationaha.109.863795.
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trialBakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA, investigators F. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. The Lancet 2010, 375: 1173-1181. PMID: 20170948, DOI: 10.1016/s0140-6736(09)62100-0.
Usefulness of the Duke Sudden Cardiac Death Risk Score for Predicting Sudden Cardiac Death in Patients With Angiographic (>75% Narrowing) Coronary Artery DiseaseAtwater BD, Thompson VP, Vest RN, Shaw LK, Mazzei WR, Al-Khatib SM, Hranitzky PM, Bahnson TD, Velazquez EJ, Califf RM, Lee KL, Roe MT. Usefulness of the Duke Sudden Cardiac Death Risk Score for Predicting Sudden Cardiac Death in Patients With Angiographic (>75% Narrowing) Coronary Artery Disease. The American Journal Of Cardiology 2009, 104: 1624-1630. PMID: 19962465, DOI: 10.1016/j.amjcard.2009.07.042.
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trialPiccini JP, Zhang M, Pieper K, Solomon SD, Al-Khatib SM, Van de Werf F, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ. Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial. European Heart Journal 2009, 31: 211-221. PMID: 19854729, DOI: 10.1093/eurheartj/ehp425.
Use of phase analysis of gated SPECT perfusion imaging to quantify dyssynchrony in patients with mild-to-moderate left ventricular dysfunctionAtchley AE, Trimble MA, Samad Z, Shaw LK, Pagnanelli R, Chen J, Garcia EV, Iskandrian AE, Velazquez EJ, Borges-Neto S. Use of phase analysis of gated SPECT perfusion imaging to quantify dyssynchrony in patients with mild-to-moderate left ventricular dysfunction. Journal Of Nuclear Cardiology 2009, 16: 888-894. PMID: 19690935, PMCID: PMC3048054, DOI: 10.1007/s12350-009-9136-3.
ACE-Hemmer-Fixkombinationen. Kalziumantagonist ist Diuretikum überlegenJamerson K, Weber M, Bakris G, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez E. ACE-Hemmer-Fixkombinationen. Kalziumantagonist ist Diuretikum überlegen. Focus Neurogeriatrie 2009, 3: 21-22. DOI: 10.1007/s12151-009-0161-y.
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT TrialMoukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, Velazquez EJ, Califf RM, Scheiman JM, Solomon SD. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. European Heart Journal 2009, 30: 2226-2232. PMID: 19556260, DOI: 10.1093/eurheartj/ehp256.
Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial)Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA. Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial). The American Journal Of Cardiology 2009, 104: 151-157. PMID: 19576338, DOI: 10.1016/j.amjcard.2009.03.020.
Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT)Berry C, Pieper KS, White HD, Solomon SD, Van de Werf F, Velazquez EJ, Maggioni AP, Califf RM, Pfeffer MA, McMurray JJ. Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). European Heart Journal 2009, 30: 1450-1456. PMID: 19346225, DOI: 10.1093/eurheartj/ehp102.
Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: Results from the Surgical Treatment for Ischemic Heart Failure trialMark DB, Knight JD, Velazquez EJ, Howlett JG, Spertus JA, Djokovic LT, Harding TM, Rankin GR, Drew LA, Szygula-Jurkiewicz B, Adlbrecht C, Anstrom KJ, Investigators F. Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: Results from the Surgical Treatment for Ischemic Heart Failure trial. American Heart Journal 2009, 157: 837-844.e3. PMID: 19376309, PMCID: PMC2694042, DOI: 10.1016/j.ahj.2009.03.008.
Coronary Bypass Surgery with or without Surgical Ventricular ReconstructionJones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL. Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction. New England Journal Of Medicine 2009, 360: 1705-1717. PMID: 19329820, PMCID: PMC3265934, DOI: 10.1056/nejmoa0900559.
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, Swedberg K, Pfeffer MA, McMurray JJ, Maggioni AP, Investigators F. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). European Journal Of Heart Failure 2009, 11: 292-298. PMID: 19176539, PMCID: PMC2645058, DOI: 10.1093/eurjhf/hfp001.
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk PatientsJamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. New England Journal Of Medicine 2008, 359: 2417-2428. PMID: 19052124, DOI: 10.1056/nejmoa0806182.
Impact of Left Ventricular Dysfunction on Hospital Mortality Among Patients Undergoing Elective Percutaneous Coronary InterventionWallace TW, Berger JS, Wang A, Velazquez EJ, Brown DL. Impact of Left Ventricular Dysfunction on Hospital Mortality Among Patients Undergoing Elective Percutaneous Coronary Intervention. The American Journal Of Cardiology 2008, 103: 355-360. PMID: 19166689, DOI: 10.1016/j.amjcard.2008.09.088.
Left Ventricular Mechanical Dyssynchrony as Assessed by Phase Analysis of ECG‐Gated SPECT Myocardial Perfusion ImagingChen J, Garcia EV, Lerakis S, Henneman MM, Bax JJ, Trimble MA, Borges‐Neto S, Velazquez EJ, Iskandrian AE. Left Ventricular Mechanical Dyssynchrony as Assessed by Phase Analysis of ECG‐Gated SPECT Myocardial Perfusion Imaging. Echocardiography 2008, 25: 1186-1194. PMID: 18986406, DOI: 10.1111/j.1540-8175.2008.00782.x.
Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ. Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). The American Journal Of Cardiology 2008, 102: 1427-1432. PMID: 19026290, DOI: 10.1016/j.amjcard.2008.07.033.
Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic StudyVerma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD. Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovascular Imaging 2008, 1: 582-591. PMID: 19356485, DOI: 10.1016/j.jcmg.2008.05.012.
Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunctionTrimble MA, Borges-Neto S, Honeycutt EF, Shaw LK, Pagnanelli R, Chen J, Iskandrian AE, Garcia EV, Velazquez EJ. Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction. Journal Of Nuclear Cardiology 2008, 15: 663-670. PMID: 18761269, PMCID: PMC3048059, DOI: 10.1016/j.nuclcard.2008.06.007.
Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF)Allen LA, Metra M, Milo-Cotter O, Filippatos G, Reisin LH, Bensimhon DR, Gronda EG, Colombo P, Felker GM, Dei Cas L, Kremastinos DT, O'connor CM, Cotter G, Davison BA, Dittrich HC, Velazquez EJ. Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF). Journal Of Cardiac Failure 2008, 14: 777-784. PMID: 18995183, PMCID: PMC3961584, DOI: 10.1016/j.cardfail.2008.07.188.
Differences in Electrical and Mechanical Dyssynchrony as Quantified by Phase Analysis of Gated SPECT Imaging in Patients with Mild-Moderate Left Ventricular DysfunctionTrimble M, Atchley A, Samad Z, Shaw L, Pagnanelli R, Chen J, Garcia E, Iskandrian A, Borges-Neto S, Velazquez E. Differences in Electrical and Mechanical Dyssynchrony as Quantified by Phase Analysis of Gated SPECT Imaging in Patients with Mild-Moderate Left Ventricular Dysfunction. Journal Of Cardiac Failure 2008, 14: s61. DOI: 10.1016/j.cardfail.2008.06.315.
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo StudyMeris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L, Bourgoun M, McMurray JJ, Velazquez EJ, Maggioni AP, Ghali J, Arnold JM, Zelenkofske S, Pfeffer MA, Solomon SD. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo Study. European Heart Journal 2008, 30: 56-65. PMID: 19001474, DOI: 10.1093/eurheartj/ehn499.
The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participantsPayne K, Caro J, Daley W, Khan Z, Ishak K, Stark K, Purkayastha D, Flack J, Velázquez E, Nesbitt S, Morisky D, Califf R, Committee F. The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participants. International Journal Of Clinical Practice 2008, 62: 1313-1321. PMID: 18647193, PMCID: PMC2658016, DOI: 10.1111/j.1742-1241.2008.01840.x.
Detection of Left Ventricular Thrombus by Delayed-Enhancement Cardiovascular Magnetic Resonance Prevalence and Markers in Patients With Systolic DysfunctionWeinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R, James OG, Patel MR, Heitner J, Parker M, Velazquez EJ, Steenbergen C, Judd RM, Kim RJ. Detection of Left Ventricular Thrombus by Delayed-Enhancement Cardiovascular Magnetic Resonance Prevalence and Markers in Patients With Systolic Dysfunction. Journal Of The American College Of Cardiology 2008, 52: 148-157. PMID: 18598895, DOI: 10.1016/j.jacc.2008.03.041.
Emerging Role of Myocardial Perfusion Imaging to Evaluate Patients for Cardiac Resynchronization Therapy††Conflicts of interest: Dr. Garcia has an ownership interest in and serves as a consultant and advisory board member for Syntermed, Inc., Atlanta, Georgia. Dr. Garcia also receives royalties from the sale of clinical software that was used as part of this research. Dr. Borges-Neto and Dr. Trimble have received research support from the Duke-Medtronic Strategic Alliance, which funded some of the studies reviewed in this report.Trimble MA, Borges-Neto S, Velazquez EJ, Chen J, Shaw LK, Pagnanelli R, Garcia EV, Iskandrian AE. Emerging Role of Myocardial Perfusion Imaging to Evaluate Patients for Cardiac Resynchronization Therapy††Conflicts of interest: Dr. Garcia has an ownership interest in and serves as a consultant and advisory board member for Syntermed, Inc., Atlanta, Georgia. Dr. Garcia also receives royalties from the sale of clinical software that was used as part of this research. Dr. Borges-Neto and Dr. Trimble have received research support from the Duke-Medtronic Strategic Alliance, which funded some of the studies reviewed in this report. The American Journal Of Cardiology 2008, 102: 211-217. PMID: 18602524, DOI: 10.1016/j.amjcard.2008.03.043.
PCV8 BLOOD PRESSURE SUCCESS ZONE LONGITUDINAL STUDY OF SUCCESS (BPSZ-BLISS). AN OBSERVATIONAL, MULTI-CENTER STUDY OF THE IMPACT OF THE BPSZ EDUCATIONAL PROGRAM ON BLOOD PRESSURE CONTROL, PERSISTENCE, COMPLIANCE, AND TREATMENT SATISFACTION. ENROLLMENT METRICS AND BASELINE COHORT CHARACTERISTICSPayne K, Ishak K, Caro J, Khan Z, Stark K, Flack J, Velazquez E, Nesbitt S, Califf R. PCV8 BLOOD PRESSURE SUCCESS ZONE LONGITUDINAL STUDY OF SUCCESS (BPSZ-BLISS). AN OBSERVATIONAL, MULTI-CENTER STUDY OF THE IMPACT OF THE BPSZ EDUCATIONAL PROGRAM ON BLOOD PRESSURE CONTROL, PERSISTENCE, COMPLIANCE, AND TREATMENT SATISFACTION. ENROLLMENT METRICS AND BASELINE COHORT CHARACTERISTICS. Value In Health 2008, 11: a187-a188. DOI: 10.1016/s1098-3015(10)70596-9.
PCV65 CHANGE IN HEALTH-RELATED QUALITY OF LIFE FOLLOWING NON-FATAL CARDIOVASCULAR EVENTS IN POST-MYOCARDIAL INFARCTION PATIENTSLewis E, Li Y, Pfeffer M, Solomon S, Weinfurt K, Velazquez E, Califf R, White H, Rouleau J, Schulman K, Reed S. PCV65 CHANGE IN HEALTH-RELATED QUALITY OF LIFE FOLLOWING NON-FATAL CARDIOVASCULAR EVENTS IN POST-MYOCARDIAL INFARCTION PATIENTS. Value In Health 2008, 11: a205-a206. DOI: 10.1016/s1098-3015(10)70652-5.
Response to The J-Point RevisitedThune J, Signorovitch J, Kober L, Velazquez E, McMurray J, Califf R, Maggioni A, Rouleau J, Howlett J, Zelenkofske S, Pfeffer M, Solomon S. Response to The J-Point Revisited. Hypertension 2008, 51: e35. DOI: 10.1161/hypertensionaha.108.109975.
Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or BothPrisant LM, Thomas KL, Lewis EF, Huang Z, Francis GS, Weaver WD, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ. Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both. Journal Of The American College Of Cardiology 2008, 51: 1865-1871. PMID: 18466801, DOI: 10.1016/j.jacc.2007.12.050.
Measuring left ventricular mechanical dyssynchrony from ECG-gated SPECT myocardial perfusion imaging.Chen J, Garcia EV, Henneman MM, Bax JJ, Boogers MJ, Trimble MA, Borges-Neto S, Velazquez EJ, Iskandrian AE. Measuring left ventricular mechanical dyssynchrony from ECG-gated SPECT myocardial perfusion imaging. Minerva Cardioangiologica 2008, 56: 227-35. PMID: 18319701.
Comparison of Renal Function and Cardiovascular Risk Following Acute Myocardial Infarction in Patients With and Without Diabetes MellitusAnavekar NS, Solomon SD, McMurray JJ, Maggioni A, Rouleau JL, Califf R, White H, Kober L, Velazquez E, Pfeffer MA. Comparison of Renal Function and Cardiovascular Risk Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus. The American Journal Of Cardiology 2008, 101: 925-929. PMID: 18359309, DOI: 10.1016/j.amjcard.2007.11.037.
Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchronyTrimble MA, Velazquez EJ, Adams GL, Honeycutt EF, Pagnanelli RA, Barnhart HX, Chen J, Iskandrian AE, Garcia EV, Borges-Neto S. Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nuclear Medicine Communications 2008, 29: 374-381. PMID: 18317303, PMCID: PMC3048057, DOI: 10.1097/mnm.0b013e3282f81380.
Usefulness of Right Ventricular Fractional Area Change to Predict Death, Heart Failure, and Stroke Following Myocardial Infarction (from the VALIANT ECHO Study)Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, Velazquez E, Califf R, Pfeffer MA, Solomon SD. Usefulness of Right Ventricular Fractional Area Change to Predict Death, Heart Failure, and Stroke Following Myocardial Infarction (from the VALIANT ECHO Study). The American Journal Of Cardiology 2008, 101: 607-612. PMID: 18308007, DOI: 10.1016/j.amjcard.2007.09.115.
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT studyLewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. European Heart Journal 2008, 29: 748-756. PMID: 18308687, DOI: 10.1093/eurheartj/ehn062.
High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trialAnderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD. High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal 2008, 155: 706-711. PMID: 18371480, DOI: 10.1016/j.ahj.2007.11.016.
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH StudyKjeldsen SE, Jamerson KA, Bakris GL, Pitt B, Dahlöf B, Velazquez EJ, Gupte J, Staikos L, Hua TA, Shi V, Hester A, Tuomilehto J, Östergren J, Ibsen H, Weber M, Investigators F. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study. Blood Pressure 2008, 17: 7-17. PMID: 18568687, DOI: 10.1080/08037050801972857.
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trialVelazquez EJ, Lee KL, O’Connor C, Oh JK, Bonow RO, Pohost GM, Feldman AM, Mark DB, Panza JA, Sopko G, Rouleau JL, Jones RH, Investigators S. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Journal Of Thoracic And Cardiovascular Surgery 2007, 134: 1540-1547.e4. PMID: 18023680, PMCID: PMC3638867, DOI: 10.1016/j.jtcvs.2007.05.069.
Effect of Antecedent Hypertension and Follow-Up Blood Pressure on Outcomes After High-Risk Myocardial InfarctionThune JJ, Signorovitch J, Kober L, Velazquez EJ, McMurray JJ, Califf RM, Maggioni AP, Rouleau JL, Howlett J, Zelenkofske S, Pfeffer MA, Solomon SD. Effect of Antecedent Hypertension and Follow-Up Blood Pressure on Outcomes After High-Risk Myocardial Infarction. Hypertension 2007, 51: 48-54. PMID: 18025296, DOI: 10.1161/hypertensionaha.107.093682.
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortalityThomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray JJ, Califf RM, Velazquez EJ. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. American Heart Journal 2007, 155: 87-93. PMID: 18082495, DOI: 10.1016/j.ahj.2007.09.010.
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis After Myocardial Infarction The VALIANT Echo StudyVerma A, Anavekar NS, Meris A, Thune JJ, Arnold JM, Ghali JK, Velazquez EJ, McMurray JJ, Pfeffer MA, Solomon SD. The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis After Myocardial Infarction The VALIANT Echo Study. Journal Of The American College Of Cardiology 2007, 50: 1238-1245. PMID: 17888840, DOI: 10.1016/j.jacc.2007.06.018.
Polymorphisms in Adenosine Receptor Genes are Associated with Infarct Size in Patients with Ischemic CardiomyopathyTang Z, Diamond MA, Chen J, Holly TA, Bonow RO, Dasgupta A, Hyslop T, Purzycki A, Wagner J, McNamara DM, Kukulski T, Wos S, Velazquez EJ, Ardlie K, Feldman AM. Polymorphisms in Adenosine Receptor Genes are Associated with Infarct Size in Patients with Ischemic Cardiomyopathy. Clinical Pharmacology & Therapeutics 2007, 82: 435-440. PMID: 17728764, DOI: 10.1038/sj.clpt.6100331.
Phase Analysis of Gated SPECT Perfusion Imaging Can Quantify Left Ventricular Mechanical DyssynchronyTrimble M, Velazquez E, Iskandrian A, Chen J, Garcia E, Honeycutt E, Borges-Neto S. Phase Analysis of Gated SPECT Perfusion Imaging Can Quantify Left Ventricular Mechanical Dyssynchrony. Journal Of Cardiac Failure 2007, 13: s131. DOI: 10.1016/j.cardfail.2007.06.506.
The Relationship of Systolic Synchrony and Cardiac Remodeling in Patients with a Narrow QRS ComplexHaithcock D, Jackson K, Hranitzky P, Gilliam F, Velazquez E. The Relationship of Systolic Synchrony and Cardiac Remodeling in Patients with a Narrow QRS Complex. Journal Of Cardiac Failure 2007, 13: s129-s130. DOI: 10.1016/j.cardfail.2007.06.500.
Dissociation of Patient and Physician Assessed Symptoms during Hospitalization for Acute Heart Failure: The Measure-HF RegistryAllen L, Weatherley B, Milo-Cotter O, Filippatos G, Reisen L, Bensimhon D, Gronda E, Colombo P, Felker G, Fontanella B, O'Connor C, Cotter G, Dittrich H, Metra M, Velazquez E, Group 1. Dissociation of Patient and Physician Assessed Symptoms during Hospitalization for Acute Heart Failure: The Measure-HF Registry. Journal Of Cardiac Failure 2007, 13: s181. DOI: 10.1016/j.cardfail.2007.06.687.
Relationship between Mechanical Dyssynchrony as Measured by Phase Analysis of Gated SPECT Perfusion Imaging and Cardiac Structure and FunctionTrimble M, Borges-Neto S, Chen J, Garcia E, Iskandrian A, Velazquez E. Relationship between Mechanical Dyssynchrony as Measured by Phase Analysis of Gated SPECT Perfusion Imaging and Cardiac Structure and Function. Journal Of Cardiac Failure 2007, 13: s128. DOI: 10.1016/j.cardfail.2007.06.495.
Left Ventricular Dyssynchrony in Patients with Prolonged QRS without Left Bundle Branch BlockJackson K, Haithcock D, Jollis J, Velazquez E. Left Ventricular Dyssynchrony in Patients with Prolonged QRS without Left Bundle Branch Block. Journal Of Cardiac Failure 2007, 13: s122. DOI: 10.1016/j.cardfail.2007.06.475.
Heart Failure Patients with Prolonged QRS Duration Have Higher Degrees of Mechanical Dyssynchrony as Measured by Phase Analysis of Gated SPECT Perfusion Imaging Than Patients with Normal QRS DurationTrimble M, Velazquez E, Honeycutt E, Chen J, Garcia E, Iskandrian A, Borges-Neto S. Heart Failure Patients with Prolonged QRS Duration Have Higher Degrees of Mechanical Dyssynchrony as Measured by Phase Analysis of Gated SPECT Perfusion Imaging Than Patients with Normal QRS Duration. Journal Of Cardiac Failure 2007, 13: s128. DOI: 10.1016/j.cardfail.2007.06.494.
Patients with Ischemic Cardiomyopathy Have Higher Degrees of Dyssynchrony Than Patients with Non-Ischemic Cardiomyopathy as Measured by Phase Analysis of Gated SPECT Perfusion ImagingTrimble M, Borges-Neto S, Honeycutt E, Chen J, Garcia E, Iskandrian A, Velazquez E. Patients with Ischemic Cardiomyopathy Have Higher Degrees of Dyssynchrony Than Patients with Non-Ischemic Cardiomyopathy as Measured by Phase Analysis of Gated SPECT Perfusion Imaging. Journal Of Cardiac Failure 2007, 13: s127-s128. DOI: 10.1016/j.cardfail.2007.06.493.
25.15 Relationship Between Mechanical Dyssynchrony as Measured by Phase Analysis of Gated SPECT Perfusion Imaging and Cardiac Structure and FunctionTrimble M, Borges-Neto S, Chen J, Garcia E, Iskandrian A, Velazquez E. 25.15 Relationship Between Mechanical Dyssynchrony as Measured by Phase Analysis of Gated SPECT Perfusion Imaging and Cardiac Structure and Function. Journal Of Nuclear Cardiology 2007, 14: s121-s122. DOI: 10.1016/j.nuclcard.2007.06.063.
25.16 Patients with Ischemic Cardiomyopathy Have Higher Degrees of Dyssnchrony than Patients with Non-Ischemic Cardiomyopathy as Measured by Phase Analysis of Gated SPECT ImagingTrimble M, Borges-Neto S, Honeycutt E, Chen J, Garcia E, Iskandrian A, Velazquez E. 25.16 Patients with Ischemic Cardiomyopathy Have Higher Degrees of Dyssnchrony than Patients with Non-Ischemic Cardiomyopathy as Measured by Phase Analysis of Gated SPECT Imaging. Journal Of Nuclear Cardiology 2007, 14: s122. DOI: 10.1016/j.nuclcard.2007.06.064.
25.17 Heart Failure Patients with Prolonged QRS Duration Have Higher Degrees of Mechanical Dyssynchrony as Measured by Phase Analysis of Gated SPECT Perfusion Imaging than Patients with Normal QRS DurationTrimble M, Velazquez E, Honeycutt E, Chen J, Garcia E, Iskandrian A, Borges-Neto S. 25.17 Heart Failure Patients with Prolonged QRS Duration Have Higher Degrees of Mechanical Dyssynchrony as Measured by Phase Analysis of Gated SPECT Perfusion Imaging than Patients with Normal QRS Duration. Journal Of Nuclear Cardiology 2007, 14: s122. DOI: 10.1016/j.nuclcard.2007.06.065.
Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%Thomas KL, Al-Khatib SM, Kelsey RC, Bush H, Brosius L, Velazquez EJ, Peterson ED, Gilliam FR. Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%. The American Journal Of Cardiology 2007, 100: 924-929. PMID: 17826371, DOI: 10.1016/j.amjcard.2007.04.024.
PCV69 BLOOD PRESSURE SUCCESS ZONE LONGITUDINAL STUDY OF SUCCESS (BPSZ-BLISS). AN OBSERVATIONAL, MULTICENTER STUDY OF THE IMPACT OF THE BPSZ EDUCATIONAL PROGRAM ON BLOOD PRESSURE CONTROL, PERSISTENCE, COMPLIANCE, AND TREATMENT SATISFACTION. DESIGN AND METHODSPayne K, Caro J, Daley W, Khan Z, Ishak K, Stark K, Flack J, Velázquez E, Nesbitt S, Califf R. PCV69 BLOOD PRESSURE SUCCESS ZONE LONGITUDINAL STUDY OF SUCCESS (BPSZ-BLISS). AN OBSERVATIONAL, MULTICENTER STUDY OF THE IMPACT OF THE BPSZ EDUCATIONAL PROGRAM ON BLOOD PRESSURE CONTROL, PERSISTENCE, COMPLIANCE, AND TREATMENT SATISFACTION. DESIGN AND METHODS. Value In Health 2007, 10: a57. DOI: 10.1016/s1098-3015(10)68711-6.
Mortality risk associated with ejection fraction differs across resting nuclear perfusion findingsBourque JM, Velazquez EJ, Tuttle RH, Shaw LK, O’Connor C, Borges-Neto S. Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings. Journal Of Nuclear Cardiology 2007, 14: 165-173. PMID: 17386378, DOI: 10.1016/j.nuclcard.2006.11.011.
8.51 Phase analysis of ECG-gated myocardial SPECT imaging can detect and quantify left ventricular mechanical dyssynchronyTrimble M, Iskandrian A, Chen J, Honeycutt E, Shaw L, Velazquez E, Garcia E, Borges-Neto S. 8.51 Phase analysis of ECG-gated myocardial SPECT imaging can detect and quantify left ventricular mechanical dyssynchrony. Journal Of Nuclear Cardiology 2007, 14: s70. DOI: 10.1016/j.nuclcard.2006.12.278.
8.55 Manual base parameter placement improves processing variability and reproducibility in the determination of left ventricular mechanical dyssynchrony using phase analysis of ECG-gated SPECT myocardialTrimble M, Velazquez E, Honeycutt E, Barnhart H, Chen J, Garcia E, Iskandrian A, Borges-Neto S. 8.55 Manual base parameter placement improves processing variability and reproducibility in the determination of left ventricular mechanical dyssynchrony using phase analysis of ECG-gated SPECT myocardial. Journal Of Nuclear Cardiology 2007, 14: s71. DOI: 10.1016/j.nuclcard.2006.12.282.
8.56 Variability in dyssynchrony evaluation using phase analysis of ECG-gated SPECT myocardial perfusion imaging in subjects with left ventricular dysfunctionTrimble M, Velazquez E, Honeycutt E, Barnhart H, Chen J, Garcia E, Iskandrian A, Borges-Neto S. 8.56 Variability in dyssynchrony evaluation using phase analysis of ECG-gated SPECT myocardial perfusion imaging in subjects with left ventricular dysfunction. Journal Of Nuclear Cardiology 2007, 14: s71. DOI: 10.1016/j.nuclcard.2006.12.283.
11.4 Electrical dyssynchrony does not correlate with mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imagingTrimble M, Borges-Neto S, Honeycutt E, Shaw L, Chen J, Garcia E, Iskandrian A, Velazquez E. 11.4 Electrical dyssynchrony does not correlate with mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imaging. Journal Of Nuclear Cardiology 2007, 14: s79. DOI: 10.1016/j.nuclcard.2006.12.313.
Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and functionAmigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, Warnica JW, Barvik S, Arnold JM, Velazquez EJ, Van de Werf F, Ghali J, McMurray JJ, Køber L, Pfeffer MA, Solomon SD. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. European Heart Journal 2007, 28: 326-333. PMID: 17251259, DOI: 10.1093/eurheartj/ehl464.
Chapter 16 Surgical Treatment of Heart FailureVelazquez E. Chapter 16 Surgical Treatment of Heart Failure. 2007, 373-384. DOI: 10.1016/b978-1-4160-3358-5.50022-x.
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular riskWeber MA, Bakris GL, Dahlöf B, Pitt B, Velazquez E, Gupte J, Lefkowitz M, Hester A, Shi V, Weir M, Kjeldsen S, Massie B, Nesbitt S, Ofili E, Jamerson K, Investigators F. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk. Blood Pressure 2007, 16: 13-19. PMID: 17453747, DOI: 10.1080/08037050701217643.
Exceptional early blood pressure control rates: The ACCOMPLISH trialJamerson K, Bakris GL, Dahlöf B, Pitt B, Velazquez E, Gupte J, Lefkowitz M, Hester A, Shi V, Kjeldsen SE, Cushman W, Papademetriou V, Weber M, Jamerson K, Bakris G, Dahlöf B, Pitt B, Velazquez E, Gupte J, Lefkowitz M, Hester A, Shi V, Kjeldsen S, Cushman W, Papademetriou V, Weber M. Exceptional early blood pressure control rates: The ACCOMPLISH trial. Blood Pressure 2007, 16: 80-86. PMID: 17612905, DOI: 10.1080/08037050701395571.
Comparison of Regional Versus Global Assessment of Left Ventricular Function in Patients with Left Ventricular Dysfunction, Heart Failure, or Both After Myocardial Infarction: The Valsartan in Acute Myocardial Infarction Echocardiographic StudyThune JJ, Køber L, Pfeffer MA, Skali H, Anavekar NS, Bourgoun M, Ghali JK, Arnold JM, Velazquez EJ, Solomon SD. Comparison of Regional Versus Global Assessment of Left Ventricular Function in Patients with Left Ventricular Dysfunction, Heart Failure, or Both After Myocardial Infarction: The Valsartan in Acute Myocardial Infarction Echocardiographic Study. Journal Of The American Society Of Echocardiography 2006, 19: 1462-1465. PMID: 17138030, DOI: 10.1016/j.echo.2006.05.028.
Racial Differences Among High-Risk Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes (Results from the SYNERGY Trial)††Disclosure: Drs. Mahaffey, Cohen, Newby, Ferguson, and Califf have received honoria for speaking from sanofi-aventis. Drs. Mahaffey, Ferguson, and Califf have acted as consultants for sanofi-aventis. Drs. Echols, Velazquez, Santos, and Gurfinkel have no financial relationships to disclose.Echols MR, Mahaffey KW, Banerjee A, Pieper KS, Stebbins A, Lansky A, Cohen MG, Velazquez E, Santos R, Newby LK, Gurfinkel EP, Biasucci L, Ferguson JJ, Califf RM. Racial Differences Among High-Risk Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes (Results from the SYNERGY Trial)††Disclosure: Drs. Mahaffey, Cohen, Newby, Ferguson, and Califf have received honoria for speaking from sanofi-aventis. Drs. Mahaffey, Ferguson, and Califf have acted as consultants for sanofi-aventis. Drs. Echols, Velazquez, Santos, and Gurfinkel have no financial relationships to disclose. The American Journal Of Cardiology 2006, 99: 315-321. PMID: 17261389, DOI: 10.1016/j.amjcard.2006.08.031.
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experienceStephenson K, Skali H, McMurray JJ, Velazquez EJ, Aylward PG, Kober L, Van de Werf F, White HD, Pieper KS, Califf RM, Solomon SD, Pfeffer MA. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience. Heart Rhythm 2006, 4: 308-313. PMID: 17341394, DOI: 10.1016/j.hrthm.2006.11.021.
Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction☆Køber L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, Maggioni AP, Mareev V, Opolski G, Van de Werf F, Zannad F, Ertl G, Solomon SD, Zelenkofske S, Rouleau J, Leimberger JD, Califf RM. Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction☆. European Journal Of Heart Failure 2006, 8: 591-598. PMID: 16507350, DOI: 10.1016/j.ejheart.2005.11.007.
Navigating the Crossroads of Coronary Artery Disease and Heart FailureGheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, Sadowski Z, Golba KS, Prior DL, Rouleau JL, Bonow RO. Navigating the Crossroads of Coronary Artery Disease and Heart Failure. Circulation 2006, 114: 1202-1213. PMID: 16966596, DOI: 10.1161/circulationaha.106.623199.
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialReed SD, McMurray JJ, Velazquez EJ, Schulman KA, Califf RM, Kober L, Maggioni AP, Van de Werf F, White HD, Diaz R, Mareev V, Murin J, Committees and Investigators F. Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal 2006, 152: 500-508. PMID: 16923421, DOI: 10.1016/j.ahj.2006.02.032.
Contemporary performance of surgical ventricular restoration procedures: Data from the Society of Thoracic Surgeons' National Cardiac DatabaseHernandez AF, Velazquez EJ, Dullum MK, O'Brien SM, Ferguson TB, Peterson ED. Contemporary performance of surgical ventricular restoration procedures: Data from the Society of Thoracic Surgeons' National Cardiac Database. American Heart Journal 2006, 152: 494-499. PMID: 16923420, DOI: 10.1016/j.ahj.2006.01.016.
Letter by Bourque et al Regarding Article, “Changing Incidence and Survival for Heart Failure in a Well-Defined Older Population, 1970–1974 and 1990–1994”Bourque JM, O’Connor C, Velazquez EJ. Letter by Bourque et al Regarding Article, “Changing Incidence and Survival for Heart Failure in a Well-Defined Older Population, 1970–1974 and 1990–1994”. Circulation 2006, 114: e255-e255. PMID: 16908779, DOI: 10.1161/circulationaha.106.632786.
Renal Function and Cardiac Structure and Function Following MI: The VALIANT Echo StudyVerma A, Anavekar N, Meris A, Thune J, Arnold J, Ghali J, Velazquez E, McMurray J, Pfeffer M, Solomon S. Renal Function and Cardiac Structure and Function Following MI: The VALIANT Echo Study. Journal Of Cardiac Failure 2006, 12: s26. DOI: 10.1016/j.cardfail.2006.06.093.
Serial Changes in Symptoms and Signs of Heart Failure in Patients Admitted for Acute Heart Failure – The Measure HF StudyMetra M, Fillipatos G, Reisin E, Bensimhon D, Gronda E, Cotter G, Velazquez E, Weatherly B, M. O, Dittrich H, Tansey M. Serial Changes in Symptoms and Signs of Heart Failure in Patients Admitted for Acute Heart Failure – The Measure HF Study. Journal Of Cardiac Failure 2006, 12: s75. DOI: 10.1016/j.cardfail.2006.06.255.
Predicting significant coronary artery disease in patients with left ventricular dysfunctionWhellan DJ, Tuttle RH, Velazquez EJ, Shaw LK, Jollis JG, Ellis W, O'Connor CM, Califf RM, Borges-Neto S. Predicting significant coronary artery disease in patients with left ventricular dysfunction. American Heart Journal 2006, 152: 340-347. PMID: 16875920, DOI: 10.1016/j.ahj.2005.12.001.
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothJanardhanan R, Kenchaiah S, Velazquez EJ, Park Y, McMurray JJ, Weaver WD, Finn PV, White HD, Marin-Neto JA, O'Connor C, Pfeffer MA, Califf RM, Solomon SD, Investigators F. Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. American Heart Journal 2006, 152: 183-189. PMID: 16824854, DOI: 10.1016/j.ahj.2005.11.013.
Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic ImportanceWeir RA, McMurray JJ, Velazquez EJ. Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic Importance. The American Journal Of Cardiology 2006, 97: 13-25. PMID: 16698331, DOI: 10.1016/j.amjcard.2006.03.005.
Association of QRS duration and outcomes after myocardial infarction: the VALIANT trialYerra L, Anavekar N, Skali H, Zelenkofske S, Velazquez E, McMurray J, Pfeffer M, Solomon SD. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm 2006, 3: 313-316. PMID: 16500304, DOI: 10.1016/j.hrthm.2005.11.024.
The Effect of Valsartan, Captopril, or Both on Atherosclerotic Events After Acute Myocardial Infarction An Analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M. The Effect of Valsartan, Captopril, or Both on Atherosclerotic Events After Acute Myocardial Infarction An Analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Journal Of The American College Of Cardiology 2006, 47: 726-733. PMID: 16487836, DOI: 10.1016/j.jacc.2005.09.055.
The cost of acute myocardial infarction in the new millennium: Evidence from a multinational registryKauf TL, Velazquez EJ, Crosslin DR, Weaver WD, Diaz R, Granger CB, McMurray JJ, Rouleau JL, Aylward PE, White HD, Califf RM, Schulman KA. The cost of acute myocardial infarction in the new millennium: Evidence from a multinational registry. American Heart Journal 2006, 151: 206-212. PMID: 16368320, DOI: 10.1016/j.ahj.2005.02.028.
Use of Valsartan in Post-Myocardial Infarction and Heart Failure PatientsLiu PP, Maggioni A, Velazquez EJ. Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients. Journal Of The Renin-Angiotensin-Aldosterone System 2006, 7: s19-s22. PMID: 16986231, DOI: 10.3317/jraas.2006.019.
Therapies to prevent heart failure post-myocardial infarctionThomas KL, Velazquez EJ. Therapies to prevent heart failure post-myocardial infarction. Current Heart Failure Reports 2005, 2: 174-182. PMID: 16332310, DOI: 10.1007/bf02696647.
Left Ventricular Assessment in Myocardial Infarction: The VALIANT RegistryHernandez AF, Velazquez EJ, Solomon SD, Kilaru R, Diaz R, O’Connor C, Ertl G, Maggioni AP, Rouleau JL, van Gilst W, Pfeffer MA, Califf RM. Left Ventricular Assessment in Myocardial Infarction: The VALIANT Registry. JAMA Internal Medicine 2005, 165: 2162-2169. PMID: 16217008, DOI: 10.1001/archinte.165.18.2162.
Outcomes by Race and Etiology of Patients With Left Ventricular Systolic DysfunctionThomas KL, East MA, Velazquez EJ, Tuttle RH, Shaw LK, O’Connor C, Peterson ED. Outcomes by Race and Etiology of Patients With Left Ventricular Systolic Dysfunction. The American Journal Of Cardiology 2005, 96: 956-963. PMID: 16188524, DOI: 10.1016/j.amjcard.2005.07.002.
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)Reed SD, Radeva JI, Weinfurt KP, McMurray JJ, Pfeffer MA, Velazquez EJ, Allsbrook JS, Masselink LE, Sellers MA, Califf RM, Schulman KA, Investigators F. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). American Heart Journal 2005, 150: 323-329. PMID: 16086938, DOI: 10.1016/j.ahj.2004.08.037.
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or BothSolomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA. Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. New England Journal Of Medicine 2005, 352: 2581-2588. PMID: 15972864, DOI: 10.1056/nejmoa043938.
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registrySzummer KE, Solomon SD, Velazquez EJ, Kilaru R, McMurray J, Rouleau JL, Mahaffey KW, Maggioni AP, Califf RM, Pfeffer MA, White HD. Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry. European Heart Journal 2005, 26: 2114-2119. PMID: 15972293, DOI: 10.1093/eurheartj/ehi352.
Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial InfarctionSolomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray JV, Pfeffer MA. Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction. Circulation 2005, 111: 3411-3419. PMID: 15967846, DOI: 10.1161/circulationaha.104.508093.
Is amiodarone associated with a higher risk of death in patients with advanced congestive heart failure?Al-Khatib S, Lokhnygina Y, Velazquez E, Califf R. Is amiodarone associated with a higher risk of death in patients with advanced congestive heart failure? Heart Rhythm 2005, 2: s151. DOI: 10.1016/j.hrthm.2005.02.473.
Discovering the Full Spectrum of Cardiovascular DiseaseBenjamin EJ, Jessup M, Flack JM, Krumholz HM, Liu K, Nadkarni VM, Rhoades DA, Rodriguez BL, Scott RP, Taylor MP, Velazquez EJ, Winkleby MA. Discovering the Full Spectrum of Cardiovascular Disease. Circulation 2005, 111: e124-33. PMID: 15769754, DOI: 10.1161/01.cir.0000157742.95689.65.
To STICH or not to STICH: We know the answer, but do we understand the question?Doenst T, Velazquez EJ, Beyersdorf F, Michler R, Menicanti L, Di Donato M, Gradinac S, Sun B, Rao V, Investigators S. To STICH or not to STICH: We know the answer, but do we understand the question? Journal Of Thoracic And Cardiovascular Surgery 2005, 129: 246-249. PMID: 15678031, DOI: 10.1016/j.jtcvs.2004.07.060.
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarctionAnavekar N, McMurray J, Velazquez E. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. ACC Current Journal Review 2004, 13: 9-10. DOI: 10.1016/j.accreview.2004.11.009.
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registryVelazquez EJ, Francis GS, Armstrong PW, Aylward PE, Diaz R, O'Connor CM, White HD, Henis M, Rittenhouse LM, Kilaru R, van Gilst W, Ertl G, Maggioni AP, Spac J, Weaver WD, Rouleau JL, McMurray JJ, Pfeffer MA, Califf RM. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. European Heart Journal 2004, 25: 1911-1919. PMID: 15522470, DOI: 10.1016/j.ehj.2004.08.006.
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial InfarctionAnavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction. New England Journal Of Medicine 2004, 351: 1285-1295. PMID: 15385655, DOI: 10.1056/nejmoa041365.
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial InfarctionAguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O’Connor C, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA. Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction. Circulation 2004, 110: 1572-1578. PMID: 15364810, DOI: 10.1161/01.cir.0000142047.28024.f2.
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trialJamerson K, Bakris G, Wun C, Dahlöf B, Lefkowitz M, Manfreda S, Pitt B, Velazquez E, Weber M. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial. American Journal Of Hypertension 2004, 17: 793-801. PMID: 15363822, DOI: 10.1016/j.amjhyper.2004.05.004.
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trialThe first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertensionJAMERSON K, BAKRIS G, WUN C, DAHLOF B, LEFKOWITZ M, MANFREDA S, PITT B, VELAZQUEZ E, WEBER M. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trialThe first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension. American Journal Of Hypertension 2004, 17: 793-801. DOI: 10.1016/s0895-7061(04)00840-4.
Influence of body mass index on mortality following high-risk myocardial infarction: the VALIANT experienceMirza A, Kober L, Velazquez E, White H, Aylward P, Kenchaiah S, Wright R, Solomon S. Influence of body mass index on mortality following high-risk myocardial infarction: the VALIANT experience. Journal Of Cardiac Failure 2004, 10: s104. DOI: 10.1016/j.cardfail.2004.06.320.
Is the combination of valsartan and captopril better than captopril alone in patients with heart failure and left ventricular systolic dysfunction after myocardial infarction? results of VALIANTVelazquez E, Califf R, White H, Zelenkofske S, Francis G, Lewis E, Pfeffer M, McMurray J. Is the combination of valsartan and captopril better than captopril alone in patients with heart failure and left ventricular systolic dysfunction after myocardial infarction? results of VALIANT. Journal Of Cardiac Failure 2004, 10: s76. DOI: 10.1016/j.cardfail.2004.06.213.
Does the Gender Gap Still Persist after Myocardial Infarction? Treatments and Outcomes in VALIANTVelazquez E, Moreira M, Rouleau J, Swedberg K, Kvasnicka J, Marin-Neto J, Manes C, Pfeffer M, McMurray J. Does the Gender Gap Still Persist after Myocardial Infarction? Treatments and Outcomes in VALIANT. Journal Of Cardiac Failure 2004, 10: s114. DOI: 10.1016/j.cardfail.2004.06.357.
Increased risk of both mortality and morbidity with prior as well as current atrial fibrillation after myocardial infarction: results of VALIANTKober L, Maggioni A, McMurray J, Velazquez E, Zelenkofske S, Zannad F, Van de Werf F, Swedberg K. Increased risk of both mortality and morbidity with prior as well as current atrial fibrillation after myocardial infarction: results of VALIANT. Journal Of Cardiac Failure 2004, 10: s100. DOI: 10.1016/j.cardfail.2004.06.305.
Patterns and outcomes of revascularization in patients with heart failure and/or left ventricular systolic dysfunction following acute myocardial infarction: observations from the VALIANT registryTang W, Velazquez E, Kilaru R, Maroo A, White H, Kober L, Rouleau J, McMurray J, Califf R, Francis G. Patterns and outcomes of revascularization in patients with heart failure and/or left ventricular systolic dysfunction following acute myocardial infarction: observations from the VALIANT registry. Journal Of Cardiac Failure 2004, 10: s104. DOI: 10.1016/j.cardfail.2004.06.321.
Heart failure post-myocardial infarction in the new millennium: how often does it occur, can we predict it, and what are the consequences?Lewis E, Velazquez E, McMurray J, Rouleau J, Solomon S, Maggioni A, Swedberg K, Kober L, White H, Dalby A, Francis G, Pieper K, Zannad F, Califf R, Pfeffer M. Heart failure post-myocardial infarction in the new millennium: how often does it occur, can we predict it, and what are the consequences? Journal Of Cardiac Failure 2004, 10: s101. DOI: 10.1016/j.cardfail.2004.06.309.
Hypertension and the risk of adverse cardiovascular outcomes following myocardial infarction: the VALIANT experienceSolomon S, Velazquez E, White H, Zelenkofske S, Dalby A, Leimberger J, Myers M, McMurray J. Hypertension and the risk of adverse cardiovascular outcomes following myocardial infarction: the VALIANT experience. Journal Of Cardiac Failure 2004, 10: s107. DOI: 10.1016/j.cardfail.2004.06.333.
Who is at risk of early Hypotension and renal dysfunction with an inhibitor of the Renin Angiotensin System after myocardial infarction? data from VALIANTMaggioni A, McMurray J, Rouleau J, Velazquez E, Califf R, White H, Opolski G, Pfeffer M. Who is at risk of early Hypotension and renal dysfunction with an inhibitor of the Renin Angiotensin System after myocardial infarction? data from VALIANT. Journal Of Cardiac Failure 2004, 10: s89-s90. DOI: 10.1016/j.cardfail.2004.06.262.
Can the Risk of Sudden Death after myocardial infarction be predicted by simple clinical criteria? experience from the VALIANT trialZelenkofske S, Califf R, Maggioni A, Van de Werf F, Velazquez E, Pfeffer M, Kober L, Solomon S. Can the Risk of Sudden Death after myocardial infarction be predicted by simple clinical criteria? experience from the VALIANT trial. Journal Of Cardiac Failure 2004, 10: s22. DOI: 10.1016/j.cardfail.2004.06.015.
Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)Reed SD, Friedman JY, Velazquez EJ, Gnanasakthy A, Califf RM, Schulman KA. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). American Heart Journal 2004, 148: 122-128. PMID: 15215801, DOI: 10.1016/j.ahj.2003.12.040.
CV1 HEALTH PREFERENCES AFTER CABG OR PCI FOLLOWING AN ACUTE MYOCARDIAL INFARCTIONRadeva J, Reed S, Weinfurt K, Anstrom K, Velazquez E, Schulman K. CV1 HEALTH PREFERENCES AFTER CABG OR PCI FOLLOWING AN ACUTE MYOCARDIAL INFARCTION. Value In Health 2004, 7: 219. DOI: 10.1016/s1098-3015(10)62063-3.
Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularizationLiao L, Cabell CH, Jollis JG, Velazquez EJ, Smith WT, Anstrom KJ, Pappas PA, Ryan T, Kisslo JA, Landolfo CK. Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization. The American Journal Of Cardiology 2004, 93: 1275-1279. PMID: 15135703, DOI: 10.1016/j.amjcard.2004.01.071.
1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocationBourque J, Velazquez E, Tuttle R, Shaw L, Lee K, O'Connor C, Borges-Neto S. 1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocation. Journal Of The American College Of Cardiology 2004, 43: a325. DOI: 10.1016/s0735-1097(04)91375-7.
Clinical characteristics and referral pattern of patients with left ventricular dysfunction and significant coronary artery disease undergoing radionuclide imagingBourque JM, Velazquez EJ, Borges-Neto S, Shaw LK, Whellan DJ, O'Connor C. Clinical characteristics and referral pattern of patients with left ventricular dysfunction and significant coronary artery disease undergoing radionuclide imaging. Journal Of Nuclear Cardiology 2004, 11: 118-125. PMID: 15052242, DOI: 10.1016/j.nuclcard.2003.09.005.
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothPfeffer M, McMurray J, Velazquez E, Investigators V. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. ACC Current Journal Review 2004, 13: 31. DOI: 10.1016/j.accreview.2003.12.039.
Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and deathCrawford TC, Smith WT, Velazquez EJ, Taylor SM, Jollis JG, Kisslo J. Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death. The American Journal Of Cardiology 2004, 93: 500-503. PMID: 14969636, DOI: 10.1016/j.amjcard.2003.10.056.
Acute Heart Failure Complicating Acute Coronary SyndromesVelazquez EJ, Pfeffer MA. Acute Heart Failure Complicating Acute Coronary Syndromes. Circulation 2004, 109: 440-442. PMID: 14757680, DOI: 10.1161/01.cir.0000113460.23813.50.
Importance of echocardiography in patients with severe nonischemic heart failure: the second prospective randomized amlodipine survival evaluation (PRAISE-2) echocardiographic studyCabell CH, Trichon BH, Velazquez EJ, Dumesnil JG, Anstrom KJ, Ryan T, Miller AB, Belkin RN, Cropp AB, O'Connor CM, Jollis JG. Importance of echocardiography in patients with severe nonischemic heart failure: the second prospective randomized amlodipine survival evaluation (PRAISE-2) echocardiographic study. American Heart Journal 2004, 147: 151-157. PMID: 14691434, DOI: 10.1016/j.ahj.2003.07.010.
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or BothPfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM. Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both. New England Journal Of Medicine 2003, 349: 1893-1906. PMID: 14610160, DOI: 10.1056/nejmoa032292.
Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysisBourque JM, Hasselblad V, Velazquez EJ, Borges-Neto S, O'Connor CM. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. American Heart Journal 2003, 146: 621-627. PMID: 14564314, DOI: 10.1016/s0002-8703(03)00428-9.
Making Two Wrongs Right – Case of Using a Patient’s Diabetes insipidus to Treat HisHeart Failure: Experience with Vasopress in Antagonists from Animal Studies and Clinical TrialsFischi M, Trichon B, Velazquez E, Blazing M, O’Conner C. Making Two Wrongs Right – Case of Using a Patient’s Diabetes insipidus to Treat HisHeart Failure: Experience with Vasopress in Antagonists from Animal Studies and Clinical Trials. Cardiology 2003, 3: 107-112. DOI: 10.1159/000071029.
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in contextVelazquez EJ, Pfeffer MA, McMurray JV, Maggioni AP, Rouleau J, Van de Werf F, Kober L, White HD, Swedberg K, Leimberger JD, Gallo P, Sellers MA, Edwards S, Henis M, Califf RM, Investigators F. VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context. European Journal Of Heart Failure 2003, 5: 537-544. PMID: 12921816, DOI: 10.1016/s1388-9842(03)00112-0.
P-431: Design of the accomplish (avoiding cardiovascular events through combination therapy in patients living with systolic hypertension) trialJamerson K, Bakris G, Douglas J, Pitt B, Velazquez E, Weber M. P-431: Design of the accomplish (avoiding cardiovascular events through combination therapy in patients living with systolic hypertension) trial. American Journal Of Hypertension 2003, 16: 193a-193a. DOI: 10.1016/s0895-7061(03)00603-4.
P-450: Prognostic information derived from blood pressure indices in patients with left ventricular systolic dysfunction early post-myocardial infarctionDelgado D, Rouleau J, Spac J, McMurray J, Maggioni A, Van de Werf F, Velazquez E, Califf R, Edwards S, White H, Kober L, Swedberg K, Leimberger J, Pfeffer M. P-450: Prognostic information derived from blood pressure indices in patients with left ventricular systolic dysfunction early post-myocardial infarction. American Journal Of Hypertension 2003, 16: 201a-201a. DOI: 10.1016/s0895-7061(03)00622-8.
Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?Bourque JM, Velazquez EJ, Borges-Neto S, Shaw LK, Whellan DJ, O’Connor C. Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease? American Heart Journal 2003, 145: 758-767. PMID: 12766731, DOI: 10.1016/s0002-8703(02)94818-0.
Myocardial viability predicts long-term survival for patients with severe left ventricular dysfunctionLiao L, Jollis J, Smith W, Velazquez E, Ryan T, Kisslo J, Landolfo C. Myocardial viability predicts long-term survival for patients with severe left ventricular dysfunction. Journal Of The American College Of Cardiology 2003, 41: 426. DOI: 10.1016/s0735-1097(03)81271-8.
In-hospital and discharge utilization of medications in patients with and without heart failure presenting with acute coronary syndromes: Insights from the PURSUIT studySrichai M, Harrington R, Hochman J, Houghtaling P, Velazquez E, Lincoff A, Simoons M, Jaber W. In-hospital and discharge utilization of medications in patients with and without heart failure presenting with acute coronary syndromes: Insights from the PURSUIT study. Journal Of The American College Of Cardiology 2003, 41: 382. DOI: 10.1016/s0735-1097(03)81089-6.
Assessment of long-term outcome in a population at high risk for coronary artery disease: Mortality risk associated with ejection fraction differs across resting nuclear perfusion findingsBourque J, Shaw L, Velazquez E, O'Connor C, Borges-Neto S. Assessment of long-term outcome in a population at high risk for coronary artery disease: Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings. Journal Of The American College Of Cardiology 2003, 41: 219. DOI: 10.1016/s0735-1097(03)81604-2.
Heart failure and/or left ventricular systolic dysfunction complicating myocardial infarction is common and accounts for the majority of in-hospital myocardial infarction mortality: Results of the VALIANT registryVelazquez E, Weaver W, Armstrong P, Kilaru R, Diaz R, White H, van Gilst W, Spac J, O'Connor C, Francis G, Drexler H, Mareev V, Maggioni A, Leimberger J, Myers M, Henis M, Califf R. Heart failure and/or left ventricular systolic dysfunction complicating myocardial infarction is common and accounts for the majority of in-hospital myocardial infarction mortality: Results of the VALIANT registry. Journal Of The American College Of Cardiology 2003, 41: 148. DOI: 10.1016/s0735-1097(03)80855-0.
Early use of beta-blockade in complicated myocardial infarction: The VALIANT trialCaliff R, Pfeffer M, McMurray J, Maggioni A, Rouleau J, Kober L, Van de Werf F, Leimberger J, Henis M, Edwards S, Sellers M, Drexler H, Kvasnicka J, Spac J, Myers M, Velazquez E. Early use of beta-blockade in complicated myocardial infarction: The VALIANT trial. Journal Of The American College Of Cardiology 2003, 41: 322. DOI: 10.1016/s0735-1097(03)82498-1.
Symposium reporter 2003. New therapeutic options in the management of hypertension to heart failure. Orlando, Florida, USA, March 6, 2003.Cohn JN, Velazquez EJ, Musher J. Symposium reporter 2003. New therapeutic options in the management of hypertension to heart failure. Orlando, Florida, USA, March 6, 2003. Journal Of The American Medical Directors Association 2003, 1-16, quiz 17. PMID: 12924409.
A Reappraisal of Myocardial Viability Testing in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Can Meta-Analysis Be Trusted?Bourque J, Velazquez E, Borges-Neto S, Hasselblad V, O’Connor C. A Reappraisal of Myocardial Viability Testing in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Can Meta-Analysis Be Trusted? Cardiology 2002, 2: 204-205. DOI: 10.1159/000065943.
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank)O’Connor C, Velazquez EJ, Gardner LH, Smith PK, Newman MF, Landolfo KP, Lee KL, Califf RM, Jones RH. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). The American Journal Of Cardiology 2002, 90: 101-107. PMID: 12106836, DOI: 10.1016/s0002-9149(02)02429-3.
Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarctsShah BR, Velazquez E, Shaw LK, Bart B, O'Connor C, Wagner GS. Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts. American Heart Journal 2002, 143: 111-117. PMID: 11773920, DOI: 10.1067/mhj.2002.119996.
Highlights from the XXII Congress of the European Society of Cardiology: August 26 to 30, 2000McGuire D, O’Shea J, Dyke C, Velazquez E, Hudson M. Highlights from the XXII Congress of the European Society of Cardiology: August 26 to 30, 2000. American Heart Journal 2001, 141: 164-172. PMID: 11136503, DOI: 10.1067/mhj.2001.111923.
Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and designPfeffer M, McMurray J, Leizorovicz A, Maggioni A, Rouleau J, Van de Werf F, Henis M, Neuhart E, Gallo P, Edwards S, Sellers M, Velazquez E, Califf R, Investigators* F. Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design. American Heart Journal 2000, 140: 727-750. PMID: 11054617, DOI: 10.1067/mhj.2000.108832.
All that glitters is not goldVelazquez E, Califf R. All that glitters is not gold. The Lancet 2000, 355: 1568-1569. PMID: 10821355, DOI: 10.1016/s0140-6736(00)02207-8.
Heart failure after myocardial infarction: A good heart is hard to findVelazquez E, O’Connor C. Heart failure after myocardial infarction: A good heart is hard to find. American Heart Journal 1999, 138: 1009-1011. PMID: 10577426, DOI: 10.1016/s0002-8703(99)70061-x.
Age-related deficits in retention of the classically conditioned nictitating membrane response in rabbits.Solomon PR, Barth CL, Wood MS, Velazquez E, Groccia-Ellison M, Yang BY. Age-related deficits in retention of the classically conditioned nictitating membrane response in rabbits. Behavioral Neuroscience 1995, 109: 18-23. PMID: 7734073.
c-kit receptor and ligand expression in postnatal development of the mouse cerebellum suggests a function for c-kit in inhibitory interneurons.Manova K, Bachvarova RF, Huang EJ, Sanchez S, Pronovost SM, Velazquez E, McGuire B, Besmer P. c-kit receptor and ligand expression in postnatal development of the mouse cerebellum suggests a function for c-kit in inhibitory interneurons. The Journal Of Neuroscience : The Official Journal Of The Society For Neuroscience 1992, 12: 4663-76. PMID: 1281492.
Attenuation of age-related conditioning deficits in humans by extension of the interstimulus interval.Solomon PR, Blanchard S, Levine E, Velazquez E, Groccia-Ellison M. Attenuation of age-related conditioning deficits in humans by extension of the interstimulus interval. Psychology And Aging 1991, 6: 36-42. PMID: 2029366.

Edit Profile

Eric Velazquez, MD

Contact Information

Mailing Address

Patient Care

Research & Publications

Biography

News

Research Summary

Coauthors

Selected Publications